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These	   studies	   have	   greatly	   increased	   our	   knowledge	   regarding	   the	   interaction	  between	  early	  life	  environment	  and	  neurodevelopment,	  especially	  in	  light	  of	  its	  impact	  on	  later	  development	  of	  mental	   illnesses.	  It	   is	  now	  widely	  recognised	  that	  factors	  such	  as	  maternal	  stress,	  prenatal	  infection,	  undernutrition,	  obstetric	  complications,	  childhood	  trauma	  and	  abuse	  all	  confer	  increased	  risk	  for	  the	  development	  of	  psychiatric	  disorders	  later	   in	   life	   (Brown,	   2011).	   For	   example,	   different	   studies	   demonstrated	   an	   increased	  risk	  of	   schizophrenia	   and	  autism	  among	   individuals	  born	  and	   raised	   in	   an	  urban	  area	  compared	  to	  a	  rural	  area	  (Lauritsen	  et	  al,	  2014;	  March	  et	  al,	  2008;	  Mortensen	  et	  al).	  Per	  
se,	   this	   coincidence	   does	   not	   represent	   an	   early	   life	   adversity,	   but	   it	   could	   determine	  fetal	   exposure	   to	   environmental	   stressors	   like	   pollution	   and	   infectious	   microbes.	  Prenatal	   exposure	   to	   infectious	  agents	  has,	   in	   fact,	  been	   identified	  as	  a	  noticeable	   risk	  factor	   for	   many	   mental	   disorders,	   which	   will	   be	   discussed	   in	   depth	   in	   the	   following	  sections	  of	  this	  thesis.	  	  Maternal	   nutrition	   has	   also	   been	   identified	   as	   a	   possible	   factor	   involved	   in	   the	  fetal	   programming	   of	   adult	   disease,	   as	   demonstrated	   by	   epidemiological	   studies	   from	  the	  Dutch	  Hunger	  Winter	  and	  the	  Chinese	  Famines	  (Brown	  and	  Susser,	  2008;	  Brown	  et	  
al,	   2000b;	   Xu	   et	   al,	   2009)	   that	   found	   a	   statistically	   significant	   increase	   in	   the	   risk	   of	  developing	   schizophrenia	   and	   major	   affective	   disorder	   as	   a	   consequence	   of	   prenatal	  malnutrition.	  Moreover,	   prenatal	   deficiency	   of	   specific	  micronutrients,	   as	   for	   example	  folate,	  iron	  and	  vitamin	  D,	  has	  also	  been	  associated	  with	  adult	  mental	  disease	  (Brown	  et	  















cytokines	   produced	   by	   the	   mother	   could	   disturb	   normal	   fetal	   brain	   development,	  increasing	   the	   risk	   of	   developmental	   psychiatric	   diseases	   such	   as	   schizophrenia	  (Gilmore	   and	   Jarskog,	   1997).	   This	   theory	   has	   been	   extensively	   supported	   by	   many	  epidemiological	  and	  preclinical	  studies,	  and	  has	  further	  been	  broadened	  to	  include	  the	  concept	  that	  infection-­‐induced	  developmental	  neuroinflammation	  could	  also	  be	  relevant	  beyond	  early	  life	  (Meyer,	  2013a).	  In	  particular,	  exposure	  to	  prenatal	  immune	  challenge	  could	  prime	  early	  alterations	  in	  peripheral	  and	  central	  inflammatory	  response	  systems	  that	  could	  in	  turn	  disrupt	  processes	  that	  are	  pivotal	  for	  normal	  brain	  development,	  such	  as	  myelination,	  synaptic	  pruning	  and	  neuronal	  remodelling,	  which	  occur	  mainly	  during	  postnatal	   brain	   maturation	   (Meyer,	   2013a).	   This	   topic	   will	   be	   discussed	   in	   detail	   in	  subsequent	  sections	  of	  my	  thesis.	  Activation	  of	  the	  HPA	  axis	  is	  a	  common	  end	  point	  of	  many	  environmental	  insults,	  as	   for	   example	   stress,	   malnutrition,	   hypoxia	   and	   infection.	   Moreover,	   psychosocial	  factors	  such	  as	  migration,	  low	  socioeconomic	  status	  and	  living	  in	  a	  hostile	  or	  dangerous	  area	   can	   similarly	   induce	   HPA	   hyperactivity.	   Ultimately,	   activation	   of	   the	   HPA	   axis	  results	   in	   the	   release	   of	   glucocorticoids,	   which	   are	   detrimental	   for	   normal	   brain	  development	   (Painter	   et	   al,	   2012).	   In	   particular,	   glucocorticoids	   exert	   their	   biological	  functions	   through	   two	   different	   types	   of	   receptors	   (the	   glucocorticoid	   and	   the	  mineralocorticoid	   receptor)	   that	   are	   expressed	   at	   relatively	   high	   levels	   during	   fetal	  development	   (Welberg	   and	   Seckl,	   2001).	   Thus,	   altered	   levels	   of	   glucocorticoids	   in	   the	  maternal	  host	  and	  fetal	  environment	  could	  readily	  affect	  programming	  of	  physiological,	  endocrinological	  and	  behavioural	  functions	  (Seckl,	  2004;	  Welberg	  et	  al,	  2001)	  (Owen	  et	  
al,	  2005).	  
	  





utero	   exposure	   to	   infectious	   agents	   was	   related	   to	   an	   increased	   incidence	   of	   various	  psychiatric	   conditions.	   In	   the	   following	   sections	   I	   will	   summarize	   the	   most	   relevant	  epidemiological,	  clinical	  and	  preclinical	  studies	  that	  provide	  support	  for	  this	  association.	  	  
	  
	  
Figure1.	  The	  cytokine	  model	  of	  schizophrenia.	  From	  Ragy	  et	  al.,	  2014.	  	  
	  





between	  influenza	  exposure	  and	  psychotic	  disease	  in	  patients	  who	  were	  admitted	  to	  the	  Boston	   Psychiatric	   Hospital	   after	   the	   influenza	   pandemic	   of	   1918	   (Menninger,	   1919).	  This	   hypothesis	   was	   fuelled	   in	   the	   1970s	   by	   Torrey	   et	   al.,	   who	   suggested	   that	   latent	  viruses	   could	   be	   involved	   in	   the	   development	   of	   schizophrenia	   (Torrey	   and	   Peterson,	  1973).	   Since	   then,	   this	   field	   of	   investigation	   has	   greatly	   expanded,	   and	   many	   other	  infectious	   agents	   are	   now	   considered	   to	   play	   a	   role	   in	   the	   development	   of	   different	  psychiatric	   conditions.	   In	   the	   1980s,	   Mednick	   et	   al.	   reported	   an	   increased	   risk	   of	  schizophrenia	   after	   prenatal	   exposure	   to	   the	   influenza	   pandemic	   in	   greater	   Helsinki	  (Mednick	   et	   al,	   1988)	   in	   the	   second	   trimester	   of	   pregnancy,	   and	   his	   findings	   were	  replicated	  by	  subsequent	  studies	  evaluating	  other	  influenza	  epidemics	  (Barr	  et	  al,	  1990;	  Kendell	  and	  Kemp,	  1989;	  Kunugi	  et	  al,	  1995;	  McGrath	  and	  Castle,	  1995;	  O'Callaghan	  et	  
al,	   1991).	  The	   association	  between	  prenatal	   infection	   and	   schizophrenia	  was	   revealed	  also	  by	  studies	  on	  other	  infections,	  including	  respiratory	  viral	  infections	  (O'Callaghan	  et	  
al,	  1994;	  Watson	  et	  al,	  1984),	  measles	  (Torrey	  et	  al,	  1988),	  varicella-­‐zoster	  (O'Callaghan	  
et	   al,	   1994)	   (Torrey	   et	   al,	   1988),	   and	   polio	   (Suvisaari	   et	   al,	   1999).	   There	   have	   been,	  however,	   numerous	   studies	   that	   failed	   to	   replicate	   these	   associations	   (Erlenmeyer-­‐Kimling	   et	   al,	   1994;	   Selten	   et	   al,	   2010;	   Susser	   et	   al,	   1994;	  Westergaard	   et	   al,	   1999),	  probably	   because	   of	   the	   methodological	   limitations	   of	   using	   ecological	   data,	   such	   as	  misclassification	  of	  exposure	  and	  assumption	  of	   full	   term	  pregnancy.	  For	  this	  purpose,	  investigators	   started	   to	   conduct	   birth	   cohort	   studies,	   which	   sought	   to	   document	  infections	  by	  measuring	  biomarkers	   in	   individual	  pregnancies	  and	   to	   relate	  confirmed	  exposure	   to	   the	  development	  of	  schizophrenia	  among	   individuals	   followed	  up	   into	   the	  age	   risk	   of	   the	   disorder.	   These	   studies	   provided	   serologic	   evidence	   for	   various	  pathogens	   implicated	   in	   the	   prenatal	   infectious	   aetiology	   of	   schizophrenia,	   such	   as	  rubella	   (Brown	   et	   al,	   2001;	   Brown	   et	   al,	   2000a),	   influenza	   (Brown	   et	   al,	   2004),	  
Toxoplasma	  Gondii	  (Brown	  et	  al,	  2005;	  Mortensen	  et	  al,	  2007),	  Herpes	  simplex	  virus	  type	  





proinflammatory	  citokines	  in	  the	  maternal	  compartment	  and	  amniotic	  fluid	  (Abdallah	  et	  
al,	  2012;	  Goines	  et	  al,	  2011).	  Recently,	  Parboosing	  and	  colleagues	  demonstrated	  a	  4-­‐fold	  increase	  in	  bipolar	  disorder	  risk	  after	  exposure	  to	  maternal	  influenza	  in	  a	  serologically	  documented	  prospective	  epidemiological	  setting	  (Parboosing	  et	  al,	  2013).	  
	  















reduced	   social	   interaction	   and	   exploratory	   behaviour,	   increased	   sensitivity	   to	   NMDA	  receptor	   antagonists,	   reduced	   cortico-­‐	   and	   neurogenesis	   in	   the	   hippocampus	   and	  prefrontal	   cortex,	   reduced	   purkinje	   cells	   in	   the	   cerebellum,	   increased	   gliolisis	   and	  reduced	   expression	   of	   GABAergic	   markers	   such	   as	   reelin	   in	   the	   frontal	   cortex	   and	  hippocampus	   (Fatemi	   et	   al,	   2004;	  Fatemi	   et	   al,	   2000;	  Fatemi	   et	   al,	   2002;	  Fatemi	   et	   al,	  2008;	   Fatemi	   et	   al,	   1998a;	   Fatemi	   et	   al,	   1998b;	   Shi	   et	   al,	   2003).	   In	   addition	   to	   these	  behavioural	  and	  morphological	  alterations,	  prenatal	  exposure	  to	  influenza	  virus	  leads	  to	  persistent	  changes	  in	  gene	  expression	  levels	  in	  the	  offspring’s	  CNS	  (Fatemi	  et	  al,	  2005;	  Fatemi	   et	   al,	   2008),	   and	   long-­‐term	   deficiency	   in	   serotonin	   production	   has	   also	   been	  noted	  in	  offspring	  born	  to	  influenza-­‐infected	  mice	  (Winter	  et	  al,	  2008).	  Interestingly,	  this	  model	  has	  also	  been	  used	  to	  investigate	  the	  impact	  of	  the	  precise	  prenatal	  timing	  of	  the	  insult,	  by	  exposing	  pregnant	  dams	  to	  the	  immunological	  insult	  at	  different	  times	  during	  pregnancy	   (Kneeland	   and	   Fatemi,	   2013).	   In	   light	   of	   these	   findings,	   it	   is	   clear	   that	   the	  prenatal	   influenza	   model	   is	   highly	   suitable	   for	   the	   investigation	   of	   the	   relationship	  between	   exposure	   to	   viral	   infection	   during	   pregnancy	   and	   increased	   risk	   of	  psychopathology	   later	   in	   life.	  Moreover,	   the	  model	   is	   characterized	   by	   a	   high	   level	   of	  construct	   and	   face	   validity,	   and	   accounts	   for	   one	   of	   the	   well-­‐known	   environmental	  factors	   implicated	   in	   the	   aetiology	   of	   schizophrenia	   and	   autism.	   However,	   when	  compared	  to	  other	  models	  of	  prenatal	  immune	  activation	  that	  do	  not	  use	  live	  pathogens,	  this	   model	   allows	   a	   lower	   degree	   of	   control	   over	   the	   time	   course	   and	   dose	   of	  immunogen	  exposure,	  while	  on	  the	  other	  hand	  it	  more	  closely	  mimics	  the	  entire	  course	  of	  a	  propagating	  viral	   infection	  compared	   to	  other	  models	   that	  use	   immune-­‐activating	  agents	  instead	  of	  live	  pathogens.	  The	  model	  has	  been	  recently	  expanded	  to	  experimental	  investigations	   in	   rhesus	  monkeys,	   demonstrating	   the	   emergence	   of	   reduced	   grey	   and	  white	  matter	  in	  different	  cortical	  and	  parieto-­‐cortical	  brain	  regions	  (Short	  et	  al,	  2010).	  This	  finding	  is	  particularly	  relevant	  in	  light	  of	  the	  fact	  that	  corticogenesis	  is	  much	  more	  complex	   in	  monkeys	   than	   in	   rodents,	   and	   therefore	  primate	  models	  help	   to	  verify	   the	  relevance	   of	   the	   findings	   in	   rodent	   models	   to	   human	   conditions.	   Lastly,	   significant	  alterations	   in	   postnatal	   brain	   structure	   and	   function	   have	   been	   observed	   in	   rodents	  born	  to	  mothers	  exposed	  to	  other	  viral	  and	  bacterial	  infections,	  such	  as	  Campylobacter	  










contains	  different	  pyrogenic	  and	  cytokinogenic	  activity,	  since	  it	  is	  purified	  from	  bacteria	  (Ray	  et	  al,	  1991),	  and	  it	  also	  exhibits	  tolerance,	  which	  could	  be	  important	  in	  paradigms	  characterized	  by	  daily	  administration	  of	  LPS	  (Chen	  et	  al,	  2005).	  	  Numerous	   studies	   in	   both	   rats	   and	   mice	   have	   proven	   that	   LPS	   precipitates	   a	  number	   of	   behavioural	   and	   neurochemical	   abnormalities	   that	   are	   relevant	   to	  schizophrenia	  and	  other	  psychotic	  disorders.	  Indeed,	  prenatal	  exposure	  to	  LPS	  has	  been	  shown	   to	   induce	   impaired	   sensorimotor	   gating	   in	   the	   offspring	   (Borrell	   et	   al,	   2002;	  Fortier	   et	   al,	   2004a;	   Fortier	   et	   al,	   2007;	   Romero	   et	   al,	   2007;	   Romero	   et	   al,	   2010),	  increased	  sensitivity	  to	  psychotomimetic	  drugs	  (Fortier	  et	  al,	  2004a;	  Fortier	  et	  al,	  2007),	  impaired	  working	  memory	  and	  spatial	  learning	  (Coyle	  et	  al,	  2009;	  Hao	  et	  al,	  2010;	  Lante	  
et	  al,	  2008)	  and	   impaired	  social	   interaction	  (Golan	   et	  al,	  2005;	  Kirsten	   et	  al,	  2012).	  Of	  note,	   the	   precise	   functional	   abnormalities	   that	   emerge	   after	   prenatal	   exposure	   to	   LPS	  are	  critically	  influenced	  by	  the	  timing	  of	  the	  prenatal	  manipulation	  (Meyer	  and	  Feldon,	  2009a;	  Meyer	  et	  al,	  2007).	  Moreover,	  prenatal	  immune	  challenge	  with	  LPS	  induces	  also	  many	  morphological	   and	   neurochemical	   abnormalities,	   such	   as	   reduced	   hippocampal	  neurogenesis	   (Cui	   et	   al,	   2009;	   Lin	   and	   Wang,	   2014),	   decreased	   dendritic	   length,	  arborisation	   and	   spine	   density	   in	   the	   hippocampus	   and	   medial	   prefrontal	   cortex	  (Baharnoori	  et	  al,	  2009)	  and	  white	  matter	  abnormalities	  (Kumral	  et	  al,	  2007;	  Paintlia	  et	  










Aguilar-­‐Valles	   et	   al,	   2012;	   Aguilar-­‐Valles	   et	   al,	   2011).	   These	   findings	   provide	   further	  support	   to	   the	   hypothesis	   that	   induction	   of	   the	   maternal	   immune	   response	   during	  pregnancy	  could	  be	  a	  key	  factor	  in	  mediating	  the	  association	  between	  prenatal	  infection	  and	  increased	  risk	  of	  developing	  psychiatric	  diseases	  later	  in	  life.	  Moreover,	  they	  could	  encourage	   human	   epidemiological	   studies	   focusing	   on	   potential	   associations	   between	  maternal	   physical	   trauma	   and	   increased	   risk	   of	   neurodevelopmental	   disorders	   in	   the	  offspring,	  seeing	  that	  turpentine	  injection	  causes	  local	  tissue	  damage.	  	  





using	   viral-­‐like	   immune	   activating	   agents,	   such	   as	   poly(I:C),	   compared	   to	   live	   viral	  agents:	   first	  of	   all,	   they	  can	  be	  easily	  handled	  without	   stringent	  biosafety	  precautions;	  secondly,	   the	   intensity	   of	   the	   cytokine	   associated	   immune	   response	   can	   be	   readily	  controlled	   by	   appropriate	   dose-­‐response	   studies	   (Meyer	   et	   al,	   2005;	   Shi	   et	   al,	   2003);	  thirdly,	  the	  acute	  poly(I:C)-­‐induced	  immunological	  challenges	  are	  time	  limited,	  ranging	  from	  24	  to	  48h	  depending	  on	  the	  dose	  used	  (Cunningham	  et	  al,	  2007;	  Meyer	  et	  al,	  2005);	  finally,	   prenatal	   poly(I:C)	   exposure	   is	   capable	   of	   altering	   cytokine	   levels	   in	   three	  compartments	  of	   the	  maternal-­‐foetal	   interface,	  namely	   the	  placenta,	   the	  amniotic	   fluid	  and	  the	  foetus	  (Graciarena	  et	  al,	  2010;	  Meyer	  et	  al,	  2006a;	  Meyer	  et	  al,	  2008d;	  Urakubo	  





(Brown	  and	  Derkits,	  2010),	  while	   recent	  studies	  suggest	  a	  critical	   impact	  of	   infections	  occurring	   in	  early	  pregnancy	   ((Babulas	   et	   al,	   2006;	  Brown	   et	   al,	   2004;	   Sorensen	   et	   al,	  2009).	   On	   these	   basis,	   it	   is	   clear	   that	   animal	   models,	   such	   as	   the	   poly(I:C)	   model,	  represent	  valuable	  tools	  to	  examine	  the	  ‘critical	  window’	  hypothesis	  of	  this	  association,	  and	   this	   can	   be	   achieved	   by	   comparing	   the	   effects	   of	   prenatal	   immune	   challenge	   at	  distinct	   gestational	   ages.	   Meyer	   et	   al.	   designed	   a	   series	   of	   experiments	   that	   directly	  explored	  this	  issue,	  and	  confirmed	  that	  the	  precise	  timing	  of	  the	  prenatal	  immunological	  activation	   is	   indeed	   a	   critical	   determinant	   of	   the	   specificity	   of	   both	   the	   brain	   and	  behavioural	  abnormalities	  that	  develop	  in	  the	  offspring	  (Meyer	  et	  al,	  2006a;	  Meyer	  et	  al,	  2006b;	  Meyer	  et	  al,	  2008d;	  Meyer	  et	  al,	  2006c).	  In	  particular,	  the	  gestational	  stage	  of	  the	  manipulation	   determines	   specific	   psychopathological	   and	   neuropathological	   symptom	  clusters	  in	  the	  offspring.	  More	  specifically,	  prenatal	  immune	  activation	  on	  gestation	  day	  9	   (GD9)	   (poly(I:C)	   5mg/kg)	   leads	   to	   a	   pathological	   profile	   characterized	   by	   reduced	  exploratory	   behaviour,	   alterations	   in	   selective	   associative	   learning	   in	   the	   form	   of	   LI	  disruption,	   impairments	   in	   sensorimotor	   gating,	   enhanced	   sensitivity	   to	  psychotomimetic	  drugs	  and	  deficiency	  in	  spatial	  working	  memory	  when	  the	  demand	  on	  temporal	  retention	  is	  high	  (Meyer	  et	  al,	  2006b;	  Meyer	  et	  al,	  2008d).	  On	  the	  other	  hand,	  an	   identical	  manipulation	  on	  GD17	  leads	  to	  perseverative	  behaviour,	  deficits	   in	  spatial	  working	   memory	   and	   recognition	   memory	   even	   when	   the	   demand	   on	   temporal	  retention	  is	  low,	  potentiated	  response	  to	  amphetamine	  and	  the	  non-­‐competitive	  NMDA	  antagonist	   dizolcipine,	   abolition	   of	   the	   US-­‐pre-­‐exposure	   effect	   and	   social	   interaction	  deficits	  (Bitanihirwe	  et	  al,	  2010a;	  Bitanihirwe	  et	  al,	  2010b;	  Meyer	  et	  al,	  2006a;	  Meyer	  et	  











Alterations	   Immunogen	   Time	   Species	   Reference	  
TNF-­‐α	  (24h	  fetal	  brain)	  
TNF-­‐α	  (Liver,	  Spleen)	  
	  TNF-­‐α	  (placenta)	   Poly(I:C)	  10-­‐20mg/kg	  ip	   GD16	   Rat	   Gilmore	  et	  al.	  (2005)	  
IL-­‐1β,	  IL-­‐10	  	  IL-­‐6	  (3h	  fetal	  brain)	  
	  IL-­‐6,	  IL-­‐1β,	  TNF-­‐α	  (6h	  fetal	  brain)	   Poly(I:C)	  2-­‐5mg/kg	  iv	   GD9	   Mouse	   Meyer	  et	  al.	  	  (2006,	  2008)	  
	  IL-­‐6,	  IL-­‐1β,	  TNF-­‐α,	  IFN-­‐γ	  	  (2-­‐4h	  placenta)	   Poly(I:C)	  4.5mg/kg	  ip	   GD16.5	   Mouse	   Koga	  et	  al.	  (2009)	  
	  IL-­‐10,	  IL-­‐1β	  (3h	  fetal	  brain)	  
	  IL-­‐6	  (6h	  fetal	  brain)	   Poly(I:C)	  5mg/kg	  iv	   GD17	   Mouse	   Meyer	  et	  al.	  	  (2006)	  
TNF-­‐α	  (2-­‐24h	  fetal	  brain)	   Poly(I:C)	  5mg/kg	  sc	   GD20	   Spiny	  Mouse	   Ratnayake	  et	  al.	  (2014)	  
	  IL-­‐7,	  IL-­‐1β,	  IL-­‐13,	  MCP-­‐1,	  MIP1-­‐	  α,	  MIG,	  VEGF	  (6h	  fetal	  brain)	  
	  IL-­‐1β	  (24h	  fetal	  brain)	   Poly(I:C)	  20mg/kg	  ip	   GD16	   Mouse	   Arrode-­‐Bruses	  et	  al.	  (2012)	  
	  
Table	  1.	   Significant	   acute	   changes	   in	   immune	  mediators	   in	   the	   fetal	   compartment	   after	  





interesting	   and	   warrant	   further	   examination,	   especially	   with	   respect	   to	   the	   human	  population	  where	  individual	  responses	  to	  infection	  might	  account	  for	  the	  wide	  variety	  of	  effects	  that	  have	  been	  observed	  after	  prenatal	  exposure	  to	  infection.	  Of	   note,	   environmental	   insults	   targeting	   the	  pregnant	  maternal	   host	  may	   affect	  brain	   and	   behavioural	   development	   differently	   in	   male	   and	   female	   offspring,	   and	  numerous	   studies	   investigating	   the	   effects	   of	   stress	   on	   brain	   development	   have	  highlighted	  critical	  sex	  differences	  in	  the	  development	  of	  long-­‐term	  structural	  and	  brain	  abnormalities	  (Mueller	  and	  Bale,	  2008;	  Weinstock,	  2007).	  The	  poly(I:C)	  model	  offers	  the	  opportunity	  to	  investigate	  this	  issue	  also	  after	  prenatal	  exposure	  to	  infection,	  even	  if	  this	  aspect	   has	   so	   far	   received	   less	   attention	   because	  many	   existing	   studies	   focus	   only	   on	  male	   offspring	   in	   order	   to	   avoid	   the	   possible	   confounds	   and	   interpretative	   problems	  arising	  from	  hormonal	  fluctuations	  in	  female	  subjects	  (Fortier	  et	  al,	  2007;	  Romero	  et	  al,	  2007;	   Wolff	   and	   Bilkey,	   2008).	   Of	   the	   studies	   that	   have	   considered	   this	   issue,	   the	  majority	   did	   not	   reveal	   marked	   sex	   differences	   in	   brain	   and	   behavioural	   alterations	  (Meyer	  et	  al,	  2005;	  Meyer	  et	  al,	  2006b;	  Ozawa	  et	  al,	  2006;	  Shi	  et	  al,	  2003;	  Zuckerman	  et	  
al,	   2003a;	  Zuckerman	  and	  Weiner,	  2003b),	   as	  opposed	   to	  a	   few	  studies	   that	  observed	  clear	   sex-­‐dependent	   alterations	   in	   specific	   pathological	   domains	   (Meyer	   et	   al,	   2008a;	  Schwendener	  et	  al,	  2009;	  Zhang	  et	  al,	  2012).	  Lastly,	   it	   must	   be	   noted	   that	   the	   poly(I:C)	   model,	   when	   compared	   to	   infection	  models	  that	  are	  based	  on	  the	  use	  of	  live	  pathogens,	  falls	  short	  in	  mimicking	  the	  precise	  immunological	   insult	   that	  occurs	   in	   the	  human	  environment,	   as	   it	  does	  not	   reproduce	  the	  full	  spectrum	  of	  immune	  responses	  normally	  induced	  by	  viral	  exposure	  (Meyer	  et	  al,	  2009b).	   Actually,	   it	   mimics	   especially	   the	   viral-­‐like	   acute	   phase	   responses	   in	   the	  maternal	  host,	   and	   this	  needs	   to	  be	   taken	   into	  account	  when	   investigating	   the	  precise	  cellular	  and	  molecular	  mechanisms	  that	  mediate	  the	  deleterious	  effects	  of	  prenatal	  viral	  infection.	  However,	  this	  limitation	  does	  not	  undermine	  the	  relevance	  of	  the	  model,	  as	  it	  does	   not	   influence	   its	   capacity	   in	   reproducing	   many	   behavioural	   neurochemical	   and	  anatomical	  features	  of	  schizophrenia	  related	  disorders.	  	  















Behavioural	  Alterations	   References	  
Mouse	   Early/Middle	   PPI,	  LI,	  Social	  Behaviour,	  Exploratory	  Behaviour,	  Working	  Memory	  	  
 	  Sensitivity	  to	  DA-­‐R	  agonists	  and	  NMDA-­‐R	  Agonists	  
Shi	  et	  al.	  (2003);	  	  Meyer	  et	  al.	  (2005,	  2006a,b,c,	  2008b,c,d,	  2010b);	  Makinodan	  et	  al.	  (2008);	  Li	  et	  al.	  (2009);	  Vuillermot	  et	  al.	  (2010,	  2011);	  Li	  et	  al.	  (2014)	  
Mouse	  
Middle	  or	  Middle/Late	  
PPI,	  Exploratory	  Behaviour,	  Working	  Memory	  
 	  Sensitivity	  to	  DA-­‐R	  agonists,	  Repetitive	  Behaviours	  
Ozawa	  et	  al.	  (2008);	  Cardon	  et	  al.	  (2010);	  De	  Miranda	  et	  al.	  (2010);	  Wolff	  et	  al.	  (2011);	  Connor	  et	  al.	  (2012);	  Xuan	  et	  al.	  (2014)	  
Mouse	   Late	  
	  Social	  Behaviour,	  Working	  Memory,	  Cognitive	  Flexibility,	  Ultrasound	  Vocalizations	  
 	  LI,	  Repetitive	  Behaviours,	  Sensitivity	  to	  DA-­‐R	  agonists	  and	  NMDA-­‐R	  Agonists	  
Meyer	  et	  al.	  (2006b,c,	  2008c,	  2010b);	  Li	  et	  al.	  (2009);	  Bitanihirwe	  et	  al.	  (2010a,b);	  Richetto	  et	  al.	  (2013);	  Malkova	  et	  al.	  (2012)	  
Rat	   Middle/Late	   PPI,	  LI,	  Working	  Memory	  /	  Cognitive	  Flexibility,	  Sensitivity	  to	  DA-­‐R	  agonists	  and	  NMDA-­‐R	  Agonists	  
Zuckerman	  et	  al.	  (2003);	  Zuckerman	  and	  Weiner	  (2003,	  2005);	  Wolff	  and	  Bilkey	  (2008);	  Piontkewitz	  et	  al.	  (2009,	  2011a,b)	  Dickerson	  et	  al.,	  (2010)	  Bronson	  et	  al.	  (2010);	  Han	  et	  al.	  (2011);	  Zhang	  et	  al.	  (2012)	  Richtand	  et	  al.	  (2011);	  Wolff	  et	  al.	  (2011);	  Savanthrapadian	  et	  al.	  (2013)	  
	  
Table	  2.	  Significant	  behavioural	  alterations	  of	  offspring	  exposed	  to	  prenatal	  poly(I:C).	  PPI:	  Prepulse	  Inhibition,	  LI:	  Latent	  Inhibition.	  
	  














Morphological	  Alterations	   References	  
Mouse	   Early/Middle	  
Cortico-­‐/neurogenesis	  in	  the	  hippocampus	  	  
axonal	  size,	  myelin	  thickness	  in	  HPC,	  MBP	  immunostaining	  
Cerebellar	  Purkinje	  Cells	  
 	  lateral	  and	  4th	  ventricle	  volumes	  by	  MRI	  
Meyer	  et	  al.	  (2006a);	  Makinodan	  et	  al.	  (2008);	  Li	  et	  al.	  (2009);	  Shi	  et	  al.	  (2009);	  Liu	  et	  al.	  (2013)	  
Mouse	   Late	   Cortico-­‐/neurogenesis	  in	  the	  HPC	   	  lateral	  and	  4th	  ventricle	  volumes	  by	  MRI	   Meyer	  et	  al.	  (2006a);	  Li	  et	  al.	  (2009);	  




Neurochemical	  Alterations References	  
Mouse	   Early/Middle	  
	  D1	  in	  mPFC	  
	  5-­‐HT,	  5-­‐HTIAA	  in	  NAc,	  GP,	  HPC,	  taurine	  in	  HPC	  
	  GluR1	  subunit	  in	  NAc	  
	  GABAAα2	  subunit	  in	  Amy	  
 	  DA,	  DOPAC	  in	  PFC	  and	  GP	  
 	  THir,	  DATir	  in	  mesencephalon	  
 	  TH	  immunoreactivity	  in	  NAc	  and	  ST	  
 	  TH	  positive	  cells	  in	  SN	  and	  VTA	  
Meyer	  et	  al.	  (2008a,c,e);	  Nyffeler	  et	  al.	  (2006);	  Winter	  et	  al.	  (2008a);	  Vuillermot	  et	  al.	  (2010)	  
Mouse	   Late	  
DA,	  Glutamate	  in	  PFC	  and	  HPC	  
GABA	  in	  HPC	  
NR1	  subunit	  immunoreactivity	  in	  ST	  
D2	  receptor	  binding	  in	  ST	  
 	  DOPAC,	  HVA	  in	  ST	  
Ozawa	  et	  al.	  (2006);	  Meyer	  et	  al.	  (2008);	  Bitanihirwe	  et	  al.	  (2010)	  
Rat	   Late	   KCl-­‐induced	  DA	  release	  from	  striatal	  slices Zuckerman	  et	  al.	  (2003)	  
	  
Table	  3.	  Significant	  morphological	  and	  neurochemical	  alterations	  of	  offspring	  exposed	  to	  
prenatal	   poly(I:C).	   HPC:	   Hippocampus;	   PFC:	   Prefrontal	   Cortex;	   Amy:	   Amygdala;	   GP:	   Globus	  Pallidus;	  NAc:	  Nucleus	  Accumbens;	  ST:	  Striatum;	  VTA:	  Ventral	  Tegmental	  Area;	  SN:	  Substantia	  Nigra.	  
	  




















even	  if	  the	  extent	  to	  which	  prenatal	  immune	  activation	  can	  cause	  long-­‐lasting	  changes	  in	  GABAergic	  gene	  expression	  remains	  essentially	  unexplored.	  	  Second,	   in	   the	  neonatal	  cross-­‐fostering	  project,	   I	  went	  on	   to	  dissect	   the	  relative	  contribution	  of	  prenatal	  and	  postnatal	  maternal	  effects	  on	  the	  development	  of	  cognitive	  impairments	  and	  alterations	  in	  the	  GABAergic	  system	  in	  the	  offspring.	  While	  it	  has	  been	  acknowledged	   that	   the	   long-­‐term	   behavioural	   and	   molecular	   alterations	   manifest	   in	  prenatally	   immune-­‐challenged	   offspring	   may	   stem	   from	   alterations	   in	   early	   prenatal	  brain	  development	  (Garbett	  et	  al,	  2012;	  Meyer	  et	  al,	  2008a;	  Stolp	  et	  al,	  2011;	  Vuillermot	  
et	  al,	  2010),	  the	  role	  of	  the	  postpartum	  milieu,	  in	  which	  offspring	  of	  infected	  mothers	  are	  raised,	  has	  not	  been	  thoroughly	   investigated.	  As	  recent	  studies	  suggest	  that	  disruption	  of	   the	   intricate	   mother-­‐infant	   relationship	   resulting	   from	   immune	   activation	   in	   late	  pregnancy	  could	   confer	  additional	   risk	   for	   the	  offspring	   to	  develop	  brain	  pathology	   in	  later	  life	  (Schwendener	  et	  al,	  2009),	  we	  were	  motivated	  to	  address	  this	  issue	  in	  further	  detail	  by	  implementing	  an	  additional	  neonatal	  cross-­‐fostering	  design.	  	  Third,	   in	   keeping	   with	   our	   findings	   showing	   cognitive	   impairments	   and	  GABAergic	   abnormalities	   following	  prenatal	   exposure	   to	  Poly(I:C),	   I	   explored	  possible	  beneficial	   effects	   of	   a	   pharmacological	   intervention	   targeted	   at	   the	  GABAergic	   system.	  Numerous	  evidence	  suggest,	  in	  fact,	  that	  impaired	  GABA	  signalling	  may	  contribute	  to	  the	  emergence	  of	  cognitive	  deficits	  associated	  with	  psychiatric	  disorders	  (Gonzalez-­‐Burgos	  
et	   al,	   2011;	   Lewis	   et	   al,	   2012),	   and	   it	   has	   been	   proposed	   that	   pharmacological	  interventions	   targeting	   GABA	   abnormalities	   may	   prove	   useful	   in	   correcting	   both	  cognitive	   impairments	   and	   dopaminergic	   dysfunctions	   present	   in	   patients	   with	  schizophrenia	   (Guidotti	   et	   al,	   2005;	   Stan	   et	   al,	   2012).	  We	   thus	   directly	   explored	   this	  hypothesis	  in	  the	  GABA	  modulator	  project,	  and	  we	  specifically	  investigated	  the	  ability	  of	  the	   benzodiazepine	   positive	   allosteric	   modulator	   SH-­‐053-­‐2’F-­‐S-­‐CH3	   to	   modulate	   the	  behavioural	  defects	  of	  adult	  mice	  that	  were	  exposed	  to	  Poly(I:C)	  during	  late	  gestation.	  Fourth,	   we	   investigated	   the	   effects	   of	   prenatal	   immune	   activation	   on	   the	  behavioural	  and	  cognitive	   functions	  during	  the	  process	  of	  aging.	   It	  has	  been	  suggested	  that	   early-­‐life	   environmental	   insults	   such	   as	   prenatal	   infection	   could	   negatively	  influence	   brain	   aging	   (Krstic	   et	   al,	   2012).	   This	   hypothesis	   has	   been	  mainly	   driven	   by	  findings	   demonstrating	   progressive	   neuronal	   dysfunctions	   associated	   with	   prenatal	  exposure	  to	  immune	  challenge	  (Piontkewitz	  et	  al,	  2011a;	  Richetto	  et	  al,	  2014;	  Vuillermot	  





relevant	   beyond	   the	   adult	   period	   and	   could	   thus	   further	   affect	   cognitive	   functions	  during	  aging.	  	  Last,	   I	   implemented	   an	   unbiased	   genome-­‐wide	   approach	   in	   order	   to	   find	   new	  potential	   mechanisms	   underlying	   the	   association	   between	   prenatal	   infection	   and	  psychiatric	   disorders	   and	   broaden	   the	   list	   of	   putative	   targets	   for	   future	   therapeutic	  intervention	  during	  adult	  life	  or	  for	  disease	  prevention	  in	  adolescence.	  Using	  established	  microarray	  techniques,	  I	  analysed	  the	  gene	  expression	  profile	  of	  two	  brain	  areas	  that	  are	  relevant	   for	   psychiatric	   disease,	   namely	   the	   prefrontal	   cortex	   and	   the	   nucleus	  accumbens,	   in	   order	   to	   uncover	   long-­‐term	   transcriptional	   signatures	   of	   prenatal	  infection.	  	  





3.	  	  MATERIALS	  AND	  METHODS	  
	  
	  
3.1	  Animals	  	  C57BL/6	  mice	  were	  used	  throughout	  the	  whole	  study.	  Female	  and	  male	  breeders	  were	  obtained	   from	   the	   in-­‐house	   specific	   pathogen	   free	   colony	   of	   the	   Physiology	   and	  Behaviour	  Laboratory	  (Swiss	  Federal	  Institute	  of	  Technology	  (ETH)	  Zurich)	  at	  the	  age	  of	  12–14	   weeks.	   Breeding	   always	   began	   after	   two	   weeks	   of	   acclimatization	   to	   the	   new	  animal	   holding	   room,	   which	   was	   a	   temperature	   and	   humidity	   controlled	   (21±11C,	  55±5%)	   holding	   facility	   under	   a	   reversed	   light–dark	   cycle	   (lights	   off:	   08:00–20:00	  hours).	  All	  animals	  were	  kept	  in	  Macrolon	  type	  II	  cages	  (365	  ×	  207	  ×	  140	  mm,	  length	  ×	  width	  ×	  height),	  and	  they	  had	  ad	  libitum	  access	  to	  standard	  laboratory	  chow	  food	  (Kliba	  3430,	  Klibamühlen,	  Kaiseraugst,	  Switzerland)	  and	  water	  unless	  specified	  otherwise.	  All	  procedures	   described	   in	   the	   present	   study	   had	   been	   previously	   approved	   by	   the	  Cantonal	   Veterinarian’s	   Office	   of	   Zurich	   and	   are	   in	   agreement	   with	   the	   principles	   of	  laboratory	  animal	  care	  in	  the	  Guide	  for	  the	  Care	  and	  Use	  of	  Laboratory	  Animals	  (National	  Institutes	  of	  Health	  Publication	  No.	  86-­‐23,	  revised	  1985).	  
	  





adulthood	   (Bitanihirwe	   et	   al,	   2010a)	   and	   to	   alter	   postpartum	   maternal	   behaviour	  (Schwendener	  et	  al,	  2009).	  Poly(I:C)	  was	  dissolved	  in	  sterile	  pyrogen-­‐free	  0.9%	  NaCl	  (=	  vehicle)	  solution	   to	  yield	  a	   final	  concentration	  of	  1.0	  mg/ml	  and	  was	  administered	  via	  the	   intravenous	  (i.v)	  route	  at	  the	  tail	  vein	  under	  mild	  physical	  constraint.	  All	  solutions	  were	   freshly	   prepared	   at	   the	   day	   of	   administration	   and	   injected	   with	   a	   volume	   of	   5	  ml/kg.	  	  	  
3.1.2	  Allocation	  of	  Offspring	  Five	  independent	  cohorts	  of	  animals	  were	  prepared	  for	  the	  experiments	  included	  in	  this	  project	  and	  were	  allocated	  as	  follows.	  
	  





prenatal	   poly(I:C)	   exposure	   and	   raised	   by	   a	   poly(I:C)-­‐treated	   surrogate	  mother	   (POL-­‐POL).	   The	   offspring	  were	  weaned	   and	   sexed	   on	  PND	  21.	   Littermates	   of	   the	   same	   sex	  were	  caged	  separately	  and	  maintained	   in	  groups	  of	  2-­‐3	  animals	  per	  cage.	  The	  animals	  were	   left	   undisturbed	   until	   commencement	   of	   the	   behavioural	   and	   molecular	  investigations,	   which	   were	   conducted	   in	   pubescence	   and	   adulthood	   so	   as	   to	   assess	  possible	   maturation-­‐dependent	   effects	   of	   the	   prenatal	   and	   postnatal	   manipulations.	  Hence,	  one	  group	  of	  animals	  was	  behaviourally	  tested	  in	  pubescence	  (PND	  30	  to	  45)	  and	  one	   in	   adulthood	   (PND	   70	   onwards).	   Likewise,	   the	   molecular	   investigations	   were	  performed	   once	   the	   offspring	   reached	   PND	   45	   (pubescence)	   and	   90	   (adulthood),	  respectively.	   The	   pubescent	   and	   adult	   stages	   were	   defined	   based	   on	   the	   gradual	  attainment	  of	  sexual	  maturity	  and	  age-­‐specific	  behavioural	  discontinuities	  from	  younger	  to	  older	  animals	  (Spear,	  2000).	  These	  two	  developmental	  stages	  roughly	  correspond	  to	  a	  period	   between	   11–14	   years	   and	   20	   years	   onward,	   respectively,	   in	   humans.	   For	  pubescent	   and	   adult	   behavioural	   testing,	   two	   separate	   cohorts	   of	   fostered	   offspring	  were	  used	   in	  order	   to	  avoid	  potential	   confounds	  arising	   from	  repeating	   testing	  across	  peri-­‐pubertal	   development.	   In	   addition,	   separate	   cohorts	   of	   behaviourally	   naïve	  offspring	  were	  used	   for	   the	  molecular	   analyses	   in	   pubescence	   and	   adulthood	   so	   as	   to	  avoid	   possible	   confounding	   effects	   on	   gene	   transcription	   arising	   from	   prior	   stress	  exposure	  due	  to	  behavioural	  testing.	  	  	  





cognitive	   testing	   in	   order	   to	   avoid	   possible	   confounds	   and	   carry-­‐over	   effects	   arising	  from	  prior	  testing.	  	  
	  
3.1.2.3	  GABA	  modulator	  project	  All	  offspring	  were	  weaned	  and	  sexed	  at	  postnatal	  day	  (PND)	  21.	  Littermates	  of	  the	  same	  sex	   were	   caged	   separately	   and	   maintained	   in	   groups	   of	   2-­‐4	   animals	   per	   cage	   as	  described	  above.	  Only	  male	  mice	  were	   included	   in	   all	   experiments	   to	   circumvent	  bias	  arising	   from	   sexual	   dimorphism.	   A	   first	   cohort	   of	   behaviourally	   naïve	   male	   animals	  comprising	  of	  11	   control	   (CON)	  and	  9	  poly(I:C)	   (POL)	  offspring	  was	   allocated	   to	   gene	  expression	  analyses	  of	  GABAA	  receptor	  subunits	  in	  prefrontal	  and	  hippocampal	  tissues	  (see	  below).	  A	   second	   cohort	   of	  male	   animals	   comprising	  of	   34	   control	   (CON)	   and	  34	  poly(I:C)	   (POL)	  offspring	  was	  assigned	   to	   the	  behavioural	  and	  cognitive	   testing,	  which	  included	  (1)	  spatial	  working	  memory	  in	  the	  Y-­‐maze,	  (2)	  social	  approach	  and	  cognition,	  and	  (3)	  AMPH	  sensitivity	  tests.	  To	  minimize	  the	  number	  of	  animals	  required	  to	  complete	  all	   tests	   of	   interest,	   mice	   were	   repeatedly	   tested	   starting	   with	   the	   spatial	   working	  memory	  test	  and	  completing	  with	  the	  AMPH	  sensitivity	  test.	  A	  resting	  period	  of	  1	  week	  was	   inserted	  between	  each	  of	   these	   tests	  so	  as	   to	  allow	  sufficient	  drug	  wash-­‐out	   from	  one	  test	  to	  another.	  Previous	  drug	  histories	  (i.e.,	  SH-­‐053-­‐2’F-­‐S-­‐CH3	  or	  vehicle	  treatment,	  see	   below)	   were	   counterbalanced	   across	   the	   prenatal	   treatment	   conditions	   from	   one	  test	   to	   another	   in	  order	   to	   further	  minimize	  possible	   confounds	   from	  drug	   carry-­‐over	  effects.	  CON	  and	  POL	  offspring	  in	  both	  cohorts	  used	  in	  this	  study	  stemmed	  from	  multiple	  independent	   litters	   (16	  CON	   litters	   and	  14	  POL	   litters)	   in	  order	   to	   avoid	   litter	   effects.	  Hence,	  1-­‐2	  offspring	  per	  litter	  were	  used	  either	  for	  the	  gene	  expression	  analyses	  or	  the	  behavioural	  and	  cognitive	  testing.	  	  	  





at	   each	   testing	   age.	   All	   experiments	   were	   conducted	   when	   the	   offspring	   reached	   the	  pubescent	  (4-­‐7	  weeks	  of	  age),	  adult	  (4-­‐5	  months	  of	  age),	  or	  aged	  (22-­‐24	  months	  of	  age)	  stages	  of	  life.	  Pubescent	  and	  adult	  stages	  were	  defined	  as	  explained	  previously,0	  and	  the	  aged	  stage	  was	  defined	  based	  on	  previous	  normative	  aging	  studies	   in	  mice	  (Flurkey	  et	  al.,	  2007).	  Separate	  cohorts	  of	  pubescent,	  adult,	  and	  aged	  poly(I:C)-­‐	  and	  control	  offspring	  were	  used	  for	  the	  behavioural	  and	  cognitive	  tests	  at	  each	  age	  in	  order	  to	  avoid	  possible	  confounds	   and	   carry-­‐over	   effects	   arising	   from	  experimental	   testing	   at	   prior	   ages.	   In	   a	  first	   series	  of	  experiments,	  offspring	   in	  every	  age	  cohort	  were	  repeatedly	  subjected	   to	  cognitive	   testing	   assessing	   (1)	   short-­‐term	   spatial	   recognition	  memory,	   (2)	   acquisition	  and	   expression	   of	   contextual	   fear	   memories,	   and	   (3)	   spatial	   reference	   learning	   and	  memory.	  These	  cognitive	  domains	  were	  studied	  using	  tests	  that	  are	  commonly	  used	  to	  evaluate	  hippocampus-­‐regulated	  cognitive	  functions	  in	  rodent	  models	  (Bannerman	  et	  al,	  1999;	  Deacon	  et	  al,	  2002a;	  Maren	  and	  Fanselow,	  1997;	  Morris	  et	  al,	  1982;	  Moser	  et	  al,	  1993;	  Otto	  and	  Poon,	  2006).	  In	  a	  second	  series	  of	  experiments,	  independent	  cohorts	  of	  pubescent,	  adult,	  and	  aged	  offspring	  were	  subjected	  to	  an	  open	  field	  test	  assessing	  basal	  locomotor	  activity	  and	  innate	  anxiety-­‐like	  behaviour,	  followed	  by	  a	  test	  of	  food	  hoarding	  behaviour.	  The	  open	  field	  test	  served	  to	  ascertain	  whether	  prenatal	  immune	  activation	  would	   lead	   to	  altered	   innate	  anxiety-­‐like	  behaviour	  and/or	   locomotor	  activity,	  both	  of	  which	  could	  affect	  the	  animals’	  performance	  in	  the	  cognitive	  tests	  of	  primary	  interests.	  The	   food	   hoarding	   test	  was	   served	   to	   extend	   the	   cognitive	   phenotyping	   to	   a	   test	   that	  measures	   species-­‐typical	   behaviour	   known	   to	   be	   sensitive	   to	   hippocampal	   damage	  (Deacon	  et	  al,	  2002a).	  	  In	  subsequent	  experimental	  series,	  additional	  separate	  cohorts	  of	  behaviourally	  naïve	   offspring	   were	   used	   for	   the	   immunohistochemical,	   gene	   expression	   and	  serological	   analyses	   to	   circumvent	   possible	   confounding	   effects	   of	   stress	   by	   prior	  behavioural	  testing	  on	  glial	  and	  cytokine	  markers	  (Giovanoli	  et	  al,	  2013).	  	  	  





PND92	  to	  PND106.	  The	  animals	  underwent	  a	  Y-­‐maze	  test,	  and	  a	  social	   interaction	  and	  recognition	   test.	   After	   nearly	   two	   weeks	   of	   washout	   from	   the	   behavioural	   testing,	  animals	  were	  sacrificed	  at	  PND114.	  	  
3.2 Behavioural	  Testing	  	  
3.2.1	  Open	  Field	  The	   open	   field	   exploration	   test	   is	   a	  widely	   used	   behavioural	   assay	   to	   evaluate	   innate	  anxiety-­‐like	   behaviour	   and	   locomotor	   responses	   to	   novel	   environments	   in	   rodents	  (Belzung	  and	  Griebel,	  2001).	  The	  test	  was	  conducted	  in	  4	  identical	  square	  arenas	  (40	  ×	  40	  cm)	  surrounded	  by	  walls	  (35	  cm	  high).	  The	  apparatus	  was	  made	  of	  grey	  Plexiglas	  and	  was	  located	  in	  a	  testing	  room	  under	  diffused	  lighting	  (25	  lux	  as	  measured	  in	  the	  centre	  of	   the	   arenas).	   A	   digital	   camera	  was	  mounted	   directly	   above	   the	   four	   arenas.	   Images	  were	  captured	  at	  a	  rate	  of	  5	  Hz	  and	  transmitted	  to	  a	  PC	  running	  the	  Ethovision	  (Noldus	  Information	   Technology,	   The	   Netherlands)	   tracking	   system.	   The	   animals	   were	   gently	  placed	  in	  the	  centre	  of	  the	  arena	  and	  allowed	  to	  explore	  for	  1	  h.	  For	  the	  purpose	  of	  data	  collection,	   the	   arena	   was	   conceptually	   partitioned	   into	   two	   zones:	   a	   centre	   zone	  (measuring	  13.5×13.5	  cm)	  in	  the	  middle	  of	   the	  arena	  and	  a	  peripheral	  zone	  occupying	  the	  remaining	  area.	  The	  dependent	  measures	  were	  (a)	  total	  distance	  moved	  in	  the	  entire	  arena,	   (b)	   total	   time	   spent	   in	   the	   centre	   zone,	   and	   (c)	   total	   distance	   travelled	   in	   the	  centre	  zone.	  	  





room	  enriched	  with	  distal	  spatial	  cues.	  A	  digital	  camera	  was	  mounted	  above	  the	  Y-­‐maze	  apparatus.	  Images	  were	  captured	  at	  a	  rate	  of	  5	  Hz	  and	  transmitted	  to	  a	  PC	  running	  the	  EthoVision	  tracking	  system	  (Noldus	  Information	  Technology),	  which	  calculated	  the	  time	  spent	  and	  distance	  moved	  in	  the	  three	  arms	  and	  centre	  zone	  of	  the	  Y-­‐maze.	  The	  working	  memory	  test	  in	  the	  Y-­‐maze	  consisted	  of	  two	  phases,	  called	  the	  sample	  and	  choice	  phases.	  	  	   •	  Sample	  phase:	  The	  animals	  were	  allowed	   to	  explore	   two	  arms	  (referred	   to	  as	  ‘start	  arm’	  and	  ‘familiar	  arm’).	  Access	  to	  the	  remaining	  arm	  (‘novel	  arm’)	  was	  blocked	  by	  a	  barrier	  wall	  door.	  To	  begin	  a	   trial,	   the	  animal	  was	   introduced	  at	   the	  end	  of	   the	  start	  arm	  and	  was	  allowed	   to	   freely	  explore	  both	   the	  start	  and	   the	   familiar	  arms	   for	  5	  min.	  Test	   timing	   was	   initiated	   once	   the	   animal	   entered	   the	   start	   arm,	   as	   detected	   by	   the	  EthoVision	   tracking	  system.	  The	  animal	  was	   then	  removed	  and	  kept	   in	  a	  holding	  cage	  prior	   to	   commencement	   of	   the	   choice	   phase.	   The	   barrier	   door	   was	   removed	   and	   the	  sawdust	  flooring	  changed	  to	  avoid	  olfactory	  cues.	  	   •	   Choice	   phase:	   The	   animal	   was	   introduced	   to	   the	   maze	   following	   a	   retention	  interval	   of	   1	  min.	   During	   the	   choice	   phase,	   the	   barrier	  wall	  was	   removed	   so	   that	   the	  animals	   could	   freely	   explore	   all	   arms	   of	   the	   maze	   for	   2	   min.	   The	   animal	   was	   then	  removed	   from	   the	   maze	   and	   returned	   to	   the	   home	   cage.	   The	   sawdust	   flooring	   was	  changed	   in	   preparation	   for	   the	   next	   trial.	   On	   each	   trial,	   the	   time	   spent	   in	   each	   of	   the	  three	   arms	  was	   recorded.	   The	   relative	   time	   spent	   in	   the	   novel	   arm	  during	   the	   choice	  phase	  of	  the	  test	  was	  calculated	  by	  the	  formula	  (time	  spent	  in	  the	  novel	  arm/time	  spent	  in	  all	  arms)	  ×	  100	  and	  used	  as	  the	  index	  for	  working	  memory	  performance.	  In	  addition,	  total	  distance	  moved	  on	  the	  entire	  maze	  was	  recorded	  and	  analysed	  in	  order	  to	  assess	  general	  locomotor	  activity.	  	  	  





During	  habituation,	  animals	  were	  placed	  on	  the	  dry	  maze	  for	  2	  daily	  trials	  of	  2	  min	  each.	  To	  begin	  a	  trial,	  the	  animals	  were	  placed	  gently	  in	  the	  centre	  of	  the	  dry	  maze.	  The	  inter-­‐trial	  interval	  (ITI)	  was	  approximately	  1	  min.	  On	  day	  6	  and	  7,	  the	  animals	  were	  then	  pre-­‐trained	   in	   the	  dry	  maze	  using	  the	  visual	  cue	   for	  2	  consecutive	  trials.	  One	  random	  hole	  was	  cued	  with	  the	  flag	  and	  rewarded	  with	  the	  milk	  solution	  (75	  μl	  of	  freshly	  prepared	  condensed	  milk	  [Alicommerce	  SAS]	  used	  in	  a	  1:4	  [milk/water]	  dilution.).	  For	  both	  trials,	  each	  animal	  was	  left	  on	  the	  maze	  for	  2	  min.	  If	  it	  failed	  to	  reach	  the	  rewarded	  hole	  during	  this	   time,	   it	  was	   gently	   guided	   to	   the	   rewarded	  hole	  by	   the	   experimenter.	  All	   animals	  consumed	  the	  reward	  within	  the	  allowed	  maximum	  time	  of	  15	  sec.	  Following	   the	   habituation	   (days	   1-­‐5)	   and	   pre-­‐testing	   (days	   6	   and	   7)	   phases,	  working	   memory	   testing	   was	   started	   and	   lasted	   for	   3	   testing	   days	   (days	   8-­‐10).	   The	  working	  memory	   task	  was	   based	   on	   the	  matching-­‐to-­‐position	   paradigm,	   in	  which	   the	  animals	  were	  required	  to	  learn	  the	  novel	  position	  of	  a	  rewarded	  hole	  revealed	  to	  them	  on	  trial	  1	  of	  each	  day	  in	  order	  to	  navigate	  effectively	  to	  the	  same	  location	  (i.e.,	  matching)	  on	  the	  subsequent	  trial	  on	  the	  same	  day.	  Hence,	  each	  test	  day	  included	  2	  trials.	  For	  both	  trials,	  each	  animal	  was	  left	  on	  the	  maze	  for	  2	  min.	  If	  it	  failed	  to	  reach	  the	  rewarded	  hole	  during	   this	   time,	   it	   was	   gently	   guided	   to	   the	   rewarded	   hole	   by	   the	   experimenter	   as	  described	  above.	  The	  reward	  remained	  in	  the	  same	  position	  across	  trials	  on	  a	  given	  test	  day,	  but	  took	  a	  new	  position	  on	  each	  test	  day.	  To	  begin	  a	  trial,	  the	  animals	  were	  placed	  gently	  in	  the	  centre	  of	  the	  dry	  maze	  as	  described	  before.	  The	  allocation	  of	  the	  rewarded	  holes	   to	   a	   specific	   spatial	   location	   was	   counterbalanced	   across	   the	   4	   experimental	  conditions.	   An	   ITI	   of	   1	  min	  was	   used	   at	   each	   of	   the	   3	   test	   days,	   corresponding	   to	   the	  minimal	   amount	   of	   time	   needed	   to	   clean	   the	   dry	  maze	   surface	  with	  water	   and	   dry	   it	  from	   the	   first	   to	   the	   second	   trial.	  Working	  memory	   was	   indexed	   by	   the	   reduction	   in	  distance	  moved	  and	  time	  needed	  to	  find	  the	  location	  of	  the	  reward	  in	  trial	  2	  relative	  to	  trial	  1.	  All	  animals	  were	  returned	  to	  ad	  libitum	  food	  upon	  completion	  of	  the	  matching-­‐to-­‐position	  dry	  maze	  test.	  	  










One	  day	  after	  acquisition	   training	  ended,	  a	  probe	   test	  was	  performed,	   in	  which	  the	  platform	  was	  removed	  and	  the	  animals	  were	  allowed	  to	  search	  for	  it	   for	  60	  s.	  This	  served	   as	   a	   test	   of	   spatial	   memory	   retention.	   The	   percent	   time	   spent	   in	   the	   target	  quadrant,	   i.e.	   the	   quadrant	   in	   which	   the	   platform	   was	   located	   during	   the	   preceding	  acquisition	  phase,	  was	  taken	  to	  analyse	  retention	  of	  spatial	  reference	  memory.	  	  





conditioning	   chambers	   30	   s	   after	   they	   received	   the	   last	   foot	   shock,	   and	   they	   were	  brought	  back	  to	  their	  home	  cages.	  During	  the	  conditioning	  day,	  the	  amount	  of	  freezing	  during	   each	   30-­‐s	   post-­‐shock	   period	   provided	   a	   measure	   for	   the	   evaluation	   of	   the	  acquisition	  of	  conditioning.	  On	   the	   second	   day,	   the	   animals	   were	   placed	   back	   to	   the	   same	   conditioning	  chambers	   for	   a	   period	   of	   3	  min,	   during	  which	   their	   freezing	   behaviour	  was	   recorded.	  This	  served	  as	  a	  test	  of	  measuring	  conditioned	  fear	  towards	  the	  context.	  The	  expression	  of	   context	   freezing	  during	   the	  3-­‐min	   test	  period	  was	   indexed	  as	  percent	   time	   freezing	  and	  expressed	  as	  a	  function	  of	  30-­‐s	  bins.	  After	  completion	  of	  the	  contextual	  fear	  test,	  the	  animals	  were	  brought	  back	  to	  their	  home	  cages.	  	  	  





allow	  access	  to	  the	  hoarding	  tube.	  Each	  animal	  had	  free	  access	  to	  the	  hoarding	  tube	  for	  a	  total	  of	  24	  h,	  during	  which	  they	  were	  left	  undisturbed.	  After	  this	  period,	  all	  food	  pellets	  that	   had	   been	   hoarded	   into	   each	   home	   base	   box	   were	   collected	   and	   weighed.	   This	  provided	  a	  measure	  of	   food	  hoarding	  behaviour.	  The	  pellets	  that	  remained	  in	  the	  tube	  were	  also	  weighed	  to	  assess	  the	  amount	  of	  food	  intake	  during	  the	  24-­‐h	  test	  period.	  The	  amount	  of	  food	  eaten	  was	  calculated	  by	  the	  formula:	  Total	  amount	  (in	  g)	  of	  food	  pellets	  placed	  into	  the	  hoarding	  tube	  –	  (food	  pellets	  displaced	  into	  the	  home	  cage	  +	  food	  pellets	  remaining	  in	  the	  tube).	  All	  measures	  were	  taken	  and	  analysed	  by	  an	  experimenter	  who	  was	  blind	  to	  the	  experimental	  conditions.	  	  





the	  animal	  was	  removed	  and	  kept	  in	  a	  holding	  cage,	  during	  which	  the	  sawdust	  flooring	  was	  changed	  to	  avoid	  olfactory	  cues.	  	   •	  Novelty	  phase:	  Another	  unfamiliar	  C57BL6	  mouse,	  which	   is	   referred	   to	   as	   the	  ‘novel	  mouse’	   during	   the	   test	   phase,	   now	   replaced	   the	   inanimate	   dummy	  mouse.	   The	  other	   cage	   contained	   the	   ‘familiar	  mouse’	   previously	   used	   in	   the	   ‘dummy	   phase’.	   The	  allocation	   of	   the	   ‘novel	   mouse’	   and	   ‘familiar	   mouse’	   to	   the	   two	   wire	   cages	   was	  counterbalanced	   across	   experimental	   groups.	   To	   start	   the	   ‘novelty	   phase’,	   the	   animal	  was	  introduced	  into	  the	  maze	  again	  and	  was	  allowed	  to	  freely	  explore	  all	  three	  arms	  for	  5	   min.	   Behavioural	   observations	   for	   social	   interaction	   and	   locomotor	   activity	   were	  scored	  as	  described	  before.	  The	  percent	  time	  spent	  with	  the	  novel	  mouse	  was	  calculated	  by	  the	   formula	  (time	  spent	  with	   the	  novel	  mouse/(time	  spent	  with	   the	  novel	  mouse	  +	  time	  spent	  with	  the	  familiar	  mouse))	  ×	  100	  and	  used	  to	  assess	  relative	  exploration	  time	  between	  the	  familiar	  and	  unfamiliar	  congenic	  mouse.	  	  





at	  a	  dose	  of	  2.5	  based	  on	  previous	  findings	  (Meyer	  et	  al.,	  2008c).	  The	  volume	  of	  injection	  was	  5	  ml/kg	  for	  all	  solutions.	  All	  solutions	  were	  freshly	  prepared	  on	  the	  day	  of	  testing.	  	  
3.3	  Molecular	  Analyses	  	  
3.3.1	  Collection	  of	  Brain	  Samples	  Behaviourally	   naïve	   offspring	   of	   the	   different	   projects	   were	   decapitated	   on	   PND	   45	  (pubescence)	   or	   after	   PND	   90	   (adulthood)	   for	   the	   purpose	   of	   measuring	   gene	   and	  protein	  expression	  levels	  in	  prefrontal	  and	  hippocampal	  tissues.	  Following	  decapitation	  of	  the	  animals,	  the	  brains	  were	  immediately	  extracted	  from	  the	  skull	  and	  placed	  dorsal	  side	  up	  on	  an	   ice-­‐chilled	  plate.	  This	  was	  directly	   followed	  by	  preparing	  1-­‐mm	  coronal	  brain	  sections	  using	  razorblade	  cuts	  and	  subsequent	  micro-­‐dissection	  of	  the	  brain	  areas	  of	   interest.	   In	   particular,	   for	   the	   cross-­‐fostering	   project	   we	   dissected	   the	   medial	  prefrontal	   cortex	   (mPFC;	   bregma:	   +2.3	   to	   +1.3	  mm)	   and	   dorsal	   hippocampus	   (dHPC;	  bregma	   -­‐1.3	   to	   -­‐2.3	   mm);	   for	   the	   GABAergic	   transcriptome	   project	   we	   dissected	   the	  medial	   prefrontal	   cortex	   (mPFC;	   bregma:	   +2.3	   to	   +1.3	  mm);	   for	   the	   GABA-­‐modulator	  project	  we	  dissected	   the	  medial	  prefrontal	   cortex	   (mPFC;	   including	  anterior	   cingulate,	  prelimbic,	   and	   infralimbic	   subregions,	   bregma:	   +2.3	   to	   +1.3	   mm),	   striatum	   (Str;	  including	  dorsomedial	  and	  -­‐lateral	  caudate	  putamen,	  bregma	  +1.5	   to	  +0.5	  mm),	  dorsal	  hippocampus	   (dHPC;	   bregma	   −1.5	   to	   −2.5	   mm),	   and	   ventral	   hippocampus	   (vHPC;	  bregma	  −2.5	   to	  −3.5	  mm);	   for	   the	   aging	  project	  we	  dissected	   the	  dorsal	   hippocampus	  (dHPC;	   bregma	   −1.5	   to	   −2.5	   mm);	   for	   the	   microarray	   study	   we	   dissected	   the	   medial	  prefrontal	  cortex	  (mPFC;	  bregma:	  +2.3	  to	  +1.3	  mm)	  and	  the	  nucleus	  accumbens	  (bregma	  +1.5	  to	  +0.5	  mm).	  Brain	  specimens	  were	  collected	  in	  96-­‐well	  microtiter	  plates	  kept	  on	  dry	  ice	  and	  allowed	  to	  freeze	  before	  storage	  at	  −80°C	  until	  further	  use.	  	  	  












Table	  4:	  Sequences	  of	   forward	  and	  reverse	  primers	  and	  probes	  used	   in	  qRT-­‐PCR	  analysis	  and	  purchased	  from	  Eurofins	  MWG	  Operon	  (Germany).	  	  	  	   	  
Gene	   Forward	  Primer	   Reverse	  Primer	   Probe	  
gad65	   5’-­‐ACCGAGAAGGCTATGAAATGG-­‐3’	   5’-­‐TCTGGCTTTAATCACTGGCG-­‐3’	   5’-­‐AGGCGGCTCATTCTCTCTTCATTGTC-­‐3’	  
gad67	   5’-­‐GCAGATCCTGGTTGACTGTAG-­‐3’	   5’-­‐GAACATATTGGTATTGGCAGTCG-­‐3’	   5’-­‐TGGTTTAGCTGGTGAATGGCTGACA-­‐3’	  
vgat	   5’-­‐ACGACAAACCCAAGATCACG-­‐3’	   5’-­‐AAGATGATGAGGAACAACCCC-­‐3’	   5’-­‐CAGCACGAACATGCCCTGAATGG-­‐3’	  
alpha1	   5’-­‐TGAGAGCTGAATGCCCAATG-­‐3’	   5’-­‐TCTGCTACAACCACTGAACG-­‐3’	   5’-­‐CCTGCCCACTAAAATTCGGAAGCTATGC-­‐3’	  
alpha	  2	   5’-­‐CCATGAGGCTTACAGTCCAAG-­‐3’	   5’-­‐ACGGAGTCAGAAGCATTGTAAG-­‐3’	   5’-­‐CGTAGCTTCCAAATTTCAGTGGGCA-­‐3’	  
alpha	  3	   5’-­‐ACAATATGACCACACCCAACA-­‐3’	   5’-­‐AGCTTCCAAACTTCAGTGGG-­‐3’	   5’-­‐CAATACACGCTGAATGCCCCATGC-­‐3’	  
alpha	  4	   5’-­‐GCCTGCCCTTTGAAATTTGG-­‐3’	   5’-­‐GATACAGTCTGCCCAATGAGG-­‐3’	   5’-­‐ATCTACACCTGGACCAAAGGCCC-­‐3’	  
alpha	  5	   5’-­‐GGGAATGGACAATGGAATGC-­‐3’	   5’-­‐TGTCATTGGTCTCGTCTTGTAC-­‐3’	   5’-­‐CATTTGCGAAAAGCCAAAGTGACTGGA-­‐3’	  
nkcc1	   5’-­‐GCATTCAATCCGTCTTTCTGG-­‐3’	   5’-­‐GGCCACAGATCATTAAACCAAC-­‐3’	   5’-­‐AGTAAAGCAGGCCGTGAGTTTGGA-­‐3’	  
kcc2	   5’-­‐TCAAACAGATGCACCTCACC-­‐3’	   5’-­‐CCTCTGGCTTCTCCTCATTG-­‐3’	   5’-­‐CTCCCGTTCCCGCTCGTTCTT-­‐3’	  
bdnf	   5’-­‐AAGTCTGCATTACATTCCTCGA-­‐3’	   5’-­‐GTTTTCTGAAAGAGGGACAGTTTAT-­‐3’	   5’-­‐TGTGGTTTGTTGCCGTTGCCAAG-­‐3’	  
ngf	   5’-­‐CCCAATAAAGGTTTTGCCAAGG-­‐3’	   5’-­‐TTGCTATCTGTGTACGGTTCTG-­‐3’	   5’-­‐TGGACATTACGCTATGCACCTCACTG-­‐3’	  
ntf3	   5’-­‐CAGAACATAAGAGTCACCGAGG-­‐3’	   5’-­‐GTTTCACAGGAGAGTTACCGG-­‐3’	   5’-­‐TGGTGTCCCCGAATGTCAATGGC-­‐3’	  
mog	   5’-­‐CTCCATCGGACTTTTGATCC-­‐3’	   5’-­‐AGCAGATGATCAAGGCAACC-­‐3’	   5’-­‐ATTGTGCCTGTTCTTGGACC-­‐3’	  
mag	   5’-­‐CCTTCAACCTGTCTGTGGAGTT-­‐3’	   5’-­‐CGGGTTGGATTTTACCACAC-­‐3’	   5’-­‐CCCATAATCCTTCTGGAGTCAC-­‐3’	  
mobp	   5’-­‐TTCTTCGAGGATGGGTGCAT-­‐3’	   5’-­‐AGCAGCTCACACGTACAAGA-­‐3’	   5’-­‐CACCATTTCTTCCTCCTGTTCC-­‐3’	  
mal	   5’-­‐CGTGGTCCATGCTGTGTTTT-­‐3’	   5’-­‐TTTCTCCACCATCCAGTCTGTG-­‐3’	   5’-­‐GCCCATCTTCCCCATTAACTTC-­‐3’	  
36B4	   5’-­‐AGATGCAGCAGATCCGCAT-­‐3’	   5’-­‐GTTCTTGCCCATCAGCACC-­‐3’	   5’-­‐CGCTCCGAGGGAAGGCCG-­‐3’	  
β-­‐actin	   5’-­‐ACCTTCTACAATGAGCTGCG-­‐3’	   5’-­‐CTGGATGGCTACGTACATGG-­‐3’ 5’-­‐TCTGGGTCATCTTTTCACGGTTGGC-­‐3’ 





3.3.3	  Protein	  Extraction	  and	  Western	  Blot	  Analysis	  Western	  blot	  analysis	  was	  used	  to	   investigate	  GAD65/67	  and	  VGAT	  protein	   levels	   in	   the	  total	   homogenate	   of	  mPFC	   tissue.	   Brain	   samples	  were	  manually	   homogenized	  using	   a	  glass-­‐glass	  potter	  in	  a	  pH	  7.4	  cold	  buffer	  (containing	  0.32	  M	  sucrose,	  0.1	  mM	  EGTA,	  1mM	  HEPES	   solution	   in	   presence	   of	   a	   complete	   set	   of	   protease	   (Roche)	   and	   phosphatase	  (Sigma-­‐Aldrich)	  inhibitors)	  and	  then	  sonicated	  for	  10s	  at	  a	  maximum	  power	  of	  10-­‐15%	  (Bandelin	   Sonoplus).	   Total	   protein	   content	   was	   measured	   according	   to	   the	   Bradford	  Protein	   Assay	   procedure	   (Bio-­‐Rad	   Laboratories),	   using	   bovine	   serum	   albumin	   as	  calibration	  standard.	  Equal	   amounts	   of	   protein	   were	   run	   under	   reducing	   conditions	   on	   Any	   Kd	  Criterion	   TGX	   precast	   gels	   (Bio-­‐rad	   Laboratories)	   and	   then	   electrophoretically	  transferred	   onto	   nitrocellulose	   membranes	   (Bio-­‐Rad	   Laboratories).	   The	   blots	   were	  blocked	   with	   10%	   non-­‐fat	   dry	  milk	   and	   then	   incubated	   with	   the	   primary	   antibodies.	  Because	  of	  the	  limited	  availability	  of	  mPFC	  tissue	  in	  small	  animals	  such	  as	  mice,	  we	  were	  constrained	  to	  focus	  our	  Western	  blot	  analyses	  on	  two	  analyses	  only.	  Therefore,	  we	  used	  an	   anti-­‐GAD65/67	   polyclonal	   antibody	   (1:1000,	   4°C	   overnight;	  Millipore)	   that	   is	   able	   to	  simultaneously	  recognize	  both	  GAD	  isoforms	  (65	  and	  67	  kDa)	  and	  a	  primary	  anti-­‐VGAT	  polyclonal	  antibody	  (1:1000,	  4°C	  overnight,	  Millipore).	  Membranes	  were	  then	  incubated	  for	  1	  h	  at	   room	  temperature	  with	  a	  peroxidase-­‐conjugated	  anti-­‐rabbit	   IgG	   (1:1000	   for	  GAD65/67,	   1:2000	   for	   VGAT)	   and	   immunocomplexes	   were	   visualized	   by	  chemiluminescence	   using	   the	   Chemidoc	   MP	   imaging	   system	   (Bio-­‐Rad	   Laboratories).	  Results	  were	  standardized	  using	  β-­‐actin	  as	  the	  control	  protein,	  which	  was	  detected	  by	  evaluating	   the	  band	  density	  at	  43	  kDa	  after	  probing	   the	  membranes	  with	  a	  polyclonal	  antibody	   (1:10’000,	   Sigma–Aldrich)	   followed	   by	   a	   1:10’000	   dilution	   of	   peroxidase-­‐conjugated	   anti-­‐mouse	   IgG	   (Sigma–Aldrich).	   Protein	   levels	   of	   GAD65/67	   (measured	  together	  without	  discriminating	  between	  bands)	  and	  VGAT	  were	  calculated	  using	  an	  up-­‐to-­‐date	  Image	  Lab	  software	  (Bio-­‐Rad	  Laboratories).	  	  	  










3.3.5	  Optical	  Densitometry	  We	  also	  performed	  optical	  densitometry	  analyses	  in	  the	  aging	  project.	  Quantification	  of	  SYN	   and	   PSD95	   immunoreactivities	   was	   achieved	   by	   means	   of	   optical	   densitometry	  using	  ImageJ	  software	  (NIH).	  Optical	  densitometry	  was	  chosen	  because	  SYN	  and	  PSD95	  are	  highly	  enriched	  at	  pre-­‐	  and	  postsynaptic	  sites,	  respectively,	  in	  the	  hippocampal	  areas	  of	   interest	   (see	   below).	   Digital	   images	   were	   acquired	   at	   a	   magnification	   of	   40×	   (NA	  0.075)	   using	   a	   digital	   camera	   (Axiocam	   MRc5,	   Zeiss)	   mounted	   on	   a	   Zeiss	   Axioplan	  microscope.	  Exposure	  times	  were	  set	  so	  that	  pixel	  brightness	  was	  never	  saturated.	  Pixel	  brightness	  was	  measured	  in	  the	  hippocampal	  areas	  of	  interest	  of	  one	  randomly	  selected	  brain	  hemisphere.	  In	  addition,	  pixel	  brightness	  was	  measured	  in	  the	  corpus	  callosum	  as	  background	  area.	  The	  background-­‐corrected	  optical	  densities	  were	  averaged	  per	  brain	  region	   and	   animal.	   Three	   to	  4	   coronal	   brain	   sections	  per	   animal	  were	   analysed	  by	   an	  experimenter	  who	  was	  blind	  to	  the	  experimental	  conditions.	  	  SYN	   and	   PSD95	   optical	   densities	  were	  measured	   in	   the	   pyramidal	   cell	   layer	   of	  cornu	  ammonis	  areas	  1	  and	  3	  (CA1	  and	  CA3,	  respectively)	  and	  in	  the	  granule	  cell	  layer	  of	   the	   dentate	   gyrus	   (DG)	   on	   hippocampal	   sections	   ranging	   from	   Bregma	   -­‐1.5	   to	   -­‐3.0	  mm.	   These	   areas	   were	   delineated	   according	   to	   “The	   Mouse	   Brain	   in	   Stereotaxic	  
Coordinates”	  by	  Franklin	  and	  Paxinos	  (2008).	  Schematic	  illustrations	  of	  the	  hippocampal	  cell	   layers,	   in	  which	  the	  relative	  optical	  density	  of	  SYN	  and	  PSD95	  were	  measured,	  are	  provided	  in	  corresponding	  figure	  legends.	  
	  





[numerical	  aperture	  (NA),	  1.3]	  and	  included	  in	  the	  measurement	  when	  they	  came	  into	  focus	  within	  the	  optical	  dissector	  (Howard	  and	  Reed,	  2005).	  CD68-­‐	  and	  GFAP-­‐immunoreactive	  cell	  numbers	  were	  quantified	   in	   the	  CA1-­‐CA3	  and	   DG	   regions	   of	   the	   hippocampal	   formation	   ranging	   from	   bregma	   -­‐1.5	   to	   -­‐3.0	  mm.	  These	  areas	  were	  delineated	  according	  to	  “The	  Mouse	  Brain	  in	  Stereotaxic	  Coordinates”	  by	  Franklin	  and	  Paxinos	  (2008).	  Initial	  analyses	  showed	  that	  there	  were	  no	  subregion-­‐specific	  differences	  between	  control	  and	  poly(I:C)-­‐exposed	  offspring	   in	  any	  of	   the	  glial	  markers	   studied,	   and	   therefore,	   the	   individual	   CA	   areas	   were	   collapsed	   to	   a	   single	  hippocampal	  CA	  region	  for	  the	  final	  analysis	  and	  presentation	  of	  data.	  All	  stereological	  estimates	  were	  acquired	  by	  an	  experimenter	  who	  was	  blind	   to	   the	  animals’	   treatment	  conditions	  
	  





3.3.8	  Microarray	  Analyses	  Gene	   expression	   microarray	   assays	   were	   performed	   using	   Mouse	   Gene	   1.0	   ST	   Array	  Strips	   on	  GeneAtlas	   platform	   (Affymetrix),	   following	   the	   3’IVT	   one	   cycle	   labelling	   and	  amplification	   protocol	   described	   in	   the	   Affymetrix	   GeneChip	   Expression	   Analysis	  Technical	  Manuals	  and	  in	  the	  GeneAtlas™	  WT	  Expression	  Kit	  User	  Manual.	  Mouse	  Gene	  1.0	   ST	   Array	   Strips	   are	   comprised	   of	   more	   than	   530,000	   probes	   covering	  more	   than	  36,000	   transcripts	   and	   variants,	   which	   represent	   more	   than	   20,000	   genes	   mapped	  through	  UniGene	  or	  via	  RefSeq	  annotation.	  To	  synthesize	  First-­‐Strand	  cDNA,	  250ng	  RNA	  were	  reverse-­‐transcribed	  with	  the	  Gene	  Atlas	   3’IVT	  Express	  Kit	   or	  WT	  Expression	  Kit	   (Affymetrix,	   Santa	   Clara,	   CA,	  USA)	  using	   T7	   oligo(dT)	   primer.	   Second-­‐Strand	   cDNA	   synthesis	  was	   carried	   out	   using	  DNA	  polymerase	  and	  RNase	  H	  to	  simultaneously	  degrade	  RNA	  and	  synthesize	  second-­‐strand	  cDNA.	  This	   step	  was	   followed	  by	   the	   in	  vitro	   transcription	  using	   IVT	  Labelling	  Master	  Mix	   to	   generate	   multiple	   copies	   of	   biotin-­‐modified	   antisense-­‐RNA	   (aRNA)	   from	   the	  double-­‐stranded	   cDNA	   templates.	   Subsequently	   strand	   DNA	   was	   purified	   to	   remove	  unincorporated	  NTPs,	   salts,	   enzymes	   and	   inorganic	   phosphate.	   Labelled	   cDNA	   (10ug)	  was	  then	  fragmented	  and	  7.5µg	  were	  hybridized	  onto	  Mouse	  Gene	  1.0	  ST	  Array	  Strips.	  The	   reactions	   of	   hybridation,	   fluidics	   and	   imaging	  were	   performed	   on	   the	   Affymetrix	  Gene	  Atlas	  instrument	  according	  to	  the	  manufacturer’s	  protocol.	  	  





(Fischer	  et	  al,	  2010;	  Savic	  et	  al,	  2010).	  SH-­‐053-­‐2’F-­‐S-­‐CH3	  was	  dissolved	  with	  the	  aid	  of	  sonication	  in	  a	  solvent	  containing	  85%	  deionized	  water,	  14%	  propylene	  glycol,	  and	  1%	  Tween	  80.	  Corresponding	  vehicle	  (VEH)	  solution	  consisted	  of	  the	  solvent	  only.	  SH-­‐053-­‐2’F-­‐S-­‐CH3	  was	  administered	  at	  a	  dose	  of	  15	  or	  30	  mg/kg	  (i.p.)	  according	  to	  dose	  ranges	  reported	  previously	  (Savic	  et	  al,	  2010).	  All	  solutions	  were	  freshly	  prepared	  on	  the	  day	  of	  administration	   and	   were	   injected	   using	   an	   injection	   volume	   of	   5ml/kg	   (i.p.).	   The	  solutions	  (drug	  or	  vehicle)	  were	  administered	  20	  minutes	  before	  each	  behavioural	  test.	  
	  
3.5	  Statistical	  Analyses	  
	  





3.5.2	  GABAergic	  Transcriptome	  Project	  All	   gene	   expression	   (real-­‐time	  PCR)	   and	  protein	   expression	   (Western	   blot)	   data	  were	  analysed	  using	  independent	  Student’s	  t	  tests	  (two-­‐tailed).	  In	  the	  dry	  maze	  matching-­‐to-­‐position	   paradigm	   of	   working	  memory,	   the	   distance	  moved	   and	   latency	   to	   locate	   the	  reward	  served	  as	  the	  critical	  test	  read-­‐out	  and	  was	  analysed	  using	  a	  2	  ×	  2	  ×	  5	  (prenatal	  treatment	  ×	  trial	  ×	  day)	  repeated-­‐measures	  ANOVA,	  followed	  by	  Fisher’s	  least	  significant	  difference	  (LSD)	  post-­‐hoc	  comparisons	  or	  restricted	  ANOVAs	  whenever	  appropriate.	  In	  addition,	   a	   2	   ×	   5	   (prenatal	   treatment	   ×	   day)	   repeated-­‐measures	   ANOVA	   of	   the	  improvement	  scores	  (i.e.,	  [time	  or	  distance	  in	  trial	  1]	  –	  [time	  or	  distance	  in	  trial	  2])	  was	  conducted	  in	  the	  dry	  maze	  matching-­‐to-­‐position	  paradigm	  of	  working	  memory.	  All	  data	  were	   separately	   analysed	   for	   peri-­‐pubertal	   and	   adult	   subjects.	   Statistical	   significance	  was	  set	  at	  P	  <	  0.05.	  All	  statistical	  analyses	  were	  performed	  using	  the	  statistical	  software	  StatView	  (version	  5.0)	  implemented	  on	  a	  PC	  running	  the	  Windows	  XP	  operating	  system.	  	  






3.5.4	  Aging	  Project	  All	   data	  were	   analysed	  using	  parametric	   analysis	   of	   variance	   (ANOVA),	   except	   for	   the	  data	  obtained	  in	  the	  food	  hoarding	  test,	  which	  were	  analysed	  using	  non-­‐parametric	  tests	  (see	  below).	  In	  the	  Y-­‐maze	  spatial	  recognition	  test,	  the	  relative	  time	  spent	  in	  the	  novel	  arm	  and	  distance	  moved	  during	   the	  choice	  phase	  were	  analysed	  using	  2	  ×	  3	  (prenatal	  treatment	  ×	  age)	  ANOVAs.	  In	  the	  conditioning	  phase	  of	  contextual	  fear	  test,	  the	  amount	  of	  percent	  time	  freezing	  during	  each	  30-­‐s	  post-­‐shock	  period	  was	  analysed	  using	  a	  2	  ×	  3	  ×	  3	   (prenatal	   treatment	   ×	   age	   ×	   trial)	   repeated-­‐measure	   ANOVA.	   Expression	   of	  conditioned	  fear	  during	  the	  second	  phase	  of	  the	  contextual	  fear	  test	  was	  analysed	  using	  a	   2	   ×	   3	   ×	   6	   (prenatal	   treatment	   ×	   age	   ×	   bins)	   repeated-­‐measure	   ANOVA.	   In	   the	  acquisition	  phase	  of	  the	  Morris	  water	  maze	  test,	  the	  latency	  to	  find	  the	  platform	  across	  trials	   was	   analysed	   using	   a	   2	   ×	   3	   ×	   15	   (prenatal	   treatment	   ×	   age	   ×	   trial)	   repeated-­‐measure	   ANOVA.	   The	   probe	   test	   of	   spatial	  memory	   retention	   in	   the	  water	  maze	  was	  analysed	  using	  a	  2	  ×	  3	  ×	  4	  (prenatal	   treatment	  ×	  age	  ×	  quadrant)	  ANOVA.	   In	   the	  open	  field	   test,	   all	   dependent	   measures	   (total	   distance	   moved	   in	   the	   entire	   arena,	   total	  distance	  moved	   in	   the	   centre	   zone,	   and	   time	   spent	   in	   the	   centre	   zone)	  were	   analysed	  using	   2	   ×	   3	   (prenatal	   treatment	   ×	   age)	   ANOVAs.	   All	   immunohistochemical	   data	   and	  serum	   cytokine	   levels	   were	   also	   analysed	   using	   2	   ×	   3	   (prenatal	   treatment	   ×	   age)	  ANOVAs,	   whereas	   the	   gene	   expression	   data	   were	   analysed	   using	   2	   ×	   2	   (prenatal	  treatment	   ×	   age)	   ANOVAs.	   All	   ANOVAs	   were	   followed	   by	   Fisher's	   least	   significant	  difference	  (LSD)	  post-­‐hoc	  comparisons	  whenever	  appropriate.	  The	  dependent	  measures	  in	  the	  food	  hoarding	  test	  (i.e.,	  food	  hoarded	  and	  food	  eaten	  during	  the	  24-­‐h	  test	  period)	  were	  first	  subjected	  to	  logarithmic	  transformation	  (base	  e)	  to	  reduce	  data	  skewness	  and	  then	  analysed	  using	  non-­‐parametric	  Mann–Whitney	  U	  tests.	  Non-­‐parametric	  tests	  were	  used	   in	   the	   food	   hoarding	   test	   in	   view	   of	   the	   non-­‐normal	   distribution	   of	   the	   primary	  dependent	  measures	   (amount	   of	   food	   hoarded).	   Statistical	   significance	  was	   set	   at	   p	   <	  0.05.	   All	   statistical	   analyses	   were	   performed	   using	   the	   statistical	   software	   StatView	  (version	  5.0)	  implemented	  on	  a	  PC	  running	  the	  Windows	  7	  operating	  system.	  	  	  





Partek	   Genomic	   Suite	   6.6.	   All	   samples	   passed	   the	   criteria	   for	   hybridization	   controls,	  labelling	  controls	  and	  3’/5’	  Metrics.	  Background	  correction	  was	  conducted	  using	  Robust	  Multi-­‐strip	  Average	  (RMA)	  (Irizarry	  et	  al,	  2003)	  to	  remove	  noise	  from	  auto	  fluorescence.	  After	   background	   correction,	   normalization	   was	   conducted	   using	   Quantiles	  normalization	   (Bolstad	   et	   al,	   2003)	   to	   normalize	   the	   distribution	   of	   probe	   intensities	  among	  different	  microarray	  chips.	  Subsequently,	  a	   summarization	  step	  was	  conducted	  using	  a	   linear	  median	  polish	  algorithm	  (Tukey,	  1977)	   to	   integrate	  probe	   intensities	   in	  order	  to	  compute	  the	  expression	  levels	  for	  each	  gene	  transcript.	  Upon	  data	  upload,	  pre-­‐processing	  of	  CEL	  data	  for	  the	  complete	  data	  set	  [total	  of	  twelve	  samples;	  six	  biological	  replicates	   per	   sample	   for	   vehicle,	   six	   biological	   replicates	   for	   GD17	   Poly(I:C)]	   was	  performed	  using	  ANOVA	  to	  assess	  treatment	  effects.	  Differential	  gene	  expression	  across	  treatment	  was	  assessed	  by	  applying	  a	  p-­‐value	   filter	   (for	   treatment)	  of	  p	  <	  0.05	   to	   the	  ANOVA	   results.	   To	   investigate	   the	   effect	   of	   Poly(I:C),	   a	   linear	   contrast	  was	   performed	  [Poly(I:C)	   versus	   vehicle].	   In	   this	   comparison,	   a	   maximum	   filter	   of	   p	   <	   0.05	   and	   a	  minimum	   absolute	   fold	   change	   cut-­‐off	   of	   1.2	   were	   applied.	   Subsequent	   validation	  analysis	   performed	   by	   quantitative	   Real-­‐Time	   PCR	   was	   analysed	   with	   independent	  Student’s	  t	  tests	  (two-­‐tailed).	  





4	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  AND	  DISCUSSION	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relevant	  to	  schizophrenia	  and	  autism	  (Meyer	  et	  al,	  2010a;	  Meyer	  et	  al,	  2009b).	  Poly(I:C)	  is	  a	  synthetic	  analogue	  of	  double-­‐stranded	  RNA	  that	  induces	  a	  cytokine-­‐associated	  viral-­‐like	  acute	  phase	  response	  in	  maternal	  and	  fetal	  compartments,	  including	  the	  fetal	  brain	  (Meyer	  et	  al,	  2010a;	  Meyer	  et	  al,	  2009b).	  Various	   GABAergic	  markers	   were	   assessed	   in	   the	  medial	   prefrontal	   cortex	   (mPFC),	   a	  brain	   region	  known	   to	   be	   sensitive	   to	   the	   disrupting	   effects	   of	   prenatal	   immune	  challenge	  (Fatemi	  et	  al,	  1999;	  Meyer	  et	  al,	  2010a;	  Meyer	  et	  al,	  2009b;	  Meyer	  et	  al,	  2006b;	  Meyer	  et	  al,	  2008d).	  The	  examination	  of	  pre-­‐synaptic	  GABAergic	  markers	   included	  the	  two	   isoforms	  of	   the	   rate	   limiting	   enzyme	   for	  GABA	  biosynthesis,	  GAD65	   and	  GAD67,	   as	  well	   as	   the	   vesicular	   GABA	   transporter	   (VGAT)	   that	   is	   responsible	   for	   uptake	   and	  storage	  of	  GABA	  by	  synaptic	  vesicles	  (Farrant	  and	  Kaila,	  2007).	  In	  addition	  to	  these	  pre-­‐synaptic	  markers,	  we	  ascertained	  the	  expression	  of	  the	  five	  distinct	  alpha-­‐subunits	  (α1-­‐α5)	  of	  the	  GABA(A)	  receptor	  because	  of	  their	  suggested	  pathophysiological	  relevance	  to	  schizophrenia	  (Beneyto	  et	  al,	  2011).	  We	  further	  measured	  the	  expression	   levels	  of	   the	  sodium-­‐potassium-­‐chloride	   co-­‐transporter	   1	   (NKCC1)	   and	   the	   potassium-­‐chloride	   co-­‐transporter	   2	   (KCC2),	   which	   mediate	   chloride	   uptake	   and	   extrusion,	   respectively,	  thereby	  regulating	   the	  extent	   to	  which	  GABA	  signalling	   is	  predominately	  excitatory	  or	  inhibitory	   (Farrant	   et	   al,	   2007).	  All	   gene	   expression	   analyses	  were	   conducted	   in	   peri-­‐puberty	  and	  adulthood	  so	  as	  to	  assess	  possible	  maturation-­‐dependent	  effects	  of	  prenatal	  immune	  activation.	  	  	  
4.1.1	  Prenatal	   Immune	  Activation	   Induces	  Age-­‐Dependent	  Changes	   in	  Prefrontal	  





mRNA	  expression	  of	  GAD65,	   GAD67,	   and	  VGAT	  using	   two	  other	   internal	   house-­‐keeping	  genes,	  namely	  β-­‐actin	  and	  18S	  rRNA	  (Fig.	  3	  and	  Fig.	  4).	  These	  additional	  investigations	  highlight	   that	   the	  effects	  of	  prenatal	   immune	  activation	  on	  GABAergic	  gene	  expression	  are	   readily	   attributable	   to	   significant	   alterations	   in	   the	   expression	   of	   the	   target	   genes	  and	   not	   biased	   by	   possible	   effects	   on	   internal	   standard	   genes.	   Furthermore,	   we	   also	  confirmed	   the	   age-­‐dependent	   effects	   of	   prenatal	   immune	   activation	   on	   presynaptic	  GABAergic	  markers	  at	  the	  protein	  level	  using	  Western	  blot	  analyses:	  Adult	  but	  not	  peri-­‐pubertal	  offspring	  born	  to	  immune-­‐challenged	  mothers	  displayed	  a	  significant	  reduction	  in	  GAD65/67	  and	  VGAT	  protein	  in	  the	  mPFC	  (Fig.	  2b).	  	  	  
	  
	  
Figure	   2.	   Gene	   and	   protein	   expression	   profiling	   of	   presynaptic	   GABAergic	   markers	   in	  
prefrontal	  cortex	  following	  prenatal	   immune	  activation.	  (a)	  Levels	  of	  mRNA	  expression	   in	  prenatally	   poly(I:C)-­‐exposed	   (POL)	   and	   control	   (CON)	   offspring	   at	   peri-­‐pubertal	   or	   adult	   age	  assessed	   using	   quantitative	   real-­‐time	   PCR.	   *P	   <	   0.05	   and	   **P	   <	   0.01,	   based	   on	   independent	  Student’s	   t	   tests	   (two-­‐tailed).	   N(CON/peri-­‐puberty)	   =	   10,	   N(POL/	   peri-­‐puberty)	   =	   7,	  







Figure	   3.	   Gene	   expression	   profiling	   of	   presynaptic	   GABAergic	   markers	   in	   prefrontal	  




Figure	   4.	   Gene	   expression	   profiling	   of	   presynaptic	   GABAergic	   markers	   in	   prefrontal	  
cortex	   following	   prenatal	   immune	   activation	   using	   18S	   rRNA	   as	   internal	   normalizing	  
gene.	   The	   graph	   depicts	   the	   levels	   of	   normalized	   mRNA	   expression	   in	   prenatally	   poly(I:C)-­‐exposed	   (POL)	   and	   control	   (CON)	   offspring	   at	   peri-­‐pubertal	   or	   adult	   age	   assessed	   using	  quantitative	   real-­‐time	   PCR.	   *P	   <	   0.05,	   based	   on	   independent	   Student’s	   t	   tests	   (two-­‐tailed).	  
N(CON/peri-­‐puberty)	   =	   9,	   N(POL/	   peri-­‐puberty)	   =	   7,	   N(CON/adulthood)	   =	   11,	   N(POL/	  adulthood)	  =	  9.	  All	  values	  are	  means±SEM.	  	  
	  
	  





4.1.2	  Prenatal	   Immune	  Activation	   Induces	  Age-­‐Dependent	  Changes	   in	  Prefrontal	  
Transcription	  of	  GABA(A)	  Alpha-­‐Receptor	  Subunit	  We	  also	  sought	  evidence	  for	  the	  possibility	  that	  prenatal	  immune	  activation	  may	  affect	  the	  transcription	  of	  GABA(A)	  receptor	  genes.	  To	  this	  end,	  we	  focused	  on	  the	  expression	  of	  the	  five	  alpha	  subunits	  (α1-­‐α5)	  of	  the	  GABA(A)	  receptor	  because	  previous	  investigations	  have	   detected	   cellular	   changes	   in	   the	   expression	   of	   these	   subunits	   following	   prenatal	  immune	  activation	   in	  mice	  (Meyer	   et	  al,	  2008d;	  Nyffeler	   et	  al,	  2006;	  Samuelsson	   et	  al,	  2006).	   Here,	   we	   show	   that	   prenatal	   immune	   activation	   leads	   to	   age-­‐dependent	  alterations	   in	   the	  expression	  of	   the	  alpha-­‐subunits	  of	  GABA(A)	   receptor	  genes	   (Fig.	  5):	  Whereas	  prefrontal	  mRNA	  levels	  of	  the	  α2	  and	  α4	  subunits	  were	  significantly	  increased	  in	   immune-­‐challenged	   offspring	   at	   peri-­‐pubertal	   age	   (Fig.	   5),	   expression	   of	   the	   same	  genes	  was	  markedly	  down-­‐regulated	   in	   immune-­‐exposed	  offspring	  when	  they	  reached	  adulthood	   (Fig.	   5).	   Furthermore,	   adult	   but	   not	   peri-­‐pubertal	   offspring	   showed	   a	  significant	   increase	   and	   decrease	   in	   the	   expression	   of	   α3	   and	   α5	   mRNA	   levels,	  respectively	  (Fig.	  5).	  	  









Figure	   5.	   Analysis	   of	   GABA(A)	   receptor	   alpha-­‐subunits	  mRNA	   levels	   in	   prefrontal	   cortex	  
following	  prenatal	  immune	  activation.	  (a)	  The	  square	  symbols	  represent	  mRNA	  levels	  of	  the	  α1-­‐5	   subunits	   in	   prenatally	   poly(I:C)-­‐exposed	   (POL)	   and	   control	   (CON)	   offspring	   at	   peri-­‐pubertal	   age.	   *P	   <	   0.05,	   based	   on	   independent	   Student’s	   t	   tests	   (two-­‐tailed).	   N(CON)	   =	   10,	  
N(POL)	   =	   7.	   (b)	   The	   square	   symbols	   show	   mRNA	   levels	   of	   α1-­‐5	   subunits	   in	   POL	   and	   CON	  offspring	   at	   adult	   age.	   *P	   <	   0.05	   and	   **P	   <	   0.01,	   based	  on	   independent	   Student’s	   t	   tests	   (two-­‐tailed).	  N(CON/peri-­‐puberty)	  =	  9,	  N(POL/	  peri-­‐puberty)	  =	  7,	  N(CON/adulthood)	  =	  11,	  N(POL/	  adulthood)	  =	  9.	  All	  values	  are	  means±SEM.	  
	  
	  





4.1.3	   Prenatal	   Immune	   Activation	   Induces	   Age-­‐Dependent	   Changes	   in	   Genes	  
Regulating	  the	  GABA	  Excitatory/Inhibitory	  Shift	  The	  age-­‐dependent	  alterations	  of	  presynaptic	  and	  receptors-­‐associated	  GABAergic	  gene	  expression	   manifest	   in	   immune-­‐challenged	   offspring	   may	   be	   indicative	   of	   altered	  maturation	  of	  the	  prefrontal	  GABA	  system.	  To	  further	  seek	  evidence	  for	  this	  possibility,	  we	   measured	   the	   gene	   transcription	   levels	   of	   NKCC1	   and	   KCC2,	   which	   regulate	   the	  extent	  to	  which	  GABA	  signalling	  is	  either	  excitatory	  or	  inhibitory	  (Farrant	  et	  al,	  2007).	  KCC2	   is	  a	  potassium-­‐chloride	  co-­‐transporter	   that	  mediates	  chloride	  extrusion,	   thereby	  facilitating	  the	  inhibitory	  actions	  of	  GABA	  (Farrant	  et	  al,	  2007).	  It	  is	  expressed	  primarily	  in	  mature	  neurons	  and	  its	  expression	  therefore	  peaks	  only	  after	  full	  brain	  maturation	  in	  adulthood	   (Hashimoto	   et	   al,	   2008b).	   In	   contrast,	   sodium-­‐potassium-­‐chloride	   co-­‐transporter	  NKCC1	  shows	  peak	  levels	  during	  early	  postnatal	  brain	  development,	  a	  time	  when	   GABA	   signalling	   is	   primarily	   excitatory	   (Ben-­‐Ari	   et	   al,	   2012).	   Therefore,	   the	  relative	  expression	  of	  NKCC1	  versus	  KCC2	  is	  typically	  taken	  as	  a	  molecular	  index	  of	  the	  functional	  maturation	  of	  the	  central	  GABA	  system.	  	  We	   found	   that	  prenatal	   immune	  activation	   increased	   the	   transcription	   levels	  of	  both	  NKCC1	  and	  KCC2	  in	  the	  mPFC	  of	  peri-­‐pubertal	  offspring	  (Fig.	  6a).	  Because	  of	  this	  concomitant	  enhancement,	  the	  NKCC1:KCC2	  ratio	  was	  highly	  similar	  between	  immune-­‐challenged	  offspring	  ad	  controls	  at	  peri-­‐pubertal	  age	  (Fig.	  6b).	  In	  marked	  contrast,	  adult	  offspring	   born	   to	   immune-­‐challenged	   mothers	   displayed	   a	   significant	   increase	   and	  decrease	   in	   the	   transcription	   of	   NKCC1	   and	   KCC2,	   respectively	   (Fig.	   6a).	   This	  imbalanced	   expression	   was	   further	   evident	   in	   the	   NKCC1:KCC2	   ratio,	   which	   was	  significantly	  increased	  in	  immune-­‐challenged	  offspring	  relative	  to	  controls	  at	  adult	  age	  (Fig.	  6b).	  Taken	  together,	   these	  findings	  support	  the	  hypothesis	  that	  prenatal	   immune	  activation	   disrupts	   the	   normal	   maturation	   of	   the	   prefrontal	   GABA	   system,	   leading	   to	  molecular	  signs	  of	  an	  immature	  GABAergic	  system	  in	  adulthood.	  	  








Figure	  6.	  Analysis	  of	  NKCC1	  and	  KCC2	  mRNA	  levels	  in	  prefrontal	  cortex	  following	  prenatal	  
immune	   activation.	   (a)	   The	   square	   symbols	   represent	   mRNA	   levels	   of	   NKCC1	   and	   KCC2	   in	  prenatally	  poly(I:C)-­‐exposed	  (POL)	  and	  control	  (CON)	  offspring	  at	  peri-­‐pubertal	  age,	  and	  the	  bar	  plot	   depicts	   the	   NKCC1:KCC2	   ratio.	   *P	   <	   0.05,	   based	   on	   independent	   Student’s	   t	   tests	   (two-­‐tailed).	  N(CON)	  =	  10,	  N(POL)	  =	  7.	  (b)	  The	  square	  symbols	  show	  mRNA	  levels	  of	  NKCC1	  and	  KCC2	  in	  prenatally	  poly(I:C)-­‐exposed	  (POL)	  and	  control	  (CON)	  offspring	  at	  adult	  age,	  and	  the	  bar	  plot	  represents	   the	  NKCC1:KCC2	   ratio.	   *P	   <	  0.05	  and	   **P	   <	  0.01,	  based	  on	   independent	  Student’s	   t	  tests	  (two-­‐tailed).	  N(CON/peri-­‐puberty)	  =	  9,	  N(POL/	  peri-­‐puberty)	  =	  7,	  N(CON/adulthood)	  =	  11,	  
N(POL/	  adulthood)	  =	  9.	  All	  values	  are	  means±SEM.	  
	  
	  





4.1.4	   Prenatal	   Immune	   Activation	   Induces	   an	   Adult	   Onset	   of	   Working	   Memory	  
Impairments	  Because	   of	   its	   critical	   role	   in	   regulating	   neuronal	   synchronization,	   the	   prefrontal	  GABAergic	   system	   critically	   contributes	   to	   a	   variety	   of	   cognitive	   functions,	   including	  working	  memory	   (Lewis	   et	   al,	   2005).	   Impairments	   in	   prefrontal	   GABAergic	   signalling	  are	   therefore	   believed	   to	   significantly	   contribute	   to	   working	   memory	   deficits	   in	  psychiatric	   disorders,	   especially	   in	   schizophrenia	   (Lewis	   et	   al,	   2005).	   In	   view	   of	   our	  findings	  demonstrating	  maturation-­‐dependent	  alterations	  in	  prefrontal	  GABAergic	  gene	  transcription	   following	   prenatal	   immune	   activation	   (Figs.	   2	   to	   6),	   we	   further	  ascertained	  whether	  the	  presence	  of	  these	  molecular	  changes	  might	  be	  accompanied	  by	  cognitive	   dysfunctions	   in	   the	   form	   of	   working	   memory	   impairments.	   Because	   the	  prefrontal	  GABAergic	  transcriptome	  is	  arguably	  more	  affected	  in	  adult	  as	  compared	  to	  peri-­‐pubertal	   offspring	   born	   to	   immune-­‐challenged	   mothers	   (Figs.	   2	   to	   6),	   one	   clear	  expectation	   would	   be	   that	   the	   negative	   influences	   of	   prenatal	   immune	   challenge	   on	  cognitive	   functions	   may	   be	   readily	   noticeable	   in	   adulthood	   as	   compared	   to	   earlier	  maturational	  stages.	  	  
	   The	   assessment	   of	   working	   memory	   performance	   in	   immune-­‐challenged	   and	  control	  offspring	  confirmed	  this	  expectation:	  Using	  a	  matching-­‐to-­‐position	  paradigm,	  we	  found	   that	   adult	   but	   not	   peri-­‐pubertal	   offspring	   born	   to	   immune-­‐challenged	  mothers	  displayed	  a	  severe	  working	  memory	  deficit	  (Fig.	  7).	   Indeed,	  at	   the	  peri-­‐pubertal	  stage,	  both	   immune-­‐challenged	  and	   control	   subjects	   showed	  a	   clear	   reduction	   in	   the	   latency	  and	   distance	  moved	   to	   find	   the	   rewarded	   hole	   in	   trial	   2	   relative	   to	   trial	   1	   (when	   the	  position	   of	   the	   rewarded	   hole	   was	   unknown	   to	   the	   animals)	   (Fig.	   7a).	   In	   marked	  contrast,	  such	  improvement	  in	  performance	  from	  trial	  1	  to	  trial	  2	  was	  no	  longer	  evident	  in	  adult	  offspring	  subjected	  to	  prenatal	  immune	  activation,	  whilst	  at	  the	  same	  time,	  adult	  control	  offspring	  still	  displayed	  highly	  significant	  reduction	  in	  the	  latency	  and	  distance	  moved	  to	  find	  the	  rewarded	  hole	  in	  trial	  2	  relative	  to	  trial	  1	  (Fig.	  7b).	  	  
	  







Figure	  7.	  Working	  memory	  performance	   following	  prenatal	   immune	  activation.	   The	   line	  plots	  show	  the	  latency	  (sec)	  and	  distance	  moved	  (cm)	  to	  find	  the	  rewarded	  hole	  in	  trial	  1	  (T1)	  and	   T2,	   and	   the	   bar	   plots	   depicts	   the	   improvement	   in	   these	   measures	   from	   T1	   to	   T2.	   The	  drawings	  illustrate	  computer-­‐generated	  search	  path	  of	  representative	  CON	  and	  POL	  offspring	  in	  T1	  and	  T2	  of	  the	  working	  memory	  test.	  S,	  Starting	  position;	  R,	  location	  of	  the	  rewarded	  hole.	  (a)	  Working	   memory	   performance	   in	   prenatally	   poly(I:C)-­‐exposed	   (POL)	   and	   control	   (CON)	  offspring	   at	   peri-­‐pubertal	   age.	   ***P	   <	   0.001,	   reflecting	   the	   significant	   main	   effect	   of	   trials	  [latency:	  F(1,25)	   =	  14.63,	  P	   <	  0.001;	  distance:	   F(1,25)	   =	  11.75,	  P	   <	  0.001]	  obtained	  by	   a	  2	  ×	  2	  ×	  5	  (prenatal	   treatment	   ×	   trial	   ×	   day)	   repeated-­‐measures	   ANOVA.	  N(CON)	   =	   13,	  N(POL)	   =	   14.	  All	  values	   are	  means±SEM.	   (b)	  Working	  memory	  performance	   in	  POL	  and	  CON	  offspring	  at	   adult	  age.	   **P	   <	   0.01,	   reflecting	   the	   significant	  main	   effect	   of	   trials	   [latency:	   F(1,16)	   =	   7.92,	  P	   <	   0.01;	  distance:	   F(1,16)	   =	   8.95,	  P	   <	   0.01]	   in	   adult	   CON	   animals	   following	   the	   presence	   of	   a	   significant	  prenatal	  treatment	  ×	  trial	  interaction	  [latency:	  F(1,29)	  =	  4.58,	  P	  <	  0.05;	  distance:	  F(1,29)	  =	  6.48,	  P	  <	  0.05];	  §P	  <	  0.01,	  reflecting	  the	  significant	  difference	  between	  CON	  and	  POL	  animals	  in	  T2	  based	  on	  post-­‐hoc	  comparisons;	  *P	  <	  0.05,	  reflecting	  the	  significant	  difference	  between	  CON	  and	  POL	  animals	  associated	  with	  the	  significant	  main	  effect	  of	  prenatal	  treatment	  [latency:	  F(1,29)	  =	  5.01,	  P	  <	  0.05;	  distance:	  F(1,29)	  =	  5.82,	  P	  <	  0.05]	  obtained	  by	  2	  ×	  5	  (prenatal	  treatment	  ×	  day)	  repeated-­‐measures	   ANOVA	   of	   the	   improvement	   scores.	   N(CON)	   =	   17,	   N(POL)	   =	   14.	   All	   values	   are	  means±SEM.	  
	  
	  










the	  complex	  temporal	  dynamics	  underlying	  the	  normal	  maturation	  of	  the	  central	  GABA	  system,	  in	  which	  even	  subtle	  changes	  during	  development	  can	  exert	  a	  profound	  impact	  on	  long-­‐term	  GABAergic	  signalling	  (Levitt	  et	  al,	  2004).	  Our	  findings	  of	  altered	  NKCC1	  and	  KCC2	  mRNA	  expression	  in	  prenatally	  immune-­‐challenged	   offspring	   further	   support	   the	   hypothesis	   of	   altered	   GABAergic	   maturation	  following	   exposure	   to	   the	   prenatal	   immunological	   insult.	   The	   expression	   of	   these	   two	  chloride	   transporters	   is	  developmentally	   regulated,	  which	   in	   turn	   is	  pivotal	   in	   shifting	  the	  functional	  properties	  of	  GABA	  from	  initially	  excitatory	   in	  the	  developing	   immature	  brain	  to	  its	  predominantly	  inhibitory	  actions	  in	  the	  adult	  nervous	  system	  (Ben-­‐Ari	  et	  al,	  2012).	  Whereas	   the	  mRNA	   expression	   levels	   of	  NKCC1	   and	  KCC2	  were	   concomitantly	  increased	   in	   peri-­‐pubertal	   offspring	   born	   to	   immune	   challenged	  mothers,	   the	   relative	  expression	  of	  NKCC1	  versus	  KCC2	  was	  strongly	  shifted	  towards	  increased	  and	  decreased	  NKCC1	  and	  KCC2	  levels,	  respectively,	  when	  these	  offspring	  reached	  adult	  age.	  Owing	  to	  the	   normal	   developmental	   regulation	   of	   these	   chloride	   transporters,	   the	   presence	   of	  such	  imbalanced	  NKCC1	  and	  KCC2	  expression	  in	  the	  adult	  brain	  is	  typically	  taken	  as	  an	  index	  of	  an	  immature	  GABAergic	  phenotype	  (Ben-­‐Ari	  et	  al,	  2012).	  Interestingly,	  a	  similar	  pattern	  of	  imbalanced	  NKCC1	  and	  KCC2	  expression	  has	  recently	  been	  documented	  in	  the	  hippocampus	   of	   schizophrenic	   patients	   (Hyde	   et	   al,	   2011).	   In	   addition,	   some	   of	   the	  kinases	   strongly	   regulating	   KCC2	   and	  NKCC1	   activity	  were	   found	   to	   be	   altered	   in	   the	  dorsolateral	   prefrontal	   cortex	   (DLPFC)	   of	   schizophrenic	   patients	   (Arion	   and	   Lewis,	  2011).	   Hence,	   alterations	   in	   molecular	   mechanisms	   regulating	   the	   nature	   of	   GABA	  neurotransmission	  (inhibitory	  versus	  excitatory)	  are	  noticeable	  both	  in	  human	  subjects	  with	   schizophrenia	   and	   in	   the	   present	   experimental	   model	   system	   relevant	   to	  schizophrenia	  and	  related	  disorders.	  The	   present	   study	   also	   confirms	   the	   deleterious	   impact	   of	   prenatal	   immune	  activation	  on	  working	  memory	  (Bitanihirwe	  et	  al,	  2010b;	  Connor	  et	  al,	  2012;	  Meyer	  et	  
al,	   2008d;	   Vuillermot	   et	   al,	   2010).	   Working	   memory	   is	   a	   special	   short-­‐term	  memory	  buffer	  used	  to	  hold	  relevant	   information	  temporarily	  active	   in	  order	  to	  guide	  on-­‐going	  behaviour,	  and	  its	  disruption	  is	  a	  cardinal	  cognitive	  symptom	  in	  schizophrenia	  (Lewis	  et	  










stream	   molecular	   mechanisms	   modifying	   GABAergic	   gene	   transcription	   in	   offspring	  subjected	  to	  prenatal	  immune	  activation.	  For	  example,	  it	  remains	  uncharted	  whether	  the	  identified	  reductions	  in	  GAD65	  and	  GAD67	  protein	  and	  mRNA	  levels	  could	  be	  accounted	  for	   by	   reduced	   numbers	   of	   functionally	   intact	   interneurons	   and/or	   by	   altered	  transcriptional	   activity	   of	   the	   corresponding	   enzymes.	   On	   speculative	   grounds,	   one	  feasible	  and	  testable	  possibility	  would	  be	  that	  prenatal	  immune	  activation	  could	  induce	  epigenetic	  changes	  in	  the	  central	  GABA	  system,	  which	  is	  known	  to	  be	  highly	  accessible	  to	  epigenetic	  modifications	  (Guidotti	  et	  al,	  2011).	  In	   conclusion,	   our	   experimental	   data	   suggests	   that	   prenatal	   immune	   activation	  induces	  maturation-­‐dependent	   alterations	   in	   the	   prefrontal	   GABAergic	   transcriptome.	  The	   importance	  of	  GABAergic	  changes	  present	   in	  schizophrenia	  and	  related	  disorders,	  together	   with	   our	   experimental	   data	   here,	   highlights	   the	   critical	   impact	   of	   prenatal	  immune-­‐related	   insults	   on	   long-­‐term	  GABAergic	   changes	   relevant	   to	   neuropsychiatric	  disorders	  with	  prenatal	  infectious	  aetiologies.	  It	  is	  also	  highly	  interesting	  to	  note	  that	  a	  variety	  of	  pre-­‐	  or	  perinatal	  manipulations	  that	  negatively	  affect	  early	  brain	  development	  are	  capable	  of	  inducing	  similar	  long-­‐term	  GABAergic	  pathology,	  including	  lesions	  of	  the	  neonatal	   ventral	   hippocampus	   (Tseng	   et	   al,	   2008)	   and	   prenatal	   exposure	   to	   the	  antimitotic	  agent	  methylazoxymethanol	  acetate	   (MAM)(Penschuck	   et	  al,	   2006).	  Hence,	  alterations	   in	   the	   adult	   central	   GABA	   system	   may	   represent	   a	   critical	   pathological	  convergence	  point	  for	  various	  early-­‐life	  adversities.	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Prenatal	  exposure	  to	  maternal	  infection	  represents	  a	  risk	  factor	  for	  the	  development	  of	  several	   neuropsychiatric	   disorders	   with	   a	   neurodevelopmental	   origin,	   most	   notably	  schizophrenia	   and	   autism	   (Brown,	   2011).	   A	   number	   of	   translational	   rodent	   models	  support	   this	   epidemiological	   association	   by	   demonstrating	   multiple	   disease-­‐relevant	  behavioural,	   cognitive	  and	  neuroanatomical	  alterations	   following	  prenatal	  exposure	   to	  infectious	  pathogens	  or	   immune-­‐activating	   agents	   (reviewed	   in	   (Meyer	   et	   al,	   2009b)).	  Importantly,	  such	  translational	  research	  has	  been	  extended	  successfully	  to	  species	  with	  more	   advanced	   prenatal	   development,	   including	   rhesus	   monkeys	   (Short	   et	   al,	   2010;	  Willette	   et	   al,	   2011)	   and	   spiny	   mice	   (Ratnayake	   et	   al,	   2012),	   which	   further	   helps	   to	  verify	   the	   relevance	   of	   animal	  model	   findings	   to	   the	   human	   condition.	   According	   to	   a	  prevalent	  hypothesis,	   the	  maternal	   cytokine-­‐associated	   response	   (Gilmore	   et	   al,	   1997;	  Meyer	   et	   al,	   2008a;	   Smith	   et	   al,	   2007),	   together	  with	   downstream	   pathophysiological	  processes	  such	  as	  oxidative	  stress	  (Lante	  et	  al,	  2008),	  hypoferremia	  (Aguilar-­‐Valles	  et	  al,	  2010),	   and	   zinc	   deficiency	   (Coyle	   et	   al,	   2009),	   are	   critical	   in	   mediating	   the	   negative	  influences	  of	  prenatal	  infection	  on	  brain	  and	  behavioural	  development.	  	  It	  has	  been	  widely	  acknowledged	  that	  the	  long-­‐term	  brain	  dysfunctions	  manifest	  in	  prenatally	  immune-­‐challenged	  offspring	  may	  stem	  from	  alterations	  in	  early	  prenatal	  brain	  development	  (Garbett	  et	  al,	  2012;	  Meyer	  et	  al,	  2008d;	  Stolp	  et	  al,	  2011;	  Vuillermot	  





hold	   relevant	   information	   temporarily	   active	   in	   order	   to	   guide	   on-­‐going	   behaviour	  (Baddeley,	  2003),	  and	  its	  disruption	  is	  a	  cardinal	  cognitive	  symptom	  in	  neuropsychiatric	  disorders	  with	  prenatal	  infectious	  aetiologies,	  including	  schizophrenia	  (Goldman-­‐Rakic,	  1994)	   and	   autism	   (Hill,	   2004).	   Offspring	   of	   gestationally	   immune-­‐challenged	  mothers	  seem	  to	  be	  highly	  vulnerable	  to	  cognitive	  impairments	  in	  the	  form	  of	  working	  memory	  deficiency.	   For	   example,	  whereas	  numerous	   studies	   consistently	  documented	  working	  memory	   deficits	   following	   prenatal	   viral-­‐like	   immune	   activation	   (Bitanihirwe	   et	   al,	  2010b;	   Connor	   et	   al,	   2012;	  Meyer	   et	   al,	   2008a;	   Richetto	   et	   al,	   2014;	   Vuillermot	   et	   al,	  2012),	  the	  same	  manipulation	  does	  not	  appear	  to	  affect	  (spatial)	  reference	  memory	  or	  basic	   forms	   of	   classical	   fear	   conditioning,	   active	   avoidance	   learning,	   and	   left-­‐right	  discrimination	  learning	  (Meyer	  et	  al,	  2006b;	  Meyer	  et	  al,	  2006c;	  Zuckerman	  and	  Weiner,	  2005).	   In	   addition	   to	   its	   negative	   influence	   on	  working	  memory,	   however,	   prenatally	  immune-­‐challenged	   offspring	   also	   display	   abnormalities	   in	   selective	   or	   sustained	  attention	  (Meyer	  et	  al,	  2005;	  Vuillermot	  et	  al,	  2012;	  Zuckerman	  et	  al,	  2003a;	  Zuckerman	  





by	   elevated	  behavioural	   and	  neurochemical	   sensitivity	   to	   acute	   treatment	  with	  AMPH	  (Laruelle,	  2000).	  In	   addition	   the	   behavioural	   and	   cognitive	   testing,	   we	   performed	   a	   series	   of	  molecular	   investigations	   aiming	   to	   explore	   potential	   mechanisms	   underlying	   the	  anticipated	  prenatal	  and	  postnatal	  maternal	  effects	  on	   the	  offspring.	  More	  specifically,	  we	  measured	  the	  transcription	  levels	  of	  the	  two	  isoforms	  of	  the	  rate-­‐limiting	  enzyme	  for	  γ-­‐aminobutyric	  acid	  (GABA)	  biosynthesis,	  glutamic	  acid	  decarboxylase	  65-­‐kDa	  (GAD65)	  and	   67-­‐kDa	   (GAD67),	   in	   prefrontal	   and	   hippocampal	   areas	   of	   the	   fostered	   offspring.	  Converging	   evidence	   points	   to	   an	   important	   role	   of	   impaired	   presynaptic	   GABAergic	  mechanisms	   such	   as	   deficient	   GAD65	   and	   GAD67	   synthesis	   in	   the	   pathophysiology	   of	  neurodevelopmental	   brain	   disorders,	   including	   schizophrenia	   and	   autism	   (Blatt	   et	   al,	  2011;	   Lewis	   et	   al,	   2005).	   Furthermore,	   impaired	   GABAergic	   signalling	   in	   prefrontal	  and/or	  hippocampal	  areas	  is	  likely	  to	  contribute	  to	  working	  memory	  deficiency	  as	  seen	  in	  patients	  with	  schizophrenia	  (Lewis	  et	  al,	  2005).	  
	  
4.2.1	   Infection-­‐Induced	   Working	   Memory	   Impairments	   in	   the	   Matching-­‐to-­‐
Position	  Paradigm	  Are	  Mediated	  by	  Prenatal	  but	  not	  Postnatal	  Maternal	  Effects	  	  We	   first	   evaluated	   the	   impact	   of	   the	   prenatal	   and	   postnatal	  manipulations	   on	   spatial	  working	  memory	  in	  the	  dry	  maze	  matching-­‐to-­‐position	  paradigm.	  The	  critical	  measure	  of	  working	  memory	   in	   this	   task	   is	   the	   reduction	   in	   distance	  moved	   and	   time	   needed	  (latency)	  to	  find	  the	  location	  of	  the	  rewarded	  hole	  from	  trial	  one	  (when	  the	  location	  of	  the	  reward	  is	  unknown	  to	  the	  subjects)	  to	  trial	  two.	  	  
• Pubescence	  As	   shown	   in	   Fig.	   8a,	   offspring	   from	   all	   four	   experimental	   groups	   showed	   a	  noticeable	  reduction	  in	  the	  latency	  and	  distance	  moved	  in	  trial	  2	  relative	  to	  trial	  1	  of	  the	  working	   memory	   test,	   leading	   to	   a	   highly	   significant	   main	   effect	   of	   trials	   [latency:	  





reduced	   in	  prenatally	  poly(I:C)-­‐exposed	  offspring	  relative	   to	  offspring	  born	   to	  vehicle-­‐treated	  mothers	  irrespective	  of	  the	  postnatal	  rearing	  conditions.	  This	  pattern	  of	  results	  was	   also	   mirrored	   in	   the	   analysis	   of	   the	   latency	   improvement	   scores	   yielding	   a	  significant	  main	  effect	  of	  prenatal	   treatment	   [F(1,53)	  =	  5.78,	  p	  <	  0.05].	  The	  analysis	  of	  the	   distance	   improvement	   scores	   did	   not	   reveal	   any	   significant	   effects	   involving	   the	  between-­‐subjects	  factors	  of	  prenatal	  treatment	  and	  postnatal	  rearing.	  	  







Figure	   8.	   Effects	   of	   the	   prenatal	   and	   postnatal	   manipulations	   on	   spatial	   matching-­‐to-­‐
position	  working	  memory	  in	  the	  dry	  maze	  paradigm.	  The	  line	  plots	  show	  the	   latency	  (sec)	  and	   distance	  moved	   (cm)	   to	   find	   the	   rewarded	   hole	   in	   trial	   1	   (T1)	   and	   T2,	   and	   the	   bar	   plots	  depicts	  the	  improvement	  in	  these	  measures	  from	  T1	  to	  T2.	  (A)	  Working	  memory	  performance	  of	  fostered	  offspring	  at	  pubescent	  age.	  *P	  <	  0.05,	  reflecting	   the	  significant	  main	  effect	  of	  prenatal	  treatment.	   (B)	   Working	   memory	   performance	   of	   fostered	   offspring	   at	   adult	   age.	   *P	   <	   0.05,	  reflecting	   the	   significant	  main	   effect	   of	   prenatal	   treatment.	   All	   values	   are	  means±SEM.	   CON	   =	  vehicle	  control;	  POL	  =	  poly(I:C).	  
	  
	  





4.2.2	   Infection-­‐Induced	   Working	   Memory	   Impairments	   in	   the	   Spatial	   Novelty	  
Preference	  Y-­‐Maze	  Paradigm	  Are	  Mediated	  by	  Prenatal	  but	  not	  Postnatal	  Maternal	  
Effects	  	  In	  a	  next	  step,	  we	  explored	  the	   impact	  of	   the	  prenatal	  and	  postnatal	  manipulations	  on	  spatial	  working	  memory	  using	  a	  spatial	  novelty	  preference	  paradigm	  in	  the	  Y-­‐maze.	  The	   critical	  measure	   of	   spatial	   recognition	  memory	   in	   the	   Y-­‐maze	   test	   is	   the	   relative	  time	  spent	  in	  the	  novel	  (previously	  unexplored)	  arm	  during	  the	  choice	  phase	  of	  the	  test.	  	  
• Pubescence	  Pubescent	  offspring	  born	  to	  vehicle-­‐treated	  mothers	  displayed	  a	  clear	  preference	  for	  the	  novel	   arm	   regardless	   of	   the	   postnatal	   rearing	   conditions	   (Fig.	   9a).	   Hence,	   they	  performed	  markedly	  above	  the	  chance	   level	  of	  33.3%	  (Fig.	  9a).	   In	  contrast,	  pubescent	  offspring	  exposed	  to	  prenatal	  poly(I:C)	  exposure	  showed	  no	  obvious	  preference	  for	  the	  novel	  arm,	  indicating	  impaired	  spatial	  novelty	  preference	  in	  these	  animals	  (Fig.	  9a).	  The	  prenatal	   poly(I:C)-­‐induced	   impairment	   in	   spatial	   novelty	   preference	   emerged	  independently	   of	   the	   postnatal	   rearing	   conditions.	  Hence,	   prenatal	   immune	   activation	  led	   to	   significant	   Y-­‐maze	  working	  memory	   impairment	   via	   prenatal	   but	   not	   postnatal	  maternal	  factors.	  The	   interpretations	  were	   statistically	   supported	   by	   the	   presence	   of	   a	   significant	  main	  effect	   of	   prenatal	   treatment	   [F(1,53)	   =	   6.71,	   p	   <	   0.05]	   in	   the	   analysis	   of	   the	   novelty	  preference	   index	   (%	   time	   novel	   arm).	   No	   other	   main	   effects	   or	   interactions	   attained	  statistical	  significance.	  There	  were	  also	  no	  significant	  group	  differences	  with	  respect	  to	  the	  distance	  moved	  during	  the	  choice	  phase	  (Fig.	  9a)	  or	  during	  the	  initial	  sample	  phase	  (data	   not	   shown).	   Hence,	   the	   prenatal	   poly(I:C)-­‐induced	   working	   memory	   deficits	  observed	  in	  the	  spatial	  novelty	  preference	  Y-­‐maze	  task	  were	  not	  confounded	  by	  possible	  differences	  in	  basal	  locomotor	  activity	  and	  maze	  exploration	  per	  se.	  











Figure	   9.	   Effects	   of	   the	   prenatal	   and	   postnatal	   manipulations	   on	   spatial	   novelty	  
preference	  in	  the	  Y-­‐maze	  paradigm.	  The	  bar	  plots	  depicts	  the	  percent	  (%)	  time	  spent	  in	  the	  novel	  arm	  and	  total	  distance	  moved	  (cm)	  during	  the	  choice	  phase.	  (A)	  Spatial	  novelty	  preference	  in	  fostered	  offspring	  at	  pubescent	  age.	  *P	  <	  0.05,	  reflecting	  the	  significant	  main	  effect	  of	  prenatal	  treatment.	  (B)	  Spatial	  novelty	  preference	  in	  fostered	  offspring	  at	  adult	  age.	  *P	  <	  0.05,	  reflecting	  the	   significant	   main	   effect	   of	   prenatal	   treatment	   All	   values	   are	   means±SEM.	   CON	   =	   vehicle	  control;	  POL	  =	  poly(I:C).	  	  





4.2.3	   Prenatal	   and	   Postnatal	   Maternal	   Factors	   Affect	   Amphetamine	   Sensitivity	  
Following	  Prenatal	  Exposure	  to	  Infection	  We	   also	   evaluated	   the	   effects	   of	   the	   prenatal	   and	   postnatal	   manipulations	   on	   the	  offspring’s	   sensitivity	   to	   acute	   AMPH	   challenge.	   For	   this	   purpose,	   we	   exposed	   the	  animals	   to	   acute	   systemic	  AMPH	   (2.5	  mg/kg,	   i.p.)	   following	   an	   initial	   habituation	   and	  vehicle	  (saline)	  administration	  phase	  and	  measured	  the	  animals’	  locomotor	  reaction	  to	  the	  drug	  challenge	  in	  a	  standard	  open	  field.	  	  
• Pubescence	  As	  depicted	   in	  Fig.	  10a,	   the	  prenatal	   and	  postnatal	  manipulations	  did	  not	   affect	  basal	  locomotor	   activity	   during	   the	   initial	   habituation	   or	   subsequent	   vehicle	   administration	  phase.	  Acute	  treatment	  with	  AMPH	  generally	  led	  to	  an	  increase	  in	  the	  locomotor	  activity,	  leading	  to	  a	  significant	  main	  effect	  of	  bins	  [F(17,884)	  =	  11.21,	  p	  <	  0.001].	  The	  locomotor-­‐enhancing	  effects	  of	  AMPH	  were	  significantly	  potentiated	  in	  pubescent	  offspring	  raised	  by	   gestationally	   infected	   mothers	   regardless	   of	   their	   prenatal	   immune	   treatment	  histories	   (Fig.	   10a).	   The	   presence	   of	   this	   postnatal	   maternal	   effect	   was	   statistically	  supported	  by	   the	   significant	  main	   effect	   of	   postnatal	   rearing	   bins	   [F(1,52)	   =	   3.99,	  p	  <	  0.05]	  and	  its	  interaction	  with	  bins	  [F(17,884)	  =	  1.99,	  p	  <	  0.01]	  in	  the	  ANOVA	  of	  distance	  moved	   following	  AMPH	  administration.	  No	  other	  main	   effects	   or	   interactions	   attained	  statistical	  significance.	  	  





POL-­‐CON	   and	   POL-­‐POL	   animals)	   and	   in	   offspring	   that	   were	   raised	   by	   gestationally	  poly(I:C)-­‐treated	  mothers	  (i.e.,	  in	  CON-­‐POL	  animals)	  (Fig.	  10b).	  	  	  	  
	  
	  
Figure	  10.	  Effects	  of	  the	  prenatal	  and	  postnatal	  manipulations	  on	  the	  locomotor	  response	  
to	  acute	  amphetamine	  treatment.	  The	   line	  plots	  depict	   the	  distance	  moved	   in	  the	  open	  field	  arena	  as	  a	  function	  of	  5-­‐min	  bins	  during	  the	  initial	  habituation	  phase	  and	  following	  subsequent	  saline	   (SAL)	   or	   amphetamine	   (AMPH)	   administration.	   The	   bar	   plots	   depict	   the	  mean	  distance	  moved	   after	   the	   acute	   AMPH	   challenge.	   (A)	   Locomotor	   activities	   in	   fostered	   offspring	   at	  pubescent	   age.	   +P	   <	   0.05,	   reflecting	   the	   significant	   main	   effect	   of	   postnatal	   rearing.	   (B)	  Locomotor	   activities	   in	   fostered	   offspring	   at	   adult	   age.	   **P	   <	   0.01,	   reflecting	   the	   significant	  increase	  in	  CON-­‐POL,	  POL-­‐CON,	  and	  POL-­‐POL	  offspring	  relative	  to	  CON-­‐CON	  offspring	  based	  on	  post	  hoc	  comparisons.	  All	  values	  are	  means±SEM.	  CON	  =	  vehicle	  control;	  POL	  =	  poly(I:C).	  
	  
	  





4.2.4	   Prenatal	   and	   Postnatal	   Maternal	   Effects	   Influence	   GAD65	   and	   GAD67	   Gene	  
Expression	  Depending	  on	  the	  Offspring’s	  Age	  The	   transcription	   levels	  of	  GAD65	   and	  GAD67	  were	  measured	   in	   the	  prefrontal	   (mPFC)	  and	  hippocampal	  (dHPC)	  areas	  of	  the	  fostered	  offspring	  using	  RT-­‐PCR.	  
• Pubescence	  The	  gene	  transcription	   levels	  of	  GAD65	  and	  GAD67	   in	  the	  mPFC	  and	  dHPC	  of	  pubescent	  offspring	  were	  affected	  by	  both	  the	  prenatal	  and	  postnatal	  manipulations.	  As	  depicted	  in	  
Fig.	  11a,	  being	  raised	  by	  a	  gestationally	  poly(I:C)-­‐treated	  surrogate	  mother	  significantly	  increased	  GAD65	  mRNA	   levels	   in	   the	  dHPC	  (main	  effect	  of	  postnatal	   rearing:	  F(1,30)	  =	  5.39,	  p	  <	  0.05),	  whereas	  prenatal	  poly(I:C)	  exposure	  significantly	  elevated	  GAD67	  mRNA	  levels	   in	   the	   dHPC	   independently	   of	   the	   postnatal	   rearing	   condition	   (main	   effect	   of	  prenatal	  treatment:	  F(1,30)	  =	  5.12,	  p	  <	  0.05).	  In	  addition,	  offspring	  that	  were	  exposed	  to	  prenatal	   control	   treatment	   but	   raised	   by	   gestationally	   poly(I:C)-­‐exposed	   surrogate	  mothers	  displayed	  a	  reduction	  in	  mPFC	  GAD65	  mRNA	  levels	  relative	  to	  offspring	  born	  to	  and	  raised	  by	  vehicle-­‐treated	  mothers,	   and	   relative	   to	  offspring	  born	   to	  and	  raised	  by	  poly(I:C)-­‐exposed	   mothers	   (Fig.	   11a).	   No	   significant	   changes	   were	   detected	   in	   the	  analysis	  of	  mPFC	  GAD67	  mRNA	  levels	  (Fig.	  11a).	  








Figure	  11.	  Effects	  of	  the	  prenatal	  and	  postnatal	  manipulations	  on	  GAD65	  and	  GAD67	  gene	  
expression.	   The	   graphs	   depict	   the	   levels	   of	   normalized	   mRNA	   expression	   in	   the	   medial	  prefrontal	  cortex	  (mPFC)	  and	  dorsal	  hippocampus	  (dHPC)	  assessed	  using	  quantitative	  RT-­‐PCR.	  (A)	  GAD65	  and	  GAD67	  gene	  expression	  in	  fostered	  offspring	  at	  pubescent	  age.	  #P	  <	  0.05,	  reflecting	  the	  significant	  main	  effect	  of	  postnatal	  rearing;	  *P	  <	  0.05.	  (B)	  GAD65	  and	  GAD67	  gene	  expression	  in	   fostered	   offspring	   at	   adult	   age.	   #P	   <	   0.05,	   reflecting	   the	   significant	  main	   effect	   of	   postnatal	  rearing;	  ***P	  <	  0.001.	  All	  values	  are	  means±SEM.	  CON	  =	  vehicle	  control;	  POL	  =	  poly(I:C).	  
	  





4.2.5	  Discussion	  The	   present	   study	   confirms	   that	   prenatal	   immune	   activation	   in	   mice	   induces	   long-­‐lasting	  impairments	  in	  working	  memory	  (Bitanihirwe	  et	  al,	  2010b;	  Connor	  et	  al,	  2012;	  Meyer	   et	   al,	   2008a;	  Richetto	   et	   al,	   2014;	  Vuillermot	   et	   al,	   2012).	  Here,	  we	  went	  on	   to	  show	  for	  the	  first	   time	  that	  such	  cognitive	  abnormalities	  are	  mediated	  by	  prenatal	  but	  not	   postnatal	   maternal	   factors	   on	   the	   offspring.	   Indeed,	   adult	   offspring	   prenatally	  exposed	  to	  poly(I:C)	  displayed	  significant	  impairments	  in	  both	  the	  matching-­‐to-­‐position	  dry	   maze	   paradigm	   and	   the	   Y-­‐maze	   spatial	   novelty	   preference	   task	   regardless	   of	  whether	   they	   were	   raised	   by	   gestationally	   immune-­‐challenged	   or	   non-­‐challenged	  control	   surrogate	   mothers.	   Another	   implication	   of	   these	   manifestations	   is	   that	   the	  adoption	   of	   prenatally	   immune	   challenged	   neonates	   by	   control	   rearing	  mothers	   does	  not	   rescue	   the	   later	   appearance	   of	   cognitive	   deficits.	   Together,	   these	   findings	   are	  supportive	   of	   the	   hypothesis	   that	   prenatal	   immune	   challenge	   precipitates	   long-­‐term	  cognitive	  abnormalities	  by	  directly	  interfering	  with	  fetal	  brain	  development	  (Garbett	  et	  










the	  observed	  postnatal	  maternal	  effects	  on	  the	  offspring	  are	  associated	  with	  alterations	  in	  postpartum	  maternal	  behaviour.	  Consistent	  with	  previous	  findings	  (Meyer	  et	  al,	  2008c),	  we	  found	  that	  adoption	  by	  gestationally	   immune-­‐challenged	   surrogate	   mothers	   exert	   a	   significant	   influence	   on	  AMPH	   sensitivity	   in	   the	   offspring.	   Interestingly,	   these	   postnatally	  mediated	   effects	   on	  AMPH	   potentiation	   emerged	   already	   in	   pubescent	   offspring	   and	   persisted	   into	  adulthood.	   In	   addition,	   increased	   behavioural	   responsiveness	   to	   systemic	   AMPH	   also	  emerged	  as	  a	  consequence	  of	  prenatal	  exposure	  to	  immune	  challenge	  and	  was	  therefore	  also	   present	   in	   prenatally	   poly(I:C)	   offspring	   raised	   by	   control	   surrogate	   mothers.	  However,	  the	  prenatally	  mediated	  effect	  on	  AMPH	  sensitivity	  was	  only	  manifest	  once	  the	  offspring	  reached	  the	  adult	  stage	  of	  development,	  suggesting	  that	  they	  are	  dependent	  on	  post-­‐pubertal	  maturational	  processes.	   It	   thus	   follows	   that	  both	  prenatal	   and	  postnatal	  maternal	   factors	   can	   affect	   the	  offspring’s	   sensitivity	   to	  dopaminergic	   drug	   challenges	  following	  gestational	   immune	  challenge,	  but	   the	  onsets	  of	   these	  effects	   critically	  differ	  depending	  on	  whether	  the	  maternal	  mediating	  factor	  is	  acting	  prenatally	  or	  postnatally.	  Furthermore,	   the	   long-­‐term	  consequences	  of	   the	  prenatal	   immunological	   insult	   and	  of	  being	   reared	   by	   immune	   challenged	   surrogate	   mothers	   on	   AMPH	   sensitivity	   may	   be	  mediated	   by	   different	   neuronal	   mechanisms.	   In	   the	   context	   of	   maternal	   immune	  activation,	  it	  has	  been	  speculated	  that	  reduced	  expression	  of	  the	  AMPA	  receptor	  subunit	  GluR1	  in	  the	  nucleus	  accumbens	  shell	  might	  represent	  one	  mechanism	  by	  which	  cross-­‐fostering	   to	   a	   gestationally	   immune-­‐challenged	   surrogate	  mother	   can	   increase	  AMPH-­‐induced	   locomotor	   activity	   (Meyer	   et	   al,	   2008c).	   In	   contrast,	   the	   prenatally	  mediated	  effects	   on	   AMPH-­‐induced	   hyperactivity	   may	   be	   more	   directly	   related	   to	   altered	  dopaminergic	   mechanisms	   such	   as	   increased	   presynaptic	   dopamine	   synthesis	   and	  enhanced	  signalling	  at	  postsynaptic	  dopamine	  receptors	  (Meyer	  et	  al,	  2010a;	  Meyer	  et	  





maturational	   time	   points.	   The	   pubescent	   onset	   of	   (attenuated)	   cognitive	   changes	  observed	  in	  our	  model	  system	  is	  strikingly	  similar	  to	  recent	  human	  studies	  suggesting	  that	   fetal	   exposure	   to	   serologically	   determined	   influenza	   infection	   leads	   to	   an	   early	  onset	   of	   cognitive	   impairments	   that	   are	   present	   before	   the	   onset	   of	   full-­‐blown	  schizophrenic	   disease	   (Ellman	   et	   al,	   2009).	   At	   the	   same	   time,	   our	   study	   adds	   further	  weight	  to	  the	  notion	  that	  being	  reared	  by	  a	  surrogate	  mother	  that	  experienced	  immune	  activation	  during	  late	  pregnancy	  may	  constitute	  a	  risk	  factor	  for	  specific	  behavioural	  and	  molecular	  abnormalities.	  	  





4.3	   Behavioural	   Effects	   of	   the	   Benzodiazepine	   Positive	   Allosteric	  
Modulator	   SH-­‐053-­‐2’F-­‐S-­‐CH3	   in	   an	   Immune-­‐Mediated	  
Neurodevelopmental	  Disruption	  Model	  	  Richetto	  J.,	  Labouesse	  M.,	  Poe	  M.	  M.,	  Cook	  J.	  M.,	  Grace	  A.	  A.,	  Riva	  M.	  A.,	  Meyer	  U.	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schizophrenia	  (Guidotti	  et	  al,	  2005;	  Stan	  et	  al,	  2012).	  A	  first	  line	  of	  evidence	  supporting	  this	  hypothesis	  was	  derived	  from	  a	  small	  placebo-­‐controlled	  clinical	  trial	  suggesting	  that	  treatment	   with	   a	   benzodiazepine-­‐like	   agent	   with	   preferential	   activity	   at	   the	   α2/α3	  subunit	  of	  GABAA	  receptors	  can	  improve	  cognitive	  and	  electrophysiological	  measures	  of	  prefrontal	  functions	  in	  individuals	  with	  chronic	  schizophrenia	  (Lewis	  et	  al,	  2008).	  Such	  pro-­‐cognitive	   effects	   associated	  with	   positive	   allosteric	  modulation	   of	   α2/α3	   subunit,	  however,	   could	  not	  be	   replicated	   in	  a	   larger	   randomized	  clinical	   trial	   (Buchanan	   et	  al,	  2011).	   In	   contrast,	   a	   novel	   α5	   GABAA	   receptor	   positive	   allosteric	  modulator	   has	   been	  shown	  to	  reverse	  hyperactivation	  of	  the	  dopamine	  system	  in	  the	  methylazoxymethanol	  acetate	  (MAM)-­‐based	  neurodevelopmental	  disruption	  model	  of	  schizophrenia	  (Gill	  et	  al,	  2011),	   indicating	   that	   such	  GABAergic	  modulation	  may	  be	   useful	   in	   targeting	   positive	  symptoms	  of	  schizophrenic	  disease.	  	  In	   the	   present	   study,	   we	   used	   an	   established	   immune-­‐mediated	  neurodevelopmental	   disruption	  model	   to	   test	   the	  behavioural	   effects	   of	   SH-­‐053-­‐2’F-­‐S-­‐CH3,	  a	  relatively	  novel	  benzodiazepine	  positive	  allosteric	  modulator	  (PAM)	  with	  partial	  selectivity	   at	   the	   α2,	   α3,	   and	   α5	   subunits	   (Fischer	   et	   al,	   2010;	   Savic	   et	   al,	   2010).	   The	  chosen	  model	  is	  based	  on	  prenatal	  administration	  of	  the	  viral	  mimetic	  poly(I:C)	  in	  mice,	  which	  is	  known	  to	  capture	  a	  wide	  spectrum	  of	  behavioural	  and	  cognitive	  abnormalities	  relevant	   to	   neurodevelopmental	   psychiatric	   disorders	   (reviewed	   in	   (Meyer,	   2014;	  Meyer	   et	  al,	   2010a)).	  The	  prenatal	  poly(I:C)	  model	  has	  been	  established	   in	   relation	   to	  epidemiological	  studies	  showing	   increased	  risk	  of	  schizophrenia	  and	  related	  disorders	  following	  prenatal	  maternal	  exposure	  to	  infection	  or	  inflammation	  (Brown	  et	  al,	  2010).	  Importantly,	  prenatal	  poly(I:C)	  treatment	  in	  mice	  is	  capable	  of	  inducing	  a	  wide	  range	  of	  schizophrenia-­‐relevant	   prefrontal	   and	   hippocampal	   GABAergic	   abnormalities	   in	   adult	  offspring,	   including	   reduced	   mRNA	   and/protein	   expression	   of	   GAD65,	   GAD67,	   and	  parvalbumin	  (Meyer	  et	  al,	  2008b;	  Piontkewitz	  et	  al,	  2012;	  Richetto	  et	  al,	  2013a;	  Richetto	  
et	   al,	   2013b).	   Prenatally	   poly(I:C)-­‐exposed	   mice	   also	   show	   diminished	   prefrontal	  expression	   of	   the	   α4	   and	   α5	   subunits	   of	   GABAA	   receptors	   (Richetto	   et	   al,	   2014)	   and	  increased	   α2-­‐GABAA	   receptor	   immunoreactivity	   at	   axon	   initial	   segments	   (Meyer	   et	   al,	  2008c;	  Nyffeler	  et	  al,	  2006)	  akin	  to	  post-­‐mortem	  findings	  in	  schizophrenia	  (Beneyto	  et	  





and	  increased	  amphetamine	  (AMPH)	  sensitivity	  (Bitanihirwe	  et	  al,	  2010b;	  Connor	  et	  al,	  2012;	  Meyer	   et	   al,	   2005;	   Richetto	   et	   al,	   2013a;	   Richetto	   et	   al,	   2014;	   Zuckerman	   et	   al,	  2003a).	  Based	  on	  these	  findings,	  we	  tested	  whether	  positive	  allosteric	  modulation	  of	  the	  α2,	  α3,	  and	  α5	  GABAA	  receptor	  subunits	  by	  systemic	  SH-­‐053-­‐2’F-­‐S-­‐CH3	   treatment	  may	  mitigate	   working	   memory	   deficiency,	   social	   interaction	   deficits,	   and	   AMPH	  hypersensitivity	  in	  adult	  offspring	  prenatally	  exposed	  to	  poly(I:C).	  	  	  
4.3.1	  Effects	  of	  Prenatal	  Immune	  Activation	  on	  the	  Gene	  Expression	  Profile	  of	  the	  
GABAA	  Receptor	  α(1-­‐5)	  Subunits	  	  We	   first	   determined	   the	   gene	   expression	   levels	   of	   the	   α1-­‐5	   subunits	   of	   the	   GABAA	  receptor	  in	  the	  mPFC,	  Str,	  dHPC,	  and	  vHPC	  of	  prenatally	  poly(I:C)-­‐exposed	  and	  control	  offspring.	  As	  summarized	  in	  Fig	  12,	  poly(I:C)	  offspring	  displayed	  a	  significant	  reduction	  in	  the	  expression	  levels	  of	  the	  α2	  (-­‐15%;	  p	  <	  0.01,	  t18	  =	  3.76),	  α4	  (-­‐20%;	  p	  <	  0.01,	  t18	  =	  2.91)	  and	  α5	   (-­‐15%;	  p	   <	  0.05,	   t18	  =	  2.73)	   subunits	   in	   the	  mPFC	  compared	   to	   controls.	  Moreover,	   prenatal	   poly(I:C)	   treatment	   significantly	   increased	   the	   expression	  of	  α3	   in	  the	  mPFC	   by	   23%	   (p	   <	   0.05,	   t18	   =	   2.70;	   Fig	   12).	   Prenatal	   poly(I:C)	   exposure	   did	   not	  significantly	  affect	  the	  expression	  levels	  of	  the	  α1-­‐5	  subunits	  in	  the	  Str	  or	  dHPC	  (Fig	  12).	  Poly(I:C)	  offspring	  displayed,	  however,	  a	  significant	  increase	  in	  the	  expression	  levels	  of	  the	  α1	  (+20%;	  p	  <	  0.01,	  t18	  =	  2.93)	  and	  α2	  (+25%;	  p	  <	  0.01,	  t18	  =	  2.96)	  subunits	  in	  the	  vHPC	  relative	  to	  controls	  (Fig	  12).	  	  








Figure	   12.	   Prenatal	   immune	   activation	   alters	   the	   gene	   expression	   profile	   of	   the	   GABAA	  





4.3.2	  Effects	  of	  SH-­‐053-­‐2’F-­‐S-­‐CH3	  on	  Working	  Memory	  Deficits	  Induced	  by	  Prenatal	  
Immune	  Activation	  We	   evaluated	   possible	   pro-­‐cognitive	   effects	   of	   SH-­‐053-­‐2’F-­‐S-­‐CH3	   using	   a	   spatial	  recognition	   working	   memory	   test	   in	   the	   Y-­‐maze.	   The	   critical	   measure	   of	   spatial	  recognition	  memory	  is	  the	  relative	  time	  spent	  in	  the	  novel	  (previously	  unexplored)	  arm	  during	   the	   choice	   phase	   of	   this	   test.	   As	   expected,	   VEH-­‐treated	   control	   offspring	  displayed	   a	   noticeable	   preference	   towards	   the	   novel	   arm,	   indicating	   intact	   working	  memory	  in	  these	  animals	  (Fig	  13).	  Poly(I:C)	  offspring	  exhibited	  a	  significant	  reduction	  in	  this	  measure	  regardless	  of	  whether	  they	  were	  treated	  with	  VEH	  or	  SH-­‐053-­‐2’F-­‐S-­‐CH3	  (Fig	   13a),	   suggesting	   that	   the	   PAM	   failed	   to	   restore	   working	   memory	   deficits	   in	  poly(I:C)	  offspring.	  Moreover,	  administration	  of	  the	  higher	  dose	  of	  SH-­‐053-­‐2’F-­‐S-­‐CH3	  (30	  mg/kg)	   in	   prenatal	   control	   offspring	   also	   impaired	   working	  memory	   (Fig	   13a),	   with	  both	   groups	   regressing	   to	   chance	   level	   of	   performance	   after	   treatment	  with	   the	   PAM.	  ANOVA	   of	   relative	   time	   spent	   in	   the	   novel	   arm	   revealed	   a	   significant	   main	   effect	   of	  prenatal	   treatment	   (F(1,62)	   =	   7.51,	   p	   <	   0.01),	   drug	   treatment	   (F(2,62)	   =	   14.45,	   p	   <	  0.001),	   and	   their	   interaction	   (F(2,62)	   =	   4.16,	   p	   <	   0.05).	   Subsequent	   post-­‐hoc	   analysis	  confirmed	   the	   significant	   difference	   between	   VEH-­‐treated	   control	   and	   poly(I:C)	  offspring	   (p	   <	   0.01);	   between	   VEH-­‐treated	   control	   offspring	   and	   poly(I:C)	   offspring	  treated	  with	  SH-­‐053-­‐2’F-­‐S-­‐CH3	  (p’s	  <	  0.001);	  and	  between	  VEH-­‐treated	  control	  offspring	  and	  control	  offspring	   treated	  with	  SH-­‐053-­‐2’F-­‐S-­‐CH3	  at	  30	  mg/kg	   (p	  <	  0.001)	   (see	  Fig	  






Figure	  13.	  SH-­‐053-­‐2′F-­‐S-­‐CH3	  administration	  produces	  working	  memory	  deficits	   in	  the	  Y-­‐
maze	  spatial	  recognition	  paradigm	  in	  both	  control	  and	  poly(I:C)	  offspring.	  (a)	  The	  bar	  plot	  depicts	   the	   percent	   time	   spent	   in	   the	   novel	   (previously	   unexplored)	   arm	   during	   the	   choice	  phases	  of	  the	  test	  following	  vehicle	  (=	  0	  mg/kg	  SH-­‐053-­‐2′F-­‐S-­‐CH3)	  or	  SH-­‐053-­‐2′F-­‐S-­‐CH3	  (at	  15	  or	  30	  mg/kg)	  treatment	  in	  control	  (CON)	  and	  poly(I:C)	  (POL)	  offspring.	  The	  dashed	  line	  represents	  the	  chance	  level.	  *p	  <	  0.05,	  **p	  <	  0.01	  and	  ***p	  <	  0.001,	  based	  on	  Scheffe’s	  post-­‐hoc	  tests.	  (b)	  The	  graph	  shows	   the	   total	  distance	  moved	  during	   the	  choice	  phases	  of	   the	   test.	   #p	  <	  0.01	  and	   §p	  <	  0.001,	  reflecting	  the	  increase	  in	  distance	  moved	  displayed	  by	  animals	  treated	  with	  15	  mg/kg	  and	  30	  mg/kg	  SH-­‐053-­‐2′F-­‐S-­‐CH3,	  respectively,	  relative	  to	  vehicle	  treatment	  (=	  0	  mg/kg	  SH-­‐053-­‐2′F-­‐S-­‐CH3);	  p	  values	  are	  based	  on	  Scheffe’s	  post-­‐hoc	  tests.	  N(CON,	  0	  mg/kg)	  =	  12,	  N(CON,	  15	  mg/kg)	  =	  11,	  N(CON,	  30	  mg/kg)	  =	  11,	  N(POL,	  0	  mg/kg)	  =	  12,	  N(POL,	  15	  mg/kg)	  =	  11,	   and	  N(POL,	  30	  mg/kg)	  =	  11.	  All	  values	  are	  means	  ±	  SEM.	  	  	  






4.3.3	   Effects	   of	   SH-­‐053-­‐2’F-­‐S-­‐CH3	   on	   Social	   Interaction	   and	   Recognition	   Deficits	  








Figure	   14.	   SH-­‐053-­‐2′F-­‐S-­‐CH3	   does	   not	   impair	   social	   approach	   behaviour	   but	   interferes	  
with	   social	   recognition	   performance	   in	   both	   control	   and	   poly(I:C)	   offspring.	   (a)	  Behavioural	   outcomes	   in	   the	   social	   approach	   test	   (“dummy	   phase”).	   The	   line	   plot	   shows	  absolute	   exploration	   time	   of	   an	   unfamiliar	   live	   mouse	   (M)	   and	   inanimate	   dummy	   object	   (D)	  separately	  for	  control	  (CON)	  and	  poly(I:C)	  (POL)	  offspring	  treated	  with	  vehicle	  (=	  0	  mg/kg	  SH-­‐053-­‐2′F-­‐S-­‐CH3)	  or	  SH-­‐053-­‐2′F-­‐S-­‐CH3	  (at	  15	  or	  30	  mg/kg).	  The	  bar	  plot	  depicts	  the	  percent	  time	  spent	  with	  the	  live	  mouse	  in	  the	  social	  approach	  test.	  **p	  <	  0.01,	  reflecting	  the	  significant	  main	  effect	   of	   prenatal	   poly(I:C)	   exposure.	   (b)	   Behavioural	   outcomes	   in	   the	   social	   recognition	   test	  (“novelty	  phase”).	  The	  line	  plot	  shows	  absolute	  exploration	  time	  of	  a	  novel	   live	  mouse	  (N)	  and	  the	  familiar	  live	  mouse	  (F)	  separately	  for	  CON	  and	  POL	  offspring	  treated	  with	  vehicle	  (=	  0	  mg/kg	  SH-­‐053-­‐2′F-­‐S-­‐CH3)	  or	   SH-­‐053-­‐2′F-­‐S-­‐CH3	   (at	  15	  or	  30	  mg/kg).	  The	  bar	  plot	  depicts	   the	  percent	  time	  spent	  with	  the	  novel	  mouse	  in	  the	  social	  recognition	  test.	  §p	  <	  0.01,	  reflecting	  the	  significant	  decrease	   displayed	   by	   animals	   treated	   with	   30	   mg/kg	   SH-­‐053-­‐2′F-­‐S-­‐CH3	   relative	   to	   vehicle-­‐treated	  animals.	  N(CON,	  0	  mg/kg)	  =	  11,	  N(CON,	  15	  mg/kg)	  =	  12,	  N(CON,	  30	  mg/kg)	  =	  11,	  N(POL,	  0	  mg/kg)	  =	  11,	  N(POL,	  15	  mg/kg)	  =	  11,	  and	  N(POL,	  30	  mg/kg)	  =	  12.	  All	  values	  are	  means	  ±	  SEM,	  and	  all	  p	  values	  are	  based	  on	  Scheffe’s	  post-­‐hoc	  tests.	  	  





4.3.4	  Effects	  of	   SH-­‐053-­‐2’F-­‐S-­‐CH3	  on	  AMPH	  Hypersensitivity	   Induced	  by	  Prenatal	  
Immune	  Activation	  Finally,	   we	   also	   explored	   whether	   SH-­‐053-­‐2’F-­‐S-­‐CH3	   may	   be	   effective	   in	   normalizing	  potentiated	  AMPH	  sensitivity	  typically	  emerging	  following	  prenatal	  immune	  activation.	  For	  this	  purpose,	  we	  assessed	  the	  effects	  of	  the	  PAM	  on	  AMPH-­‐induced	  hyperactivity	  in	  the	  open	  field	  test.	  	  Neither	   prenatal	   poly(I:C)	   exposure	   nor	   SH-­‐053-­‐2’F-­‐S-­‐CH3	   pretreatment	  significantly	   affected	   the	   total	   distance	  moved	   during	   the	   initial	   30-­‐min	   period	   of	   the	  open	  field	  test	  (Fig	  15).	  Poly(I:C)	  and	  control	  offspring	  treated	  with	  the	  higher	  dose	  of	  SH-­‐053-­‐2’F-­‐S-­‐CH3	   (30	  mg/kg)	   tended	   to	   show	  higher	   locomotor	  activity	   scores	  during	  this	   initial	   testing	  period,	  but	   this	  effect	  did	  not	  attain	  statistical	   significance	   (Fig	  15).	  ANOVA	   of	   the	   total	   distance	   moved	   only	   revealed	   a	   significant	   main	   effect	   of	   bins	  (F(5,310)	   =	   9.04,	   p	   <	   0.001),	   reflecting	   the	   overall	   changes	   in	   locomotor	   activity	  resulting	  from	  habituation	  to	  the	  open	  field.	  Subsequent	  administration	  of	  AMPH	  led	  to	  a	  general	  increase	  in	  the	  total	  distance	  moved,	   as	   supported	   by	   the	  main	   effect	   of	   bins	   (F(11,682)	   =	   77.78,	  p	   <	   0.001)	   in	   the	  AMPH	  phase	  of	  the	  test.	  VEH-­‐treated	  poly(I:C)	  offspring	  showed	  a	  marked	  potentiation	  of	   the	  AMPH-­‐induced	  hyperactivity	   response	   compared	  with	   the	   locomotor-­‐enhancing	  effects	  of	  AMPH	  in	  VEH-­‐treated	  control	  offspring	  (Fig	  15).	  Most	   interestingly,	  SH-­‐053-­‐2’F-­‐S-­‐CH3	   pretreatment	   fully	   normalized	   the	   potentiation	   of	   the	   AMPH-­‐induced	  hyperactivity	   response	   in	   poly(I:C)	   offspring	   without	   significantly	   affecting	   the	  locomotor-­‐enhancing	   effects	   of	   AMPH	   exposure	   in	   control	   offspring	   (Fig	   15).	   These	  impressions	   were	   supported	   by	   ANOVA	   revealing	   a	   significant	   interaction	   between	  prenatal	  treatment	  and	  drug	  treatment	  (F(2,62)	  =	  3.56,	  p	  <	  0.05),	  and	  a	  significant	  three-­‐way	  interaction	  between	  prenatal	  treatment,	  drug	  treatment	  and	  bins	  (F(22,682)	  =	  1.60,	  
p	  <	  0.05).	  Subsequent	  post-­‐hoc	  analyses	  of	  the	  mean	  distance	  moved	  across	  the	  60-­‐min	  AMPH	  test	  period	  confirmed	  a	   significant	  difference	  between	  VEH-­‐treated	  control	  and	  poly(I:C)	   offspring	   (p	   <	   0.05),	   as	  well	   as	   between	  VEH-­‐treated	   poly(I:C)	   offspring	   and	  poly(I:C)	  offspring	  treated	  with	  SH-­‐053-­‐2’F-­‐S-­‐CH3	  (p’s	  <	  0.05).	  	  







Figure	  15.	  SH-­‐053-­‐2′F-­‐S-­‐CH3	  selectively	  reverses	  the	  potentiated	  amphetamine	  locomotor	  
response	  in	  poly	  (I:C)	  offspring.	  The	  line	  plots	  show	  the	  distance	  moved	  in	  the	  open	  field	  as	  a	  function	   of	   5-­‐min	   bins	   during	   the	   initial	   habituation	   phase	   and	   the	   subsequent	   amphetamine	  (AMPH;	   2.5	   mg/kg,	   i.p.)	   exposure	   phase	   separately	   for	   control	   (CON)	   and	   poly(I:C)	   (POL)	  offspring	  treated	  with	  vehicle	  (=	  0	  mg/kg	  SH-­‐053-­‐2′F-­‐S-­‐CH3)	  or	  SH-­‐053-­‐2′F-­‐S-­‐CH3	  (at	  15	  or	  30	  mg/kg).	  The	  bar	  plot	  depicts	  the	  mean	  distance	  moved	  during	  the	  AMPH	  exposure	  phase	  for	  all	  groups.	   *p	  <	  0.05	  and	  **p	  <	  0.01,	  based	  on	  Scheffe’s	  post-­‐hoc	   analyses.	  N(CON,	  0	  mg/kg)	  =	  11,	  
N(CON,	  15	  mg/kg)	  =	  11,	  N(CON,	  30	  mg/kg)	  =	  12,	  N(POL,	  0	  mg/kg)	  =	  11,	  N(POL,	  15	  mg/kg)	  =	  12,	  and	  N(POL,	  30	  mg/kg)	  =	  11.	  All	  values	  are	  means	  ±	  SEM.	  	  	  











2003a).	   In	   contrast	   to	  our	  hypothesis,	   the	  PAM	  SH-­‐053-­‐2’F-­‐S-­‐CH3	  did	  not	  mitigate	   the	  poly(I:C)-­‐induced	   working	   memory	   and	   social	   interaction	   deficits,	   two	   behavioural	  abnormalities	   commonly	   found	   in	   people	   with	   schizophrenia	   and	   related	   disorders	  (Foussias	   and	  Remington,	   2010;	   Lewis	   and	  Moghaddam,	   2006).	   In	   fact,	   SH-­‐053-­‐2’F-­‐S-­‐CH3	   administration	   to	   prenatal	   control	   offspring	   impaired	   performance	   in	   the	   Y-­‐maze	  working	   memory	   and	   social	   interaction	   tests.	   In	   the	   latter,	   SH-­‐053-­‐2’F-­‐S-­‐CH3	  pretreatment	  led	  to	  a	  selective	  impairment	  in	  social	  recognition	  but	  not	  social	  approach	  behaviour,	   suggesting	   that	   the	   drug	   negatively	   affected	   short-­‐term	   retention	   of	   social	  cues	  rather	  than	  social	  approach	  behaviour	  per	  se.	  Several	  previous	  studies	  have	  shown	  that	   prenatal	   poly(I:C)-­‐induced	   cognitive	   deficits	   in	   rats	   and	  mice	   can	   be	   restored	   or	  even	   prevented	   by	   atypical	   antipsychotic	   drugs	   such	   as	   clozapine	   and	   risperidone	  (Meyer	  et	  al,	  2010b;	  Ozawa	  et	  al,	  2006;	  Piontkewitz	  et	  al,	  2009;	  Zuckerman	  et	  al,	  2003a).	  Therefore,	  one	  implication	  is	  that	  a	  normalization	  of	  prenatal	  poly(I:C)-­‐induced	  spatial	  and	  social	  recognition	  deficits	  would	  require	  a	  modulation	  of	  neurotransmitter	  systems	  that	   go	   beyond	   those	   primarily	   mediated	   by	   GABAA	   receptors.	   However,	   one	   clear	  limitation	   of	   our	   study	   is	   that	   the	   assessment	   of	   cognitive	   functions	   was	   performed	  using	  a	   test	   that	   is	  primarily	  based	  on	  spontaneously	  motivated	  behaviour.	  Additional	  investigations	  are	  thus	  warranted	  to	  extend	  our	  findings	  to	  other	  cognitive	  domains.	  	  The	  detrimental	  effects	  of	  SH-­‐053-­‐2’F-­‐S-­‐CH3	  on	  cognitive	  functions	  revealed	  here	  are	  in	  contrast	  to	  previous	  findings	  in	  rats	  suggesting	  that	  this	  PAM	  does	  not	  negatively	  affect	  spatial	  reference	  memory	  as	  assessed	  in	  the	  Morris	  water	  maze	  test	  (Savic	  et	  al,	  2010).	   We	   have	   no	   parsimonious	   explanation	   for	   this	   discrepancy,	   but	   it	   could	   be	  related	  to	  differential	  cognitive	  processes	  involved	  (short-­‐term	  working	  memory	  versus	  long-­‐term	   reference	   memory)	   and/or	   potentially	   important	   species	   differences	   (mice	  





053-­‐2′F-­‐S-­‐CH3	  on	  short-­‐term	  memory	  revealed	  here	  may	  also	  be	  explained	  by	  positive	  modulation	  of	  the	  α5	  subunit,	  given	  that	  the	  drug	  is	  characterized	  by	  strong	  α5	  activity	  (Fischer	   et	   al,	   2010;	   Savic	   et	   al,	   2010).	   One	   clear	   possibility	   to	   further	   test	   this	  hypothesis	  would	  be	  to	  evaluate	  whether	  compounds	  with	  selective	  affinity	   for	   the	  α5	  subunit	  would	  share	  such	  cognitive	  disruptive	  effects.	   Intriguingly,	  the	  R-­‐isomer	  of	  the	  PAM	  used	  here	  (namely	  the	  SH-­‐053-­‐2′F-­‐R-­‐CH3	  isomer)	  shows	  such	  selectivity	  for	  the	  α5	  subunit	  (Fischer	  et	  al,	  2010;	  Gill	  et	  al,	  2011;	  Savic	  et	  al,	  2010),	  and	  therefore,	   it	  would	  provide	  a	  reasonable	  pharmacological	  tool	  to	  address	  these	  issues.	  In	  such	  attempts,	   it	  would	  be	  important	  to	  compare	  various	  dose	  ranges	  because	  the	  S-­‐isomer	  (SH-­‐053-­‐2′F-­‐S-­‐CH3)	   and	   R-­‐isomer	   (SH-­‐053-­‐2′F-­‐R-­‐CH3)	   differ	   in	   their	   affinity	   for	   α5	   (Fischer	   et	   al,	  2010;	  Gill	  et	  al,	  2011;	  Savic	  et	  al,	  2010).	  Hence,	  administration	  of	  the	  S-­‐isomer	  (SH-­‐053-­‐2′F-­‐S-­‐CH3)	   and	   R-­‐isomer	   (SH-­‐053-­‐2′F-­‐R-­‐CH3)	   at	   the	   same	   dose	   may	   differentially	  influence	  cognitive	  functions	  due	  to	  distinct	  α5	  affinities.	  	  Despite	   the	   inability	   of	   SH-­‐053-­‐2′F-­‐S-­‐CH3	   to	   correct	   prenatal	   infection-­‐induced	  cognitive	   impairments,	   it	   was	   highly	   effective	   in	  mitigating	   AMPH	   hypersensitivity	   in	  adult	   poly(I:C)	   offspring	   without	   concomitant	   effects	   in	   prenatal	   control	   offspring.	  AMPH	   exposure	   can	   produce	   psychosis-­‐like	   states	   in	   healthy	   human	   subjects	   and	  exacerbate	   existing	   psychoses	   in	   patients	   with	   schizophrenia	   (Laruelle,	   2000).	  Moreover,	   potentiation	   of	   AMPH-­‐induced	   dopamine	   release	   in	   schizophrenia	   patients	  tends	   to	   correlate	  with	   the	   severity	  of	  positive	   symptoms	   (Laruelle	   and	  Abi-­‐Dargham,	  1999).	  The	  efficacy	  of	  SH-­‐053-­‐2’F-­‐S-­‐CH3	  to	  correct	  the	  poly(I:C)-­‐induced	  potentiation	  of	  AMPH	  sensitivity	  may	  thus	  be	  relevant	  especially	  for	  attempts	  to	  establish	  and	  validate	  GABA-­‐based	  treatments	  targeting	  positive	  symptoms.	  Our	   data	   are	   also	   highly	   congruent	   with	   previous	   findings	   showing	   that	   acute	  treatment	   with	   a	   selective	   α5	   GABAA-­‐receptor	   PAM	   (namely	   the	   SH-­‐053-­‐2′F-­‐R-­‐CH3	  isomer)	  can	  fully	  reverse	  AMPH	  hypersensitivity	  and	  hyperactivity	  of	  ventral	  midbrain	  dopamine	  neurons	  in	  the	  MAM-­‐based	  neurodevelopmental	  model	  of	  schizophrenia	  (Gill	  










pathological	   overactivity	   of	   the	   dopaminergic	   system.	  At	   the	   same	   time,	   however,	   our	  study	   falls	   short	   in	   detecting	   possible	   pro-­‐cognitive	   effects	   of	   PAM	   treatment	   with	  selective	  activity	  at	  the	  α2,	  α3,	  and	  α5	  subunits	  of	  the	  GABAA	  receptor.	  The	  lack	  of	  such	  pro-­‐cognitive	   effects	  may	   raise	   concerns	   regarding	   the	   effective	   use	   of	   some	   types	   of	  GABA	  subunit	  selective	  compounds	  with	  the	  aim	  to	  target	  multiple	  pathological	  domains	  that	  involve	  the	  co-­‐existence	  of	  psychotic,	  social,	  and	  cognitive	  dysfunctions.	  	  
	  
	  





4.4	  Prenatal	  Immune	  Activation	  Exacerbates	  Hippocampus-­‐Regulated	  
Cognitive	  Aging	  	  Labouesse	  M.	  A.*,	  Richetto	  J.*,	  Giovanoli	  S.,	  Langhans	  W.,	  Riva	  M.	  A.,	  Meyer	  U.	  





Prenatal	   exposure	   to	   infectious	   pathogens	   or	   inflammatory	   stimuli	   is	   increasingly	  recognized	   to	   play	   an	   important	   aetiological	   role	   in	   neurodevelopmental	   brain	  disorders,	   including	  schizophrenia	  (Brown	  et	  al,	  2010),	  autism	  (Atladottir	  et	  al,	  2010),	  and	   bipolar	   disorder	   (Canetta	   et	   al,	   2014).	   A	   number	   of	   translational	   rodent	   models	  support	   such	   epidemiological	   associations	   by	   demonstrating	   multiple	   behavioural,	  cognitive,	  and	  neuroanatomical	  alterations	  following	  prenatal	  exposure	  to	  infectious	  or	  immune-­‐activating	  agents	  (Harvey,	  2012;	  Meyer,	  2014;	  Meyer	  et	  al,	  2010a).	  Many	  of	  the	  behavioural	   and	   neuronal	   changes	   induced	   by	   prenatal	   immune	   activation	   are	  dependent	  on	  maturational	  processes	  and	  thus	  only	  emerge	  once	  the	  offspring	  reach	  a	  certain	  age,	  typically	  adolescence	  or	  early	  adulthood	  (Piontkewitz	  et	  al,	  2011a;	  Richetto	  
et	  al,	  2014;	  Vuillermot	  et	  al,	  2010;	  Zuckerman	  et	  al,	  2003a).	  The	  delayed	  onset	  of	  such	  prenatal	   infection-­‐induced	   abnormalities	   suggests	   that	   the	   brain	   and	   behavioural	  consequences	  of	  this	  early-­‐life	  insult	  are,	  at	  least	  in	  part,	  progressive	  in	  nature.	  	   Whilst	   the	   importance	   of	   immune-­‐related	   prenatal	   adversities	   has	   been	   widely	  acknowledged	  in	  the	  fields	  of	  developmental	  neuropsychiatry	  (Bale	  et	  al,	  2010;	  Brown	  
et	  al,	  2010;	  Meyer	  et	  al,	  2010a),	  less	  attention	  has	  been	  given	  to	  the	  possibility	  that	  such	  early-­‐life	  environmental	  insults	  could	  also	  negatively	  influence	  brain	  aging	  (Krstic	  et	  al,	  2012).	  Such	  early-­‐life	  programming	  of	  altered	  brain	  aging	  would	  indeed	  seem	  possible	  in	   view	   of	   the	   progressive	   nature	   of	   neuronal	   dysfunctions	   associated	   with	   prenatal	  exposure	  to	  immune	  challenge	  (Piontkewitz	  et	  al,	  2011a;	  Richetto	  et	  al,	  2014;	  Vuillermot	  





2011).	   Hippocampal	   deficits	   have	   also	   been	   noted	   in	   pubescent	   and/or	   adult	   animals	  born	   to	   immune-­‐challenged	  mothers	   (reviewed	   in	   (Boksa,	  2010;	  Meyer	   et	  al,	   2009b)),	  emphasizing	  that	  the	  hippocampus	  is	  sensitive	  to	  immune-­‐related	  prenatal	  adversities.	  	  In	   addition	   to	   the	   cognitive	   assessment,	  we	  measured	   pre-­‐	   and	   postsynaptic	   proteins	  and	   neuroplasticity-­‐related	   genes	   to	   identify	   possible	   neuronal	   correlates	   of	   cognitive	  aging	   in	   immune-­‐challenged	   and	   control	   offspring.	   Based	   on	   the	   idea	   that	   prenatal	  immune	   activation	   may	   exacerbate	   neuronal	   aging	   by	   inducing	   persistent	   systemic	  inflammation	  and	  accompanied	  neuroinflammatory	  reactions	  (Krstic	  and	  Knuesel,	  2013;	  Krstic	  et	  al,	  2012),	  we	  also	  compared	  peripheral	  and	  central	  cytokine	   levels	  as	  well	  as	  microglia	   and	   astroctye	   cell	   populations	   between	   prenatally	   immune-­‐exposed	   and	  control	  offspring	  at	  different	  ages	  of	  life.	  	  	  
4.4.1	   Prenatal	   Immune	   Activation	   Induces	   a	   Pubescent	   Onset	   of	   Spatial	   Short-­‐





offspring	  or	  aged	  control	  mice	  thus	  seem	  to	  represent	  genuine	  cognitive	  effects	  rather	  than	  alterations	  in	  exploratory	  behaviour	  per	  se.	  	  
	  
	  
Figure	  16.	  Short-­‐term	  spatial	  recognition	  memory	  in	  pubescent,	  adult,	  and	  aged	  offspring	  
born	  to	  poly(I:C)-­‐exposed	  (POL)	  or	  control	  (CON)	  mothers	  as	  assessed	  using	  the	  Y-­‐maze	  
test.	  (A)	  Percent	  time	  spent	  in	  the	  novel	  arm	  during	  the	  choice	  phase	  of	  the	  test.	  The	  dashed	  line	  represents	   the	   chance	   level	   of	   33.3%.	   **p	   <	   0.01	   and	   ***p	   <	   0.001,	   reflecting	   the	   significant	  difference	  between	  aged	  CON	  and	  pubescent	  CON	  offspring,	   and	  between	  aged	  CON	  and	  adult	  CON	   offspring,	   respectively.	   #p	   <	   0.001,	   reflecting	   the	   significant	   difference	   between	   POL	   and	  CON	   offspring.	   p	   values	   are	   based	   on	   post-­‐hoc	   analyses	   following	   the	   presence	   of	   significant	  main	  effects	  of	  age	  (F(2,68)	  =	  3.65,	  p	  <	  0.05)	  and	  prenatal	  treatment	  (F(1,68)	  =	  9.05,	  p	  <	  0.01),	  and	  of	  its	  interaction	  (F(2,68)	  =	  4.18,	  p	  <	  0.05).	  (B)	  Total	  distance	  moved	  during	  the	  choice	  phase	  of	  the	  test.	   N(pubescent	   CON)	   =	   9,	   N(pubescent	   POL)	   =	   9,	   N(adult	   CON)	   =	   12,	   N(adult	   POL)	   =	   12,	  
N(aged	  CON)	  =	  16,	  N(aged	  POL)	  =	  16.	  All	  values	  are	  means±SEM.	  	  
	  
	  





4.4.2	  Prenatal	   Immune	  Activation	   Induces	  Age-­‐Dependent	  Deficits	   in	   Contextual	  
Fear	  Memory	  	  In	  a	  next	  step,	  we	  explored	  whether	  prenatal	  immune	  activation	  might	  induce	  deficits	  in	  another	   cognitive	   domain	   known	   to	   be	   regulated	   by	   the	   hippocampus,	   namely	  contextual	  processing	  (Maren	  et	  al,	  1997;	  Otto	  et	  al,	  2006).	  To	  this	  end,	  we	  studied	  the	  acquisition	  and	  expression	  of	  contextual	  fear	  in	  pubescent,	  adult	  and	  aged	  mice	  born	  to	  poly(I:C)-­‐exposed	  or	  control	  mothers.	  	  	   During	  the	  conditioning	  phase	  of	  the	  contextual	  fear	  test,	  the	  amount	  of	  percent	  time	  freezing	   generally	   increased	   across	   the	   3	   successive	   post-­‐shock	   periods	   (Fig.	   17a),	  indicating	   that	   the	   animals	   developed	   a	   noticeable	   fear	   response	   as	   a	   result	   of	   shock	  exposure.	  The	  development	  of	  such	  fear	  responses	  was	  largely	  comparable	  between	  all	  experimental	   groups	   (Fig.	   17a).	   Hence,	   neither	   prenatal	   immune	   activation	   nor	   aging	  significantly	  affected	  the	  acquisition	  of	  contextual	  fear.	  	  	   Contextual	  memory	  was	  then	  evaluated	  24	  h	  following	  conditioning	  and	  was	  indexed	  by	   the	   expression	   of	   conditioned	   fear	   towards	   the	   context,	   in	   which	   aversive	  conditioning	   took	   place.	   Pubescent,	   adult	   and	   aged	   control	   mice	   displayed	   largely	  comparable	   levels	   of	   conditioned	   fear	   towards	   the	   context	   (Fig.	   17b),	   suggesting	   that	  aging	  did	  not	  affect	  contextual	  memory	   in	  mice	  born	   to	  control	  mothers.	  On	   the	  other	  hand,	   prenatal	   immune	   challenge	   caused	   an	   age-­‐dependent	   reduction	   in	   conditioned	  fear	  expression,	  which	  emerged	  only	  once	  poly(I:C)-­‐exposed	  offspring	  reached	  the	  aged	  stage	  of	  life	  (Fig.	  17b).	  Against	  the	  background	  of	  intact	  acquisition	  of	  learned	  fear	  (Fig.	  
17b),	  these	  data	  thus	  demonstrate	  that	  prenatal	  immune	  activation	  selectively	  impairs	  the	  retention	  of	  contextual	  fear	  memories	  at	  the	  aged	  stage	  of	  life.	  
	  








Figure	  17.	  Contextual	  learning	  and	  memory	  in	  pubescent,	  adult,	  and	  aged	  offspring	  born	  
to	  poly(I:C)-­‐exposed	  (POL)	  or	  control	  (CON)	  mothers	  as	  assessed	  using	  a	  contextual	  fear	  





4.4.3	   Prenatal	   Immune	   Activation	   Causes	   Severe	   Deficits	   in	   Spatial	   Reference	  
Learning	  and	  Memory	  during	  Aging	  We	  extended	  the	  investigations	  of	  cognitive	  functions	  to	  the	  domain	  of	  spatial	  reference	  learning	  and	  memory	  using	  a	  place	  navigation	  task	   in	   the	  Morris	  water	  maze.	  Optimal	  performance	  in	  this	  task	  depends	  on	  the	  functional	  integrity	  of	  the	  hippocampus	  (Morris	  
et	  al,	  1982),	  especially	  on	  its	  dorsal	  part	  (Moser	  et	  al,	  1993).	  First,	   the	   animals	   underwent	   pretraining	   using	   a	   visible	   cued	   platform	   to	  ascertain	   the	   integrity	  of	   sensorimotor	   functions.	  Animals	   from	  all	   groups	  displayed	  a	  significant	  reduction	  in	  the	  latency	  to	  locate	  the	  cued	  escape	  platform	  across	  the	  3	  trials,	  suggesting	   that	   neither	   prenatal	   immune	   activation	   nor	   aging	   affected	   essential	  sensorimotor	   functions	  such	  as	  vision	  and	  motor	  coordination	   (Vorhees	  and	  Williams,	  2006).	   The	   overall	  means±S.E.M	   of	   escape	   latencies	   during	   the	   3	   cued	   platform	   trials	  were	  45.6±2.3	  s	  for	  trial	  1,	  24.1±2.5	  s	  for	  trial	  2,	  and	  17.6±2.2	  s	  for	  trial	  3.	  Following	   cued	   platform	   training,	   spatial	   reference	   learning	   was	   assessed	   by	  measuring	  the	  latency	  to	  find	  an	  invisible	  platform	  across	  15	  learning	  trials.	  As	  shown	  in	  





swim	  speed	  during	  spatial	  reference	  training	  was	  17.3±5.6	  cm/s	  in	  pubescent	  offspring,	  17.9±4.9	  cm/s	  in	  adult	  offspring,	  and	  16.7±5.4	  cm/s	  in	  aged	  offspring.	  Consistent	  with	   the	   preceding	   learning	   phase,	   aged	   offspring	   born	   to	   immune-­‐challenged	   mothers	   also	   displayed	   a	   severe	   deficit	   in	   spatial	   reference	   memory	  retention,	  which	  was	  assessed	  during	  the	  probe	  test	  1	  day	  after	  completion	  of	  reference	  training	  (Fig.	  18b).	  Indeed,	  in	  contrast	  to	  all	  other	  groups,	  aged	  poly(I:C)	  offspring	  failed	  to	   show	   a	   preference	   for	   the	   target	   quadrant,	   in	   which	   the	   platform	   was	   previously	  positioned	   during	   spatial	   reference	   training	   (Fig.	   18c).	   Even	   though	   less	   severe	  compared	  to	  aged	  poly(I:C)	  offspring,	  aged	  control	  offspring	  also	  displayed	  a	  significant	  decrease	  in	  the	  time	  spent	  in	  the	  target	  quadrant	  compared	  with	  adult	  control	  offspring.	  Together,	   these	   results	   suggest	   that	   aging	   can	   generally	   impair	   spatial	   reference	  memory	   retention,	   but	   this	   effect	   is	   strongly	   exacerbated	   by	   exposure	   to	   prenatal	  immune	  challenge.	  	  	  






Figure	  18.	  Spatial	  reference	  learning	  and	  memory	  in	  pubescent,	  adult,	  and	  aged	  offspring	  
born	   to	  poly(I:C)-­‐exposed	   (POL)	  or	   control	   (CON)	  mothers	  as	  assessed	  using	   the	  Morris	  
water	   maze.	   (A)	   The	   line	   plots	   show	   the	   latency	   to	   find	   the	   invisible	   escape	   platform	   as	   a	  function	  of	  trials	  during	  the	  acquisition	  phase	  of	  the	  test.	  ***p	  <	  0.001,	  reflecting	  the	  significant	  learning	  impairment	  displayed	  by	  aged	  POL	  offspring	  relative	  to	  all	  other	  groups	  between	  trials	  6	  and	  15	  of	  the	  acquisition	  phase;	  §p	  <	  0.001,	  reflecting	  the	  significant	  reduction	  in	  the	  latency	  to	  find	  the	  platform	  displayed	  by	  pubescent	  offspring	  relative	  to	  adult	  and	  aged	  offspring.	  p	  values	  are	  based	  on	  post-­‐hoc	  analyses	  following	  the	  presence	  of	  significant	  main	  effects	  of	  age	  (F(2,68)	  =	  64.33,	  p	  <	  0.001),	  prenatal	   treatment	  (F(1,68)	  =	  11.84,	  p	  <	  0.001)	  and	  trials	  (F(14,952)	  =	  18.83,	  p	  <	  0.001),	  as	  well	  as	  of	  a	  two-­‐way	  interaction	  between	  prenatal	  and	  age	  (F(2,68)	  =	  13.07,	  p	  <	  0.001)	  and	  a	  three-­‐way	  interaction	  between	  age,	  prenatal	  treatment,	  and	  trials	  (F(28,952)	  =	  1.67,	  p	  <	  0.05).	  
(B)	  The	  bar	  plot	  shows	  the	  percent	   time	  spent	   in	   the	   target	  quadrant	  during	  the	  probe	  test	  of	  spatial	  reference	  memory	  retention	  as	  assessed	  1	  day	  after	  completion	  of	  reference	  training.	  **p	  
<	   0.01	   and	   ***p	   <	   0.001,	   based	   on	   post-­‐hoc	   tests	   following	   the	   presence	   of	   a	   significant	  main	  effect	   of	   quadrant	   (F(3,204)	   =	   58.70,	   p	   <	   0.001),	   a	   significant	   two-­‐way	   interaction	   between	  quadrant	  and	  age	   (F(6,204)	  =	  12.29,	  p	   <	  0.001),	   and	  a	   significant	   three-­‐way	   interaction	  between	  quadrant,	  age,	  and	  prenatal	  treatment	  (F(6,204)	  =	  5.13,	  p	  <	  0.001).	  (C)	  Computer-­‐generated	  search	  paths	   of	   representative	   CON	   and	   POL	   offspring	   during	   the	   probe	   test	   of	   spatial	   reference	  memory	   retention	   at	   the	   pubescent,	   adult,	   and	   aged	   stages	   of	   life.	   T,	   target	   quadrant.	  





4.4.4	  Prenatal	  Immune	  Activation	  Reduces	  Food	  Hoarding	  Behaviour	  during	  Aging	  Based	   on	   the	   preceding	   findings,	   we	   were	   further	   interested	   in	   exploring	   whether	  prenatal	   immune	  activation	  might	  cause	  deficits	   in	   species-­‐typical	  behaviours	   that	  are	  known	   to	   be	   regulated	   by	   the	   hippocampus.	   Therefore,	   we	   went	   on	   to	   assess	   the	  consequences	  of	  prenatal	  immune	  challenge	  on	  food	  hoarding,	  which	  has	  been	  shown	  to	  be	  disrupted	  by	  hippocampal	  lesions	  (Deacon	  et	  al,	  2002a).	  In	  agreement	  with	  previous	  studies	  in	  mice	  (Deacon,	  2012),	  the	  extent	  to	  which	  mice	  displaced	  food	  from	  the	  distant	   food	  source	  to	  their	  home	  cages	  was	  found	  to	  be	  variable,	  even	  within	  individual	  experimental	  groups	  (Fig.	  19a).	  Despite	  this,	  we	  found	  that	  aged	  offspring	  of	   immune-­‐challenged	  mothers	  displayed	  a	  significant	  reduction	   in	  the	  amount	  of	   food	  hoarded	  compared	   to	  aged	  control	  offspring	   (Fig.	  19a).	   Similar	   to	  mice	  with	  hippocampal	   lesions	  (Deacon	   et	  al,	  2002b),	  aged	   immune-­‐exposed	  offspring	  hoarded	  virtually	  no	  food	  (Fig.	  19a).	  On	  the	  other	  hand,	  immune-­‐challenged	  and	  control	  offspring	  exhibited	  comparable	  amounts	  of	  food	  hoarding	  when	  they	  were	  tested	  at	  the	  pubescent	  or	  adult	  ages	  (Fig.	  19a).	  Hence,	  prenatal	   immune	  activation	   induces	  a	   long-­‐term	  negative	  impact	  on	  food	  hoarding	  behaviour	  that	  emerges	  specifically	  during	  aging.	  Importantly,	   this	   impairment	   is	   unlikely	   to	   be	   attributable	   to	   possible	   differences	   in	  general	  food	  intake	  because	  no	  group	  differences	  were	  detected	  in	  the	  analysis	  of	  total	  food	  eaten	  during	  the	  test	  period	  (Fig.	  19b).	  	  
	  







Figure	   19.	   Food	   hoarding	   behaviour	   in	   pubescent,	   adult,	   and	   aged	   offspring	   born	   to	  
poly(I:C)-­‐exposed	  (POL)	  or	  control	  (CON)	  mothers.	  (A)	  The	  box	  plots	  represent	  the	  amount	  of	   food	   hoarded	   (g,	   ln-­‐transformed).	   *p	   <	   0.05,	   reflecting	   the	   significant	   reduction	   in	   food	  hoarding	   displayed	   by	   aged	   POL	   offspring	   relative	   to	   aged	   CON	   offspring	   based	   on	   non-­‐parametric	  Mann–Whitney	  analysis.	  (B)	  The	  box	  plots	  represent	  the	  amount	  of	  food	  eaten	  (g,	  ln-­‐transformed).	  N	  =	  10	  in	  each	  group.	  	  
	  
	  





4.4.5	  Prenatal	   Immune	  Activation	  does	  not	  Affect	   Innate	  Anxiety-­‐Like	  Behaviour	  
or	  Basal	  Locomotor	  Activity	  in	  a	  Novel	  Environment	  Using	   the	  open	   field	   test,	  we	   further	   investigated	  whether	  prenatal	   immune	  activation	  and	  aging	  would	  alter	  innate	  anxiety-­‐like	  behaviour	  and/or	  locomotor	  activity,	  which	  in	  turn	   could	   confound	   the	   interpretation	   of	   the	   findings	   obtained	   in	   the	   preceding	  cognitive	  tests	  of	  primary	  interest	  (Holmes	  et	  al,	  2002;	  Huang	  et	  al,	  2012).	  In	  line	  with	  previous	  findings	  (Schwendener	  et	  al,	  2009),	  we	  found	  that	  prenatal	  immune	  challenge	  did	  not	  change	  the	  primary	  indices	  of	  innate	  anxiety-­‐like	  behaviour	  in	  the	  open	  field	  test	  (i.e.,	  time	  spent	  or	  distance	  moved	  in	  the	  central	  area	  of	  the	  open	  field)	  at	  pubescent	  or	  adult	   age	   (Table	   5).	   Similarly,	   there	  were	   no	   group	   differences	  with	   respect	   to	   these	  measures	  when	  the	  offspring	  reached	  the	  aged	  stage	  (Table	  5).	  The	  prenatal	  immunological	  insult	  did	  also	  not	  affect	  basal	  locomotor	  activity	  as	  indexed	  by	  the	  total	  distance	  moved	  in	  the	  entire	  open	  field	  arena	  (Table	  5).	  The	  total	  distance	   moved	   in	   the	   open	   field	   test	   decreased	   with	   increasing	   age,	   and	   this	   age-­‐associated	   effect	   on	   basal	   locomotor	   activity	   was	   not	   influenced	   by	   prenatal	   immune	  activation	  (Table	  5).	  Together,	  these	  data	  thus	  suggest	  that	  the	  cognitive	  consequences	  of	   prenatal	   immune	   activation	   (Fig.	   1-­‐4)	   are	   unlikely	   to	   be	   confounded	   by	   possible	  changes	  in	  innate	  anxiety-­‐like	  behaviour	  and/or	  locomotor	  activity.	  	  	  
Age	   Prenatal	  
treatment	  
Total	   distance	  
moved	  (m)	  
Distance	   moved	   in	  
centre	  zone	  (m)	  
Time	   spent	   in	  
centre	  zone	  (s)	  Pubescent	   CON	   76.27±4.57a	   5.92±1.01	   196.26±35.61	  	   POL	   73.04±3.61a	   6.79±1.49	   234.58±47.07	  Adult	   CON	   65.81±2.69	  b	   8.41±0.92	  	   242.34±47.88	  	   POL	   61.51±5.21	  b	   7.02±0.69	  	   195.94±18.51	  	  Aged	   CON	   55.44±4.64	   5.99±1.	  40	   143.22±41.52	  	   POL	   52.04±3.55	   5.28±1.05	   155.36±47.59	  
	  
Table	  5.	  Summary	  of	  the	  effects	  of	  age	  and	  prenatal	  treatment	  on	  behavioural	  measures	  
in	  the	  open	  field	  test.	  Separate	  cohorts	  of	  prenatally	  poly(I:C)-­‐treated	  (=	  POL)	  and	  control	  (	  =	  CON)	  offspring	  were	   tested	  when	   they	  reached	   the	  pubescent,	  adult,	  or	  aged	  stage	  of	   life.	   ap	  <	  0.001,	  reflecting	  the	  significant	  difference	  between	  pubescent	  and	  adult	  or	  aged	  offspring	  based	  on	  post-­‐hoc	  analyses;	  and	   bp	  <	  0.05,	   reflecting	  a	  significant	  difference	  between	  adult	  and	  aged	  offspring	  based	  on	  post-­‐hoc	  analyses	  following	  presence	  of	  a	  significant	  main	  effect	  of	  age	  (F(2,54)	  =	  12.82,	  p	  <	  0.001).	  All	  values	  are	  means±SEM;	  N	  =	  10	  in	  each	  group.	  	  	  
	  





4.4.6	   Prenatal	   Immune	   Activation	   Affects	   Synaptic	   Proteins	   and	   Neurotrophins	  









Figure	  20.	  Hippocampal	  postsynaptic	  density	  protein	  95	  (PSD95)	  in	  pubescent,	  adult,	  and	  
aged	   offspring	   born	   to	   poly(I:C)-­‐exposed	   (POL)	   or	   control	   (CON)	   mothers.	   (A)	   Relative	  optical	   density	   (in	   arbitrary	   units,	   AU)	   of	   PSD95	   in	   the	   pyramidal	   cell	   layer	   of	   the	   cornu	  ammonis	  area	  1	  (CA1).	  +p	  <	  0.001,	  reflecting	  the	  significantly	  lower	  PSD95	  density	  in	  adult	  CON	  and	  POL	  offspring	  relative	  to	  pubescent	  or	  aged	  CON	  and	  POL	  offspring;	  **p	  <	  0.01,	  reflecting	  the	  significant	  difference	  between	  aged	  POL	  and	  aged	  CON	  offspring.	  p	  values	  are	  based	  on	  post-­‐hoc	  analyses	  following	  the	  presence	  of	  a	  significant	  main	  effect	  of	  age	  (F(2,44)	  =	  8.99,	  p	  <	  0.001)	  and	  its	  interaction	   with	   prenatal	   treatment	   (F(2,44)	   =	   3.49,	   p	   <	   0.05).	   (B)	   Relative	   optical	   density	   of	  PSD95	  in	  the	  pyramidal	  cell	   layer	  of	  the	  CA3	  area.	  +p	  <	  0.001,	  reflecting	  the	  significantly	   lower	  PSD95	   density	   in	   adult	   CON	   and	   POL	   offspring	   relative	   to	   pubescent	   or	   aged	   CON	   and	   POL	  offspring;	   **p	   <	   0.01,	   reflecting	   the	   significant	   difference	   between	   aged	   POL	   and	   aged	   CON	  offspring.	  p	  values	  are	  based	  on	  post-­‐hoc	  analyses	   following	  the	  presence	  of	  a	  significant	  main	  effect	  of	  age	  (F(2,44)	  =	  33.20,	  p	  <	  0.001)	  and	  its	  interaction	  with	  prenatal	  treatment	  (F(2,44)	  =	  3.08,	  p	  <	  0.05).	  (C)	  Relative	  optical	  density	  of	  PSD95	  in	  the	  granule	  cell	  layer	  of	  the	  dentate	  gyrus	  (DG).	  §p	   <	   0.001,	   reflecting	   the	   significantly	   higher	   PSD95	   density	   in	   aged	   CON	   and	   POL	   offspring	  relative	   to	   pubescent	   or	   aged	   CON	   and	   POL	   offspring;	   **p	   <	   0.01,	   reflecting	   the	   significant	  difference	  between	  aged	  POL	  and	  aged	  CON	  offspring.	  p	  values	  are	  based	  on	  post-­‐hoc	  analyses	  following	   the	   presence	   of	   a	   significant	   main	   effect	   of	   age	   (F(2,44)	   =	   21.57,	   p	   <	   0.001)	   and	   its	  interaction	  with	   prenatal	   treatment	   (F(2,44)	   =	   3.92,	   p	   <	   0.05).	   For	  A-­‐C,	  N(pubescent	   CON)	   =	   8,	  








Figure	   21.	   Hippocampal	   synaptophysin	   (SYN)	   density	   in	   pubescent,	   adult,	   and	   aged	  
offspring	   born	   to	   poly(I:C)-­‐exposed	   (POL)	   or	   control	   (CON)	  mothers.	   (A)	   Relative	   optical	  density	  (in	  arbitrary	  units,	  AU)	  of	  SYN	  in	  the	  pyramidal	  cell	   layer	  of	  the	  cornu	  ammonis	  area	  1	  (CA1).	   +p	   <	   0.001,	   reflecting	   the	   significantly	   lower	   SYN	   density	   in	   pubescent	   CON	   and	   POL	  offspring	  relative	  to	  adult	  or	  aged	  CON	  and	  POL	  offspring;	  ***p	  <	  0.001,	  reflecting	  the	  significant	  difference	  between	  aged	  POL	  offspring	  and	  adult	  or	  aged	  CON	  offspring.	  p	  values	  are	  based	  on	  post-­‐hoc	  analyses	   following	   the	  presence	  of	  a	  significant	  main	  effect	  of	  age	  (F(2,44)	  =	  52.48,	  p	  <	  0.001)	  and	  its	   interaction	  with	  prenatal	   treatment	  (F(2,44)	  =	  6.03,	  p	  <	  0.01).	  (B)	  Relative	  optical	  density	  of	  SYN	  in	  the	  pyramidal	  cell	  layer	  of	  the	  CA3	  area.	  +p	  <	  0.001,	  reflecting	  the	  significantly	  lower	  SYN	  density	   in	  pubescent	  CON	  and	  POL	  offspring	  relative	  to	  adult	  or	  aged	  CON	  and	  POL	  offspring;	   *p	  <	  0.05	  and	  **p	  <	  0.01,	   reflecting	   the	  significant	  difference	  between	  aged	  POL	  and	  CON	  offspring,	  and	  between	  adult	  and	  aged	  CON	  offspring,	   respectively.	  p	  values	  are	  based	  on	  post-­‐hoc	  analyses	   following	   the	  presence	  of	  a	  significant	  main	  effect	  of	  age	  (F(2,44)	  =	  79.14,	  p	  <	  0.001)	  and	   its	   interaction	  with	  prenatal	   treatment	  (F(2,44)	  =	  4.57,	  p	  <	  0.05).	  (C)	  Relative	  optical	  density	   of	   SYN	   in	   the	   granule	   cell	   layer	   of	   the	   dentate	   gyrus	   (DG).	   +p	   <	   0.001,	   reflecting	   the	  significantly	  lower	  SYN	  levels	  in	  pubescent	  CON	  and	  POL	  offspring	  relative	  to	  adult	  or	  aged	  CON	  and	  POL	  offspring;	  #p	  <	  0.001,	  reflecting	  the	  significantly	  lower	  SYN	  density	  in	  aged	  CON	  and	  POL	  offspring	   relative	   to	   adult	   CON	   and	   POL	   offspring;	   °p	   <	   0.05,	   reflecting	   the	   significant	   overall	  difference	  between	  POL	  and	  CON	  offspring.	  p	   values	  are	  based	  on	  post-­‐hoc	  analyses	   following	  the	   presence	   of	   a	   significant	   main	   effects	   of	   age	   (F(2,44)	   =	   52.	   59,	   p	   <	   0.001)	   and	   prenatal	  treatment	   (F(1,44)	   =	   6.59,	   p	   <	   0.05).	   For	   A-­‐C,	   N(pubescent	   CON)	   =	   8,	   N(pubescent	   POL)	   =	   8,	  
N(adult	   CON)	   =	   8,	   N(adult	   POL)	   =	   7,	   N(aged	   CON)	   =	   9,	   N(aged	   POL)	   =	   10;	   all	   values	   are	  means±SEM.	   (D)	   Schematic	   illustration	   of	   the	   hippocampal	   cell	   layers,	   in	   which	   the	   relative	  optical	   density	   of	   SYN	   was	   measured	   (as	   highlighted	   by	   the	   boundaries	   shown	   in	   grey).	   (E)	  Representative	   examples	   of	   SYN	   staining	   in	   the	   CA3	   pyramidal	   cell	   layer	   (as	   indicated	   by	   the	  square	  in	  D)	  of	  aged	  CON	  and	  POL	  offspring.	  Scale	  bar:	  20	  μm.	  
	  







Figure	  22.	  Expression	  of	  neuroplasticity-­‐related	  genes	  in	  the	  dorsal	  hippocampus	  of	  adult	  
and	   aged	   offspring	   born	   to	   poly(I:C)-­‐exposed	   (POL)	   or	   control	   (CON)	  mothers.	   The	   bar	  plots	   show	   normalized	  mRNA	   expression	   of	   brain-­‐derived	   neurotrophic	   factor	   (BDNF),	   nerve	  growth	   factor	   (NGF),	   and	   neurotrophin-­‐3	   (NT-­‐3)	   as	   assessed	   using	   quantitative	   RT-­‐PCR.	   *p	   <	  0.05	   and	   ***p	   <	   0.001,	   based	   on	   post-­‐hoc	   analyses	   following	   the	   presence	   of	   a	   significant	  interaction	   between	   prenatal	   treatment	   and	   age	   (BDNF:	  F(1,48)	   =	   5.66,	  p	   <	   0.05;	   NT-­‐3:	  F(1,48)	   =	  5.53,	  p	  <	  0.05).	  N(adult	  CON)	  =	  13,	  N(adult	  POL)	  =	  13,	  N(aged	  CON)	  =	  14,	  N(aged	  POL)	  =	  12;	  all	  values	  are	  means±SEM.	  
	  
	  





4.4.7	  Prenatal	  Immune	  Activation	  does	  not	  Induce	  Signs	  of	  Persistent	  Systemic	  or	  
Hippocampal	  Inflammation	  	  It	  has	  been	  proposed	  that	  prenatal	  immune	  activation	  may	  exacerbate	  neuronal	  aging	  by	  inducing	   persistent	   systemic	   inflammation	   and	   accompanied	   neuroinflammatory	  reactions	  throughout	  brain	  maturation	  and	  aging	  (Krstic	  et	  al,	  2013;	  Krstic	  et	  al,	  2012).	  To	   explore	   whether	   systemic	   inflammatory	   abnormalities	   might	   be	   involved	   in	   the	  precipitation	   of	   aging-­‐related	   cognitive	   and	   synaptic	   impairments	   following	   prenatal	  poly(I:C)	   exposure,	  we	   assessed	   the	   serum	   levels	   of	   cytokines	  with	   pro-­‐inflammatory	  (IL-­‐1β,	  IL-­‐6,	  TNF-­‐α,	  and	  IFN-­‐γ)	  and	  anti-­‐inflammatory	  (IL-­‐4	  and	  IL-­‐10)	  properties	  (Curfs	  













Figure	  23.	  Cytokine	  serum	  levels	  in	  pubescent,	  adult,	  and	  aged	  offspring	  born	  to	  poly(I:C)-­‐
exposed	   (POL)	   or	   control	   (CON)	  mothers.	   The	   graphs	   depict	   the	   levels	   of	   tumour	   necrosis	  factor-­‐α	   (TNF-­‐α),	   interferon-­‐γ	   (IFN-­‐γ),	   interleukin	   (IL)-­‐4,	   IL-­‐6,	   and	   IL-­‐10.	   §p	  <	  0.001,	   reflecting	  the	  significant	  difference	  between	  aged	  CON	  and	  POL	  offspring	  and	  pubescent	  or	  adult	  CON	  and	  POL	  offspring,	  based	  on	  post-­‐hoc	  comparisons	  following	  the	  presence	  of	  a	  significant	  main	  effect	  of	  age	  (TNF-­‐α:	  F(1,48)	  =	  4.74,	  p	  <	  0.05;	  IFN-­‐γ:	  F(2,44)	  =	  13.67,	  p	  <	  0.001;	  IL-­‐6:	  IFN-­‐γ:	  F(2,44)	  =	  5.65,	  p	  <	  0.01;	   IL-­‐10:	  F(2,44)	   =	   15.32,	  p	   <	   0.001).	   +p	   <	   0.01,	   reflecting	   the	   selective	   increase	   in	   aged	   POL	  offspring	  relative	  to	  all	  other	  groups,	  based	  on	  post-­‐hoc	  comparisons	  following	  the	  presence	  of	  a	  significant	   interaction	  between	  prenatal	   treatment	  and	  age	  (F(2,44)	  =	  6.15,	  p	  <	  0.01).	  **p	  <	  0.01,	  reflecting	   the	  significant	  difference	  between	  aged	  CON	  and	  aged	  POL	  offspring,	  based	  on	  post-­‐hoc	  comparison	  following	  the	  presence	  of	  a	  significant	  interaction	  between	  prenatal	  treatment	  and	  age	  (F(2,44)	  =	  3.30,	  p	  <	  0.01).	  The	  serum	  levels	  of	  TNF-­‐α	  were	  below	  detection	  limit	  (BDL)	  in	  pubescent	   offspring,	   and	   so	   were	   the	   serum	   levels	   of	   IL-­‐1β	   (not	   depicted)	   at	   all	   ages	  investigated.	  N(pubescent	  CON)	  =	  9,	  N(pubescent	  POL)	  =	  9,	  N(adult	  CON)	  =	  8,	  N(adult	  POL)	  =	  8,	  
N(aged	  CON)	  =	  8,	  N(aged	  POL)	  =	  8;	  all	  values	  are	  means±SEM.	  	  
	  







Figure	  24.	  Hippocampal	  microglia	  and	  astroctye	  numbers	   in	  pubescent,	  adult,	   and	  aged	  
offspring	   born	   to	   poly(I:C)-­‐exposed	   (POL)	   or	   control	   (CON)	   mothers.	   (A)	   Stereological	  estimates	  of	  CD68-­‐immunoreactive	  microglia	   in	  the	  entire	  cornu	  ammonis	  (CA)	  area	  (i.e.,	  CA1-­‐CA3	  areas)	  and	  dentate	  gyrus	  (DG).	  #p	  <	  0.001	  and	  +p	  <	  0.01,	  reflecting	  the	  significant	  difference	  between	   pubescent	   CON	   and	   POL	   offspring	   and	   adult	   CON	   and	   POL	   offspring,	   and	   between	  pubescent	  CON	  and	  POL	  offspring	  and	  aged	  CON	  and	  POL	  offspring,	   respectively.	  p	   values	  are	  based	   on	  post-­‐hoc	   analyses	   following	   the	   presence	   of	   a	   significant	  main	   effect	   of	   age	   (F(2,44)	   =	  10.33,	  p	  <	  0.001).	  N(pubescent	  CON)	  =	  8,	  N(pubescent	  POL)	  =	  8,	  N(adult	  CON)	  =	  8,	  N(adult	  POL)	  =	   7,	   N(aged	   CON)	   =	   9,	   N(aged	   POL)	   =	   10;	   all	   values	   are	   means±SEM.	   (B)	   Representatives	  hippocampal	   sections	   of	   pubescent,	   adult,	   and	   aged	  CON	  and	  POL	  offspring	   stained	  with	   anti-­‐CD68	   antibody.	   The	   insert	   photomicrograph	   depicts	   CD68-­‐positive	   microglia	   cells	   at	   higher	  magnification.	  (C)	   Stereological	  estimates	  of	  GFAP-­‐immunoreactive	  astrocytes	   in	   the	  entire	  CA	  and	  DG	  regions.	  N(pubescent	  CON)	  =	  8,	  N(pubescent	  POL)	  =	  8,	  N(adult	  CON)	  =	  8,	  N(adult	  POL)	  =	  7,	   N(aged	   CON)	   =	   9,	   N(aged	   POL)	   =	   10;	   all	   values	   are	   means±SEM.	   (D)	   Representatives	  hippocampal	   sections	   of	   pubescent,	   adult,	   and	   aged	  CON	  and	  POL	  offspring	   stained	  with	   anti-­‐GFAP	   antibody.	   The	   insert	   photomicrograph	   shows	   GFAP-­‐positive	   astrocytes	   at	   higher	  magnification.	  
	  





	   	   CON-­‐Adult	   POL-­‐Adult	   CON-­‐Aged	   POL-­‐Aged	  IL-­‐1β/36B4	   35.5/27.0	   36.6/26.9	   35.3/27.1	   32.6/27.1	  IL-­‐4/36B4	   35.6/26.0	   35.3/26.1	   36.0/26.0	   35.3/26.2	  IL-­‐6/36B4	   32.2/26.2	   32.1/25.9	   32.3/26.5	   32.8/26.6	  TNF-­‐α/36B4	   35.6/26.3	   35.0/25.1	   36.3/25.9	   35.2/25.0	  	  
Table	  6.	  Summary	  of	  the	  average	  cycle	  threshold	  (Ct)	  values	  for	  the	  cytokines	  genes	  (IL-­‐1β,	  IL-­‐4,	  IL-­‐6,	  and	  TNF-­‐α)	  and	  house-­‐keeping	  gene	  (36B4)	  measured	  in	  the	  hippocampi	  of	  adult	  and	  aged	  offspring	   born	   to	   poly(I:C)-­‐exposed	   (POL)	   and	   control	   (CON)	   mothers	   using	   real-­‐time	   PCR.	  
N(adult	  CON)	  =	  13,	  N(adult	  POL)	  =	  13,	  N(aged	  CON)	  =	  14,	  N(aged	  POL)	  =	  12.	  
	  
	  
4.4.8	  Discussion	  Our	   study	   demonstrates	   that	   prenatal	   exposure	   to	   viral-­‐like	   immune	   activation	  negatively	   influences	   hippocampus-­‐related	   cognitive	   and	   synaptic	   functions	   during	  aging.	  Based	  on	   its	   relevance	   to	  neurodevelopmental	  disorders	   (Atladottir	   et	  al,	   2010;	  Brown	   et	   al,	   2010;	   Canetta	   et	   al,	   2014),	   early-­‐life	   immune	   insults	   such	   as	   maternal	  infection	  have	  been	  mostly	  studied	  with	  respect	  to	  (hippocampus-­‐related)	  neuronal	  and	  behavioural	   abnormalities	   that	   emerge	   in	   the	   offspring	   when	   they	   mature	   from	  pubescence	   to	   adulthood	   (Harvey,	   2012;	   Meyer,	   2014;	   Meyer	   et	   al,	   2010a).	   Although	  some	   developmental	   dysfunctions	   induced	   by	   prenatal	   immune	   challenge	   can	   be	  detected	  as	  early	  as	  the	  fetal	  and	  early	  neonatal	  stages	  (Baharnoori	  et	  al,	  2012;	  Escobar	  















negative	  findings	  that	  either	  support	  (Borrell	  et	  al,	  2002;	  Krstic	  et	  al,	  2012;	  Mattei	  et	  al,	  2014)	  or	  refute	  (Pacheco-­‐Lopez	  et	  al,	  2013;	  Willi	  et	  al,	  2013)this	  hypothesis.	  Related	  to	  this,	   it	   is	  important	  to	  emphasize	  that	  the	  consequences	  of	  prenatal	  immune	  activation	  on	   postnatal	   inflammatory	   processes	   are	   likely	   to	   be	   influenced	   by	   various	   factors,	  including	  prenatal	  timing	  and	  immune	  stimulus	  identity	  and/or	  severity.	  It	  is	  also	  likely	  that	   the	   postnatal	   environment,	   in	   which	   the	   offspring	   mature,	   can	   significantly	  influence	  their	  immune	  parameters,	  including	  the	  levels	  of	  perceived	  stress	  (Giovanoli	  et	  
al,	  2013)	  and	  pathogen	  load	  of	  the	  animal	  holding	  facilities	  (Doom	  et	  al,	  2009;	  Montalvo	  










4.5	   Late	   Prenatal	   Immune	   Activation	   Induces	   Alterations	   in	  
Myelination:	  Insight	  from	  a	  Genome-­‐Wide	  Approach	  	  Richetto	  J.,	  Meyer	  U.,	  Riva	  M.	  A.,	  





In	  order	  to	  find	  new	  potential	  mechanisms	  underlying	  the	  association	  between	  prenatal	  infection	   and	   psychiatric	   disorders,	   such	   as	   schizophrenia,	   we	   were	   interested	   in	  investigating	   the	   long-­‐term	  molecular	  alterations	  emerging	  after	  gestational	   treatment	  with	   the	   viral	   mimetic	   polyriboinosinic-­‐polyribocytidilic	   acid	   [Poly(I:C)].	   For	   this	  purpose,	   we	   used	   an	   unbiased	   genome-­‐wide	   approach.	   This	   approach	   may	   readily	  provide	   new	   insight	   into	   the	   precise	   pathways	   and	   systems	   altered	   by	   the	   prenatal	  manipulation,	  which	   in	   turn	  may	  unravel	  novel	   targets	   for	   therapeutic	   intervention	   in	  subjects	  with	  (immune-­‐mediated)	  neurodevelopmental	  disturbances..	  	  	   We	  treated	  pregnant	  dams	  with	  Poly(I:C)	  on	  gestation	  day	  17	  (GD17).	  This	  period	  corresponds	  roughly	   to	   the	  second	  trimester	  of	  human	  pregnancy,	  which	   is	  crucial	   for	  nervous	  system	  development	  and	  neuronal	  proliferation	  and	  differentiation	  (Clancy	   et	  






4.5.1	  Prenatal	  Immune	  Activation	  Induces	  Behavioural	  Alterations	  in	  the	  Form	  of	  







Figure	  25.	  Prenatal	  poly(I:C)	  exposure	  impairs	  spatial	  working	  memory,	  social	  approach	  





4.5.2	  Prenatal	  Immune	  Activation	  Induces	  Behavioural	  Alterations	  in	  the	  Form	  of	  








Figure	  26.	  Prenatal	  exposure	  to	  Poly(I:C)	   leads	  to	  increased	  sensitivity	  to	  amphetamine.	  The	   line	   plot	   depicts	   the	   distance	   moved	   (cm)	   as	   a	   function	   of	   5-­‐min	   bins	   during	   the	   initial	  habituation	  period	  and	  after	  systemic	  treatment	  with	  AMPH,	  and	  the	  bar	  plots	  shows	  the	  mean	  distance	  moved	  across	   the	  entire	  post-­‐AMPH	  treatment	  phase.	  The	  distance	  moved	  during	   the	  initial	   saline	   phase	  was	   analysed	   using	   a	   2	   x	   6	   (prenatal	   treatment	   x	   bins)	   repeated-­‐measure	  ANOVA.	  This	  analysis	  yielded	  no	  significant	  main	  effects	  or	  interactions,	  suggesting	  that	  control	  and	   Poly(I:C)-­‐exposed	   offspring	   displayed	   similar	   basal	   locomotor	   activities.	   The	   distance	  moved	   following	   AMPH	   treatment	   was	   analysed	   using	   a	   2	   x	   12	   (prenatal	   treatment	   x	   bins)	  repeated-­‐measure	   ANOVA.	   **p	   <	   0.01,	   reflecting	   the	   significant	   main	   effect	   of	   prenatal	  treatment.	  N(CON)	  =	  18	  and	  N(POL)	  =	  11.	  
	  
	  





4.5.3	  Microarray	  Analysis	  of	  the	  Prefrontal	  Cortex	  from	  Mice	  Exposed	  to	  Prenatal	  
Immune	  Activation	  As	  shown	  in	  Fig	  27,	  which	  represents	  the	  hierarchical	  clustering	  of	  expression	  changes	  induced	  by	  prenatal	  infection	  with	  Poly(I:C),	  we	  found	  185	  genes	  that	  were	  differentially	  expressed	  in	  the	  prefrontal	  cortex	  (fold	  change	  cutoff:	  ±	  1.2;	  p	  <	  0.05).	  In	  the	  hierarchical	  clustering,	   the	   genes	   are	   grouped	   together	   with	   the	   aim	   to	   deduce	   the	   relationships	  between	   the	   different	   clusters.	   It	   represents,	   for	   each	   single	   sample,	   the	   expression	  levels	  of	  a	  given	  gene	  and	  how	  this	  gene	  is	  expressed	  in	  the	  analysed	  subjects.	  Of	  the	  185	  genes	   that	   were	   differentially	   expressed,	   71	   were	   down-­‐regulated	   and	   114	   were	   up-­‐regulated.	   The	   top	   twenty	   most	   up-­‐regulated	   genes	   in	   terms	   of	   fold	   change	   are	  presented	  in	  the	  Table	  7,	  while	  the	  top	  twenty	  most	  down-­‐regulated	  genes	  are	  listed	  in	  
Table	  8.	  








Figure	   27.	  Hierarchical	   clustering	   of	   gene	   expression	   changes	   in	   the	   prefrontal	   cortex	  
after	  prenatal	   infection	  with	  Poly(I:C).	  Each	   rectangle	  on	   the	  x	   axis	   corresponds	   to	   a	   single	  gene,	  while	  the	  rectangles	  on	  y	  axis	  represent	  each	  control	  and	  Poly(I:C)	  animal.	  Red	  indicates	  genes	  that	  are	  up-­‐regulated,	  while	  blue	  indicates	  genes	  that	  are	  down	  regulated.	  In	  the	  image	  it	  is	  clear	  how	  the	  differentially	  expressed	  genes	  are,	  for	  example,	  up-­‐regulated	  in	  control	  animals	  and	  down-­‐regulated	  in	  Poly(I:C)	  exposed	  animals.	  	  
	  





Top	  20	  Up-­‐Regulated	  Genes	  
Gene	  symbol	   	   p-­‐value	   Fold-­‐Change	  
Npas4	    0,0138476	   1,59753	  
Vmn2r87	   	   0,00098056	   1,54698	  
Mir128-­‐1	   	   0,00000971088	   1,51712	  
Mir382	   	   0,00469434	   1,48828	  
BC030499	   	   0,000214599	   1,48167	  
Fam36a	   	   0,001944	   1,46433	  
Snord14c	    0,00537517	   1,44522	  
Mir679	    0,00176899	   1,44017	  
Snord14c	    0,00567927	   1,43686	  
Mir410	    0,0000284079	   1,41920	  
Snord14e	    0,00674074	   1,40522	  
C230004F18Rik	    0,000918765	   1,39085	  
Mir344	   	   0,00126448	   1,38651	  
Leng8	   	   0,00259674	   1,37652	  
Mir377	   	   0,00154195	   1,37340	  
Mir344	   	   0,00185084	   1,36772	  
Mir376b	   	   0,00559728	   1,36103	  
Gm10759	   	   0,000588411	   1,35760	  
Ttc14	   	   0,000611469	   1,35582	  
Uggt2	   	   0,000499779	   1,35536	  
	  
Table	  7.	  Top	  twenty	  up-­‐regulated	  genes	  in	  the	  mPFC.	  
	  






Top	  20	  Down-­‐Regulated	  Genes	  
Gene	  symbol	   	   p-­‐value	   Fold-­‐Change	  
Snord47	    0,0000513461	   -­‐2,07249	  
Snord32a	   	   0,000000109466	   -­‐1,98017	  
Snord34	   	   0,0000000331084	   -­‐1,83875	  
Snord33	   	   0,00000165274	   -­‐1,81872	  
Snord87	   	   0,0000018579	   -­‐1,80696	  
Snord49a	   	   0,0000958707	   -­‐1,78046	  
Gas5	    0,0000019195	   -­‐1,72427	  
Snord82	    0,0000236971	   -­‐1,65563	  
Rpl13	    0,0000127176	   -­‐1,64535	  
Cryge	    0,0163217	   -­‐1,63784	  
Rny1	    0,00240824	   -­‐1,57444	  
Snord35b	    0,00000263206	   -­‐1,54314	  
Gm11362	   	   0,00000027052	   -­‐1,53481	  
Snord104	   	   0,000271503	   -­‐1,52484	  
Drd2	   	   0,0298378	   -­‐1,45221	  
Gpr6	   	   0,0118314	   -­‐1,43112	  
Thbs4	  	   	   0,0015016	   -­‐1,41704	  
Mobp	   	   0,000436516	   -­‐1,41191	  
Snord35a	   	   0,00000543427	   -­‐1,40553	  
5530400C23Rik	   	   0,00157834	   -­‐1,36654	  
	  
Table	  8.	  Top	  twenty	  down-­‐regulated	  genes	  in	  the	  mPFC.	  
	  





4.5.3.1	   Prenatal	   immune	   activation	   impacts	   different	   biological	   functions	   important	   for	  






Top	  Canonical	  Pathways	  
Name	   	   	   p-­‐value	   Ratio	  	    	   	  
G-­‐Protein	  Coupled	  Receptor	  Signalling	   	   1.14E-­‐02	   5/276	  
	   	   	   (0.018)	  
NGF	  Signalling	   	   1.88E-­‐02	   3/122	  
	   	   	   (0.025)	  
Gα12/13	  Signalling	   	   2.4E-­‐02	   3/127	  
	    	   (0.024)	  
cAMP-­‐mediated	  Signalling	    2.83E-­‐02	   4/226	  
	    	   (0.018)	  
Sphingomyelin	  Metabolism	    4.11E-­‐02	   1/16	  
	    	   (0.062)	  
	   	   	   	  
	  
Table	   9.	   Top	   affected	   canonical	   pathways	   in	   the	   Poly(I:C)	   prefrontal	   cortex.	   The	   top	  pathways	  are	  ranked	  together	  with	  p-­‐value,	  which	  specifies	  the	  statistical	  significance,	  and	  the	  ratio,	   the	   number	   of	   altered	   genes	   compared	   to	   the	   total	   number	   of	   genes	   for	   that	   specific	  pathway.	  
	  
	  






ID	  Associated	  Network	  Functions	   	   Score	  	    	  Cellular	   development,	   Cellular	   growth	   and	   proliferation,	   Nervous	  System	  development	  and	  function	   	   42	  	   	   	  Cell	  signalling,	  Nucleic	  Acid	  metabolism,	  Small	  molecule	  biochemistry	   	   36	  	   	   	  Connective	   tissue	   disorders,	   Developmental	   disorder,	   Hereditary	  disorder	   	   27	  	    	  Connective	   tissue	   disorders,	   Developmental	   disorder,	   Hereditary	  disorder	    25	  	    	  Nutritional	  disease,	  Molecular	  transport,	  Small	  molecule	  biochemistry	    23	  
	    	  
	   	   	  
	  
Table	  10.	  Selected	  top	   five	   implicated	  networks	   in	  the	  prefrontal	  cortex	  and	  the	  related	  
level	  of	  involvement	  (score).	  
	  
	  









Figure	   28.	   Graphical	   representation	   of	   nervous	   system	   development	   network	   in	   the	  
Poly(I:C)	  prefrontal	   cortex	  by	   Ingenuity	  system.	   In	  green	  down-­‐regulated	  genes,	   in	   red	   the	  up-­‐regulated	  ones.	  	  	  





4.5.4	   Microarray	   Analysis	   of	   the	   Nucleus	   Accumbens	   from	   Mice	   Exposed	   to	  
Prenatal	  Immune	  Activation	  	  After	   having	   analysed	   the	   prefrontal	   cortex,	  we	   performed	  microarray	   analysis	   of	   the	  nucleus	   accumbens.	   Once	   again,	   in	   Fig	   29,	   we	   report	   the	   hierarchical	   clustering	   of	  expression	  changes	  induced	  by	  prenatal	  infection	  with	  Poly(I:C),	  and	  we	  observed	  that	  325	   genes	  were	   differentially	   expressed	   in	   the	   NAc	   following	   prenatal	   infection	   (fold	  change	  cutoff:	  ±	  1.2;	  p	  <	  0.05).	  Of	   the	  325	  genes	   that	  were	  differentially	   expressed,	  159	  were	  up-­‐regulated	  while	  166	   were	   down-­‐regulated.	   The	   top	   twenty	   most	   up-­‐regulated	   genes	   in	   terms	   of	   fold	  change	  are	  presented	  in	  the	  Table	  11,	  while	  the	  top	  twenty	  most	  down-­‐regulated	  genes	  are	  listed	  in	  Table	  12.	  	  
	  
	  
Figure	  29.	  Hierarchical	  clustering	  of	  gene	  expression	  changes	   in	  the	  nucleus	  accumbens	  





Top	  20	  Up-­‐Regulated	  Genes	  in	  the	  Nucleus	  Accumbens	  
	  
Table	  11.	  Top	  twenty	  up-­‐regulated	  genes	  in	  the	  NAc.	  
Gene	  symbol	   	   p-­‐value	   Fold-­‐Change	  
Slc17a7	    0,0290275	   2,85106	  
Nov	   	   0,00894434	   2,66046	  
3110035E14Rik	   	   0,00841871	   2,29052	  
Nmbr	   	   0,0209392	   1,74568	  
Stard5	   	   0,00453269	   1,69014	  
Nptx1	   	   0,00896167	   1,65287	  
Ctgf	    0,0282534	   1,64784	  
St3gal1	    0,0000882596	   1,58939	  
Npas4	    0,00953208	   1,54037	  
Drd3	    0,000182858	   1,5163	  
Prss12	    0,0271643	   1,49249	  
Cnih3	    0,0184109	   1,46211	  
Mir382	   	   0,0107333	   1,45844	  
Npsr1	   	   0,0143958	   1,4527	  
Sidt1	   	   0,0127782	   1,43759	  
B3galt2	   	   0,0134754	   1,43701	  
Islr	   	   0,0321029	   1,41723	  
Htr1a	   	   0,0243749	   1,40838	  
Fam131a	   	   0,00111559	   1,40558	  





Top	  20	  Down-­‐Regulated	  Genes	  in	  the	  Nucleus	  Accumbens	  
Gene	  symbol	   	   p-­‐value	   Fold-­‐Change	  
Ttr	    0,00282672	   -­‐7,21783	  
Snora3	   	   0,0000480909	   -­‐3,02317	  
Tac2	   	   0,00268061	   -­‐2,34182	  
Gal	   	   0,00221473	   -­‐2,31403	  
Prlr	   	   0,00737445	   -­‐2,07634	  
Cryge	   	   0,017578	   -­‐1,85538	  
Snora44	    0,000595043	   -­‐1,83929	  
Lbp	    0,0302795	   -­‐1,82342	  
Rnu2-­‐10	    0,00177219	   -­‐1,79227	  
Rnu2-­‐10	    0,00177219	   -­‐1,79227	  
Rnu2-­‐10	    0,00177219	   -­‐1,79227	  
Rnu2-­‐10	    0,00177219	   -­‐1,79227	  
Rnu2-­‐10	   	   0,00173195	   -­‐1,78354	  
Rnu2-­‐10	   	   0,00269842	   -­‐1,72149	  
Enpp2	   	   0,00898319	   -­‐1,6902	  
Rnu2-­‐10	   	   0,00276675	   -­‐1,68464	  
Nr2f2	   	   0,00307328	   -­‐1,67239	  
Stoml3	   	   0,0336009	   -­‐1,66704	  
Snora16a	   	   0,0000892206	   -­‐1,64797	  
Rnu12	   	   0,00437322	   -­‐1,63890	  
	  





4.5.4.1	   Prenatal	   immune	   activation	   impacts	   different	   biological	   functions	   important	   for	  
nervous	  system	  development	  and	  function	  Once	   again,	   after	   the	  microarray	   analysis,	  we	   ran	   a	   pathway	   analysis	   using	   Ingenuity	  Pathways	  Analysis	  software	  (IPA).	  In	  Table	  13,	  we	  report	  the	  5	  most	  affected	  pathways	  that	  were	  significantly	  regulated	  by	  prenatal	  immune	  activation	  (p	  <	  0.05).	  They	  include	  G	   protein-­‐coupled	   receptor	   signalling	   and	   cAMP-­‐dependent	   signalling,	   which	   we	   also	  found	   enriched	   in	   the	   prefrontal	   cortex.	   This	   could	   be	   particularly	   relevant	   as	   these	  signalling	   pathways	   are	   considered	   necessary	   for	   many	   living	   organisms	   and	   life	  processes	  and	  mediate	  many	  different	  cell	  responses.	  The	  changes	  we	  observed	  are	  also	  associated	  with	  serotonin	  receptor	  signalling	  and	  ERK5	  signalling.	  Extracellular	  signal-­‐regulated	   kinase	   5	   (ERK5)	   is	   the	   most	   recently	   identified	   member	   of	   the	   mitogen-­‐activated	  protein	  kinase	  (MAPK)	   family	  and	   it	   is	  activated	  by	  a	  variety	  of	  extracellular	  stimuli,	   for	   instance	  cellular	  stresses	  and	  growth	  factors,	  and	  regulates	  processes	  such	  as	  cell	  proliferation	  and	  differentiation.	  	  Secondly,	   we	   analysed	   our	   results	   also	   in	   terms	   of	   the	   functional	   networks	  affected	   by	   the	   gene	   expression	   changes	   induced	   by	   prenatal	   immune	   activation.	  Interestingly,	   the	   main	   affected	   networks	   were	   again	   relevant	   to	   developmental	  processes	   important	   for	   nervous	   system	   development	   and	   function,	   cell	   and	   tissue	  development	   and	   embryonic	   development	   (Table	   14).	   The	   most	   relevant	   network,	  namely	   nervous	   system	   development	   and	   function,	   is	   also	   graphically	   represented	   in	  






Top	  Canonical	  pathways	  
Name	   	   p-­‐value	   Ratio	  	    	   	  
G-­‐Protein	  Coupled	  Receptor	  Signalling	   	   2.23E-­‐04	   12/276	  
	   	   	   (0.043)	  
cAMP-­‐mediated	  Signalling	   	   8.83E-­‐04	   10/226	  
	   	   	   (0.044)	  
Serotonin	  Receptor	  Signalling	   	   1.00E-­‐02	   3/49	  
	    	   (0.061)	  
ERK5	  Signalling	    1.12E-­‐02	   4/68	  
	    	   (0.059)	  
Acyl	  Carrier	  Protein	  Metabolism	    1.36E-­‐02	   1/6	  	    	   (0.167)	  
	   	   	   	  	  






ID	  Associated	  Network	  Functions	   	   	   Score	  	    	   	  Nervous	   System	   development	   and	   function,	   Tissue	   development,	  Neurological	  disease	   	   	   46	  	   	   	   	  Cell	   development,	   Embryonic	   development,	  Nervous	   System	  development	  and	  function	   	   	   44	  	   	   	   	  Cellular	   assembly	   and	   organization,	   Cellular	   compromise,	   Cardiovascular	  disease	   	   	   36	  	    	   	  Gastrointestinal	  disease,	  Lipid	  metabolism,	  Small	  molecule	  biochemistry	    	   34	  	    	   	  Neurological	  disease,	  Psychological	  disorders,	  Behaviour	    	   27	  	    	   	  
	   	   	   	  
	  
Table	  14.	  Selected	  top	   five	   implicated	  networks	   in	  the	  prefrontal	  cortex	  and	  the	  related	  
level	  of	  involvement	  (score).	  	  	  





Nervous	  System	  Development	  and	  Function	  
	  
	  
Figure	   30.	   Graphical	   representation	   of	   nervous	   system	   development	   network	   in	   the	  
Poly(I:C)	  Nucleus	  Accumbens	  by	  Ingenuity	  system.	  In	  green	  down-­‐regulated	  genes,	  in	  red	  the	  up-­‐regulated	  ones.	  
	  
	  

















Figure	  31.	  Venn	  diagram	  of	  the	  overlap	  of	  changes	  observed	  in	  the	  prefrontal	  cortex	  and	  






Gene	   Fold	  Change	  in	  PFC	   Fold	  Change	  in	  NAc	  Snord87	  	   	   	  Cryge	   	   	  Gm11362	   	   	  Mobp	   	   	  Cldn11	   	   	  Opalin	   	   	  Mal	   	   	  Mag	   	   	  Mog	   	   	  Cabp7	   	   	  Gstm6	   	   	  Trf	   	   	  Gm98	   	   	  Bcas1	   	   	  Prelp	   	   	  Nxph3	   	   	  Cspp1	   	   	  Taf1d	   	   	  Cdh12	   	   	  Mir690	   	   	  Mir539	   	   	  Mir134	   	   	  Mir369	   	   	  D930030D11Rik	   	   	  Mir300	   	   	  Mir382	   	   	  Npas4	   	   	  
	  





After	   having	   performed	   the	   overlap,	   we	   ran	   an	   Ingenuity	   Pathways	   Analysis	   and	  reported	  the	  canonical	  pathways	  over	  represented	  in	  these	  27	  common	  genes.	  Different	  pathways	  are	  significantly	  regulated	  in	  both	  areas.	  As	  shown	  in	  Table	  16,	  the	  first	  one	  is	  the	   Notch	   signalling	   pathway,	   important	   for	   cell-­‐cell	   communication,	   which	   involves	  gene	  regulation	  mechanisms	  that	  control	  multiple	  cell	  differentiation	  processes	  during	  embryonic	   and	   adult	   life.	   Notch	   signalling	   also	   plays	   a	   role	   in	   neuronal	  function	   and	  development.	   Moreover,	   the	   common	   genes	   were	   enriched	   in	   the	   G	   protein	   subunit	  receptor	  signalling,	  and	  in	  Liver	  X	  receptors	  (LXR)	  activation,	  which	  play	  a	  critical	  role	  in	  gene	  transcription,	  lipid	  synthesis	  and	  barrier	  formation.	  We	  then	  performed	  a	  network	  analysis	   to	   study	   the	   common	  biological	   processes	   affected	   in	   the	   Poly(I:C)	  model.	   As	  shown	  in	  Table	  17,	  neurological	  disease	  (graphically	  represented	  in	  Fig	  32)	  and	  cellular	  dysfunction	  are	  the	  most	  significantly	  altered	  networks.	  	  Lastly,	   we	   analysed	   in	   detail	   the	   precise	   cellular	   functions	   and	   networks	   that	  were	   associated	  with	   neurological	   disease.	   Among	   others,	  myelination	   resulted	   as	   the	  most	  affected	  function	  associated	  with	  neurological	  disease.	  In	  particular,	  we	  observed	  that	   Poly(I:C)	   exposure	   affects	   the	   expression	   of	   three	   main	   genes	   involved	   in	  myelination	   both	   in	   the	   prefrontal	   cortex	   and	   in	   the	   nucleus	   accumbens:	   myelin	   and	  lymphocyte	   protein	   (MAL),	   myelin-­‐associated	   glycoprotein	   (MAG)	   and	   myelin-­‐associated	   oligodendrocytic	   basic	   protein	   (MOBP).	   Because	   of	   this	   evidence	   and	   the	  importance	   of	   myelination	   for	   the	   correct	   functioning	   of	   the	   nervous	   system,	   we	  validated	  these	  genes,	  together	  with	  other	  genes	  associated	  with	  myelination,	  with	  qRT-­‐PCR	  analysis.	  	  





Top	  Canonical	  Pathways	  
Name	   	   p-­‐value	   Ratio	  	    	   	  
Notch	  Signalling	   	   2.35E-­‐02	   1/43	  
	   	   	   (0.023)	  
Gα12/13	  Signalling	   	   7.15E-­‐02	   1/127	  
	   	   	   (0.008)	  
LXR/RXR	  Activation	   	   7.32E-­‐02	   1/139	  
	    	   (0.007)	  
Tight	  Junction	  Signalling	    9.17E-­‐02	   1/167	  
	    	   (0.006)	  
Acute	  Phase	  Response	  Signalling	    1.01E-­‐01	   1/181	  	    	   (0.006)	  
	   	   	   	  
	  
Table	  16.	  Top	  affected	  canonical	  pathways	  common	  to	  the	  PFC	  and	  NAc.	  The	  top	  pathways	  are	  ranked	   together	  with	  p-­‐value,	  which	  specifies	   the	  statistical	  significance,	  and	   the	  ratio,	   the	  number	  of	  altered	  genes	  compared	  to	  the	  total	  number	  of	  genes	  for	  that	  specific	  pathway.	  	  
	  
Top	  Networks	  
ID	  Associated	  Network	  Functions	   	   	   Score	  	    	   	  Cellular	  compromise,	  Renal	  dysfunction,	  Neurological	  disease	   	   	   30	  	   	   	   	  Neurological	  disease,	  Drug	  metabolism,	  Molecular	  transport	   	   	   9	  
	   	   	   	  
	  
Table	  17.	  Selected	  top	  implicated	  networks	  common	  to	  the	  PFC	  and	  NAc	  and	  the	  related	  
level	  of	  involvement	  (score).	  
	  









Figure	   32.	  Neurological	   disease	   network	   common	   to	   the	   prefrontal	   cortex	   and	   nucleus	  
accumbens	  by	  Ingenuity	  system.	  
	  
	  









Figure	   33.	  Effects	   of	   the	   prenatal	  manipulation	   on	  myelination	   genes	   expression	   in	   the	  
prefrontal	   cortex.	   The	   graphs	   depict	   the	   levels	   of	   normalized	   mRNA	   expression	   in	   the	  prefrontal	  cortex	  (PF)	  assessed	  using	  qRT-­‐PCR.	  *p	  <	  0.05,	  **p	  <	  0.01	  based	  on	  T-­‐TEST.	  All	  values	  are	  means	  ±	  SEM	  of	  at	  least	  11	  animals	  per	  group	  and	  are	  expressed	  as	  %	  vs	  control	  animals.	  	  
	  
	  








Figure	   34.	  Effects	   of	   the	   prenatal	  manipulation	   on	  myelination	   genes	   expression	   in	   the	  
nucleus	   accumbens.	   The	   graphs	   depict	   the	   levels	   of	   normalized	   mRNA	   expression	   in	   the	  prefrontal	  cortex	  (PF)	  assessed	  using	  qRT-­‐PCR.	  *p	  <	  0.05,	  **p	  <	  0.01	  based	  on	  T-­‐TEST.	  All	  values	  are	  means	  ±	  SEM	  of	  at	  least	  11	  animals	  per	  group	  and	  are	  expressed	  as	  %	  vs	  control	  animals.	  	  
	  





(control	  and	  GD17),	  we	  considered	  the	  total	  time	  spent	  with	  the	  novel	  mouse	  (expressed	  in	   %	   time	   mouse)	   and	   the	   value	   of	   gene	   expression	   levels	   in	   the	   prefrontal	   cortex	  (expressed	  as	  fold	  change)	  at	  PND	  114,	  after	  the	  behavioural	  test	  performed	  at	  PDN	  92-­‐106.	  As	  shown	  in	  Fig.	  36,	  the	  correlation	  between	  the	  mRNA	  levels	  of	  each	  gene	  and	  the	  time	  spent	  with	   the	  novel	  mouse	   is	   linear	  but	   it	  does	  not	   reach	  statistical	   significance	  (MAG	  r=0,089,	  n	  =	  18,	  p	  >	  0.10;	  MAL	  r	  =	  0,372,	  n	  =	  19,	  p	  >	  0.10;	  MOBP	  r	  =	  0,055,	  n	  =	  19,	  p	  >	  0.10;	  MOG	  r	  =	  0,368,	  n	  =	  20,	  p	  >	  0.10	  Pearson’s	  correlation).	  	  	  
	  	  
Figure	   35.	   Pearson’s	   correlation	   between	   the	   social	   approach	   phase	   of	   the	   social	  
interaction	   test	   and	   the	   gene	   expression	   in	   the	   prefrontal	   cortex.	   The	   figure	   shows	   the	  correlation	  analysis	  between	  the	  social	  approach	  phase	  of	   the	  social	   interaction	   test	  and	  MAG,	  MAL,	   MOBP,	   MOG	   mRNA	   expression	   levels	   in	   the	   prefrontal	   cortex	   of	   control	   and	   Poly(I:C)	  exposed	   mice.	   Each	   dot	   represents	   the	   intersection	   between	   the	   %	   time	   spent	   with	   the	   live	  mouse	  and	  the	  level	  of	  mRNA	  expression	  levels	  (as	  fold	  change).	  







Figure	  36.	  Pearson’s	  correlation	  between	  recognition	  phase	  of	  the	  social	  interaction	  and	  
the	   gene	   expression	   in	   the	   prefrontal	   cortex.	   The	   figure	   shows	   the	   correlation	   analysis	  between	   the	   social	   approach	   phase	   of	   the	   social	   interaction	   test	   and	  MAG,	  MAL,	  MOBP,	  MOG	  mRNA	  expression	  levels	  in	  the	  prefrontal	  cortex	  of	  control	  and	  Poly(I:C)	  exposed	  mice.	  Each	  dot	  represents	   the	   intersection	  between	   the	   value	   of	  %	   time	   spent	  with	   the	  novel	  mouse	   and	   the	  level	  of	  mRNA	  expression	  (as	  fold	  change).	  





0,303,	  n	  =	  20,	  p	  >	  0.10;	  MOG	  r	  =	  0,149,	  n	  =	  19,	  p	  >	  0.10	  Pearson’s	  correlation);	  while	  MAG	  and	  MOBP	  gene	  expression	  showed	  a	  statistically	  significant	  direct	  correlation	  with	  the	  %	  time	  spent	  with	  the	  live	  mouse	  (MAG	  r	  =	  0,465,	  n	  =	  19,	  p	  <	  0.05;	  MOBP	  r	  =	  0,474,	  n	  =	  19,	  p	  <	  0.05	  Pearson’s	   correlation).	  These	   findings	   suggest	   that	   reduced	  expression	  of	  these	   genes	   in	   animals	   exposed	   to	   prenatal	   maternal	   immune	   activation	   could	   be	  associated	  with	  impaired	  social	  behaviour.	  Lastly,	  we	  explored	  the	  correlation	  between	  the	   recognition	   phase	   of	   the	   social	   interaction	   test	   with	   the	  mRNA	   levels	   of	   the	   four	  myelination	   genes	   in	   the	   nucleus	   accumbens.	   Fig.	   38	   depicts	   this	   correlation.	   In	  particular,	   the	   Pearson’s	   correlation	   is	   statistically	   significant	   only	   when	   considering	  MOBP	  gene	  expression	  levels	  (MOBP	  r	  =	  0,476,	  n	  =	  19,	  p	  <	  0.05	  Pearson’s	  correlation).	  The	  direct	  correlation	  suggests	  that	  reduced	  expression	  of	  this	  gene	  in	  animals	  exposed	  to	  prenatal	  maternal	  immune	  activation	  could	  be	  directly	  associated	  with	  alterations	  in	  social	  recognition.	  The	  others	  correlation	  do	  not	  reach	  statistical	  significance	  (MAG	  r	  =	  0,285,	  n	  =	  19,	  p	  >	  0.10;	  MAL	  r	  =	  0,342,	  n	  =	  20,	  p	  >	  0.10;	  MOG	  r	  =	  0,185,	  n	  =	  19,	  p	  >	  0.10	  Pearson’s	  correlation).	  	  







Figure	  37.	  Pearson’s	  correlation	  between	  approach	  phase	  of	  the	  social	  interaction	  and	  the	  
gene	   expression	   in	   the	   nucleus	   accumbens.	   The	   figure	   shows	   the	   correlation	   analysis	  between	   the	   social	   approach	   phase	   of	   the	   social	   interaction	   test	   and	  MAG,	  MAL,	  MOBP,	  MOG	  mRNA	  expression	  levels	  in	  the	  nucleus	  accumbens	  of	  control	  and	  Poly(I:C)	  exposed	  mice.	  Each	  dot	  represents	  the	  intersection	  between	  the	  value	  of	  %	  time	  spent	  with	  the	  live	  mouse	  and	  the	  level	  of	  mRNA	  expression	  levels	  (expressed	  as	  fold	  change).	  Pearson’s	  correlation	  coefficient:	  MAG	  r	  =	  0.465,	  p	  <	  0.05;	  MOBP	  r	  =	  0,474,	  p	  <	  0.05.	  
	  
	  







Figure	  38.	  Pearson’s	  correlation	  between	  recognition	  phase	  of	  the	  social	  interaction	  and	  
the	   gene	   expression	   in	   the	   nucleus	   accumbens.	   The	   figure	   shows	   the	   correlation	   analysis	  between	   the	   social	   approach	   phase	   of	   the	   social	   interaction	   test	   and	  MAG,	  MAL,	  MOBP,	  MOG	  mRNA	  expression	  levels	  in	  the	  nucleus	  accumbens	  of	  control	  and	  Poly(I:C)	  exposed	  mice.	  Each	  dot	  represents	  the	  intersection	  between	  the	  value	  of	  %	  time	  spent	  with	  the	  novel	  mouse	  and	  the	  level	   of	  mRNA	   expression	   levels	   (expressed	   as	   fold	   change).	   Pearson’s	   correlation	   coefficient:	  MOBP	  r	  =	  0,476,	  n	  =	  19,	  p	  <	  0.05.	  
	  
	  





4.5.8	  Discussion	  The	  aim	  of	  this	  study	  was	  to	  investigate	  the	  underlying	  molecular	  phenotypes	  that	  could	  mediate	  the	  association	  between	  prenatal	  Poly(I:C)	  exposure	  and	  long-­‐term	  behavioural	  abnormalities,	   and	   to	   do	   so	   we	   chose	   an	   unbiased	   genome-­‐wide	   based	   approach	   to	  analyse	   the	   transcription	   profile	   of	   different	   brain	   regions	   implicated	   in	   psychiatric	  disorders.	  In	  particular,	  we	  performed	  Affimetrix	  microarray	  analysis	  on	  the	  prefrontal	  cortex	  and	  the	  nucleus	  accumbens	  of	  adult	  GD17	  Poly(I:C)	  offspring,	  two	  brain	  that	  are	  pivotal	   in	  mediating	  many	  aspects	  of	  psychiatric	  disease.	  Moreover,	  before	  performing	  the	  microarray	   analysis,	  we	   subjected	   the	   animals	   to	   a	  battery	  of	   behavioural	   tests	   to	  confirm	   the	   effectiveness	   of	   the	   prenatal	   manipulation.	   Consistent	   with	   our	   previous	  results,	   Poly(I:C)	   exposed	   offspring	   displayed	   impairments	   in	   spatial	   recognition	  working	  memory	  (Richetto	  et	  al,	  2013a),	  social	  approach	  and	  recognition	  (Bitanihirwe	  
et	  al,	  2010a)	  and	   increased	  sensitivity	   to	   the	  psychostimulant	  amphetamine	  (Meyer	   et	  





infection	   (for	   a	   total	   of	   325	   affected	   genes).	   These	   genes	   are	   enriched	   in	   various	  pathways	  identified	  by	  IPA,	   including	  G	  protein-­‐coupled	  receptor	  signalling	  and	  cAMP-­‐dependent	  signalling,	  that	  were	  also	  found	  enriched	  in	  the	  prefrontal	  cortex,	  serotonin	  receptor	   signalling	   and	   ERK5	   signalling.	   Moreover,	   the	   main	   networks	   impacted	   by	  prenatal	  Poly(I:C)	  manipulation	  were	  nervous	  system	  development	  and	  function,	  which	  remains	   the	  most	   affected	  biological	   process,	   cell,	   tissue	   and	   embryonic	   development,	  neurological	   disease,	   cellular	   assembly	   and	   organization,	   lipid	   metabolism	   and	   small	  molecule	   biochemistry,	   psychological	   disorder	   and	   behaviour.	   The	   large	  magnitude	   of	  changes	   seen	   in	   Poly(I:C)	   offspring	   suggests	   that	   infection	   during	   late	   pregnancy	  may	  determine	  many	  effects	  in	  the	  exposed	  animals,	  which	  may	  contribute	  to	  the	  enhanced	  risk	  for	  the	  development	  of	  neurodevelopmental	  psychiatric	  disorders.	  In	  particular,	  our	  findings	   point	   to	   an	   effect	   of	   prenatal	   infection	   on	   the	   correct	   development	   and	  functioning	  of	  the	  nervous	  system,	  which	  is	  in	  line	  with	  the	  neurodevelopmental	  nature	  of	  this	  model.	  	   Our	   results	   are	   also	   in	   line	   with	   previous	   studies	   investigating	   alterations	   in	   the	  brain	  transcriptome	  that	   is	  manifested	  after	  prenatal	   immunological	  activation.	  Fatemi	  and	  colleagues	  investigated	  the	  effects	  of	  prenatal	  infection	  with	  influenza	  virus	  on	  GD9	  in	   mice	   on	   the	   transcription	   profile	   of	   newborn	   offspring.	   Interestingly,	   they	   also	  observed	   that	   the	   impacted	   genes	   were	   involved	   in	   signal	   transduction,	   cell	  communication,	   protein	   metabolism,	   cell	   growth	   and	   immune	   response,	   leading	   to	  permanent	   changes	   in	   brain	   structure	   and	   functions	   and	   increasing	   the	   risk	   for	  schizophrenia	  (Fatemi	  et	  al,	  2005).	  These	  initial	  findings	  were	  confirmed	  and	  amplified	  by	   more	   microarray	   analyses	   on	   the	   hippocampus	   and	   the	   prefrontal	   cortex	   of	   mice	  prenatally	  exposed	  to	  the	  human	  influenza	  virus	  at	  embryonic	  day	  7,	  16	  and	  18	  (Fatemi	  




















defects	   have	   been	   observed	   in	   the	   central	   nervous	   system	   of	   MAG-­‐deficient	   mice	  (Montag	   et	   al,	   1994;	   Schachner	  and	  Bartsch,	  2000),	  including	  delayed	  myelination	  and	  hypomyelination	  (Bartsch	  et	  al,	  1997).	  This	  mouse	  model	  has	  morphologically	  atypical	  myelin	   sheaths,	   lacks	   a	  well-­‐developed	   cytoplasmic	   collar,	   contains	   redundant	  myelin	  and	  uncompact	  areas	  of	  myelin	  and	  has	  periaxonal	  zones	  of	  degeneration	  and	  dystrophy	  of	  distal	  oligodendryte	  processes.	  Further	  support	  to	  the	  notion	  that	  myelination	  could	  be	   implicated	   in	   the	   pathophysiology	   of	   schizophrenia	   is	   derived	   by	   the	   fact	   that	   the	  temporal	  onset	  of	  psychotic	  disorders	   in	   late	  adolescence	  or	  early	  adulthood	  coincides	  with	  the	  concluding	  myelination	  of	  the	  prefrontal	  cortex	  (Tamnes	  et	  al,	  2010)	  and	  other	  areas.	  Benes	  observed	   that	  preexisting	  defects,	   like	  genetic	  predisposition	  or	  acquired	  prenatal	   insults,	   could	   remain	   dormant	   until	   changes	   in	   myelination	   mechanisms	  become	  manifest	  during	   the	   late	  adolescent	  period	   (Benes,	  1989).	   Such	  changes	  could	  involve,	   for	   example,	   increased	   myelination	   of	   certain	   pathways	   that	   mediate	  performance	   of	   delayed	   response	   tasks.	   Our	   study	   also	   supports	   the	   association	  between	   social	   impairments	   in	   schizophrenia	   and	   alterations	   in	   myelination.	   In	  particular,	   our	   correlation	   analysis	   revealed	   a	   significant	   association	   between	   gene	  expression	   levels	   of	   MOBP	   and	   MAG	   in	   the	   nucleus	   accumbens	   and	   the	   animals’	  performance	  during	  the	  social	   interaction	  tests.	   In	  detail,	   the	  down	  regulation	  of	   these	  genes	  is	  correlated	  with	  reduced	  social	  approach	  and	  social	  recognition,	  respectively.	  A	  similar	  association	  was	  observed	  by	  Makinodan	  et	  al,	  who	   investigated	   if	  and	  how	   life	  experiences	   influence	  central	  nervous	  system	  myelination	  and	   function	  (Makinodan	   et	  





contribute	  to	  the	  deficits	  in	  many	  behavioural	  functions	  (Vijayraghavan	  et	  al,	  2007).	  In	  line	  with	   these	   results,	   our	   study	   points	   to	   the	   possibility	   that	   insults	   during	   another	  critical	   period,	   namely	   neurodevelopment,	   could	   also	   alter	   correct	   myelination	   and	  consequently	   social	   behaviour.	   Regarding	   the	   association	   between	   social	   impairments	  and	   MOBP	   expression	   levels,	   a	   myelin-­‐associated	   oligodendrocytic	   basic	   protein	   that	  plays	   a	   role	   in	   the	   stabilization	   of	  myelin	   sheaths	   (Montague	   et	   al,	   2006),	   little	   is	   yet	  known,	  and	  to	  our	  knowledge	  this	  is	  the	  first	  report	  of	  such	  correlation.	  Future	  studies	  are	  thus	  warranted	  to	  dissect	  these	  findings.	  	  In	  summary,	  our	  study	  provides	  support	   to	   the	  notion	  that	  prenatal	   infection	   is	  capable	  of	   inducing	   alterations	   in	   the	   expression	   levels	  of	   various	   genes	   implicated	   in	  myelination,	  strengthening	  the	  hypothesis	  of	  a	  causal	   link	  between	  this	  prenatal	   insult	  and	   the	   emergence	   of	   neurodevelopmental	   disorders	   such	   as	   schizophrenia.	  Additionally,	   the	   alterations	   we	   observed	   regarding	   myelination	   correlate,	   at	   least	   in	  part,	   with	   the	   behavioural	   alterations	   we	   observed	   in	   our	   animals,	   underlining	   the	  possible	   implication	   of	   myelinations	   deficits	   in	   many	   symptoms	   observed	   in	  schizophrenic	   patients.	   The	   Poly(I:C)	   maternal	   manipulation	   model	   could	   thus	   be	  considered	  as	  an	  important	  tool	  for	  investigating	  these	  myelin-­‐related	  changes.	  Indeed,	  our	   molecular	   results	   are	   consistent	   with	   the	   gene	   expression	   alterations	   changes	  observed	   human	   schizophrenic	   subjects	   (Hakak	   et	   al,	   2001).	   Confirmation	   of	   our	  findings,	   together	  with	   the	   analysis	   of	   different	   brain	   regions	   and	   different	   phases	   of	  nervous	   system	  development	   in	   follow-­‐up	   studies,	  may	   increase	   the	  knowledge	  of	   the	  disease	   pathogenesis	   and	   advance	   causative	   and	   diagnostic	   understanding	   of	   this	  psychotic	   disorder.	   Investigating	   the	   role	   of	   disrupted	  myelination	  processes	   in	   depth	  could	   thus	  provide	  new	   insights	   into	   the	  pathophysiology	  of	   schizophrenia,	   leading	   to	  the	   identification	   of	   novel	   targets	   for	   therapeutic	   intervention	   aimed	   at	   reversing	  underlying	  molecular	  abnormalities	  and	  eventually	  improving	  clinical	  outcomes.	  
	  





5.	  	  SUMMARY	  AND	  CONCLUSIONS	  
	  
	  All	   in	  all,	   the	  studies	  conducted	  during	  my	  PhD	  add	  substantial	  preclinical	  evidence	  to	  the	  hypothesis	  that	  prenatal	  infection	  can	  confer	  increased	  risk	  for	  the	  development	  of	  psychiatric	   disease	  by	   interfering	  with	  normal	   brain	   and	  behavioural	   development.	   In	  particular,	   we	   demonstrated	   that	   prenatal	   treatment	   with	   poly(I:C)	   during	   the	   late	  phase	  of	  gestation	  (GD17)	  induces	  a	  variety	  of	  molecular	  and	  behavioural	  abnormalities	  that	  are	  relevant	  to	  various	  psychiatric	  disorders,	  and	  in	  particular	  schizophrenia.	  	  Indeed,	   we	   found	   that	   late	   prenatal	   infection	   induces	   a	   wide	   spectrum	   of	  abnormalities	   in	   the	   GABAergic	   system	   that	   are	  more	   pronounced	   in	   adult	   compared	  with	  peripubertal	  offspring	  born	  to	  immune-­‐challenged	  mothers.	  These	  included	  altered	  mRNA	  expression	  levels	  of	  enzymes	  regulating	  γ-­‐aminobutyric	  acid	  (GABA)	  biosynthesis	  (glutamic	  acid	  decarboxylase	  65-­‐kDa	  [GAD65]	  and	  GAD67),	  vesicular	  GABA	  transporter	  (VGAT),	  alpha-­‐subunits	  of	  the	  GABA(A)	  receptor	  (α2,	  α3,	  α4,	  and	  α5),	  and	  the	  chloride	  transporters	   sodium-­‐potassium-­‐chloride	   cotransporter	   1	   and	   potassium-­‐chloride	  cotransporter	   2.	   Intriguingly,	   these	   age-­‐dependent	   changes	   in	   GABAergic	   gene	  expression	   were	   paralleled	   by	   an	   adult	   onset	   of	   working	   memory	   deficiency,	  emphasizing	   a	   critical	   impact	   of	   prenatal	   immune-­‐related	   insults	   on	   long-­‐term	  GABAergic	   changes	   relevant	   to	   neuropsychiatric	   disorders	   with	   prenatal	   infectious	  aetiologies,	  especially	  for	  those	  with	  delayed	  onset	  in	  early	  adulthood.	  










various	  functional	  processes	  that	  could	  underlie	  the	  behavioural	  phenotype	  induced	  by	  the	   prenatal	   immunological	   manipulation.	   Interestingly,	   when	   performing	   an	   overlap	  between	   the	   changes	   observed	   in	   the	   prefrontal	   cortex	   and	   nucleus	   accumbens,	  myelination	   highlights	   as	   the	   main	   function	   impacted	   by	   these	   common	   alterations,	  suggesting	   that	   abnormalities	   in	   this	   process	   could	   be	   of	   pivotal	   importance	   in	  mediating	   the	  deleterious	  effects	  of	  prenatal	  poly(I:C).	   In	   line	  with	   this	  hypothesis,	  we	  show	   that	   gene	   expression	   changes	   in	   myelin	   markers	   positively	   correlate	   with	   the	  severity	  of	  the	  behavioural	  alterations	  observed	  in	  our	  animals.	  	   	  	   In	  conclusion,	  the	  results	  obtained	  during	  my	  PhD	  thesis	  broaden	  the	  knowledge	  regarding	   the	   association	   between	   prenatal	   immune	   activation	   and	   increased	   risk	   of	  developing	   psychopathology	   later	   in	   life.	   In	   particular,	   we	   focused	   on	   dissecting	   the	  molecular	   consequences	   of	   such	   manipulation,	   as	   information	   on	   this	   aspect	   of	   the	  model	  is	  still	  somewhat	  lacking.	  Our	  results	  point	  to	  a	  strong	  implication	  of	  GABAergic	  system	   abnormalities	   in	   the	   behavioural	   and	   cognitive	   alterations	   induced	   by	   late	  prenatal	  immune	  activation,	  even	  if	  pharmacological	  interventions	  directly	  targeting	  the	  GABAergic	   system	   proved	   useful	   in	   correcting	   only	   some	   of	   such	   abnormalities.	  Interestingly,	   the	   genome-­‐wide	   approach	   shed	   light	   onto	   a	   wide	   array	   of	   different	  molecular	   mechanism	   associated	   with	   prenatal	   poly(I:C)	   exposure,	   and	   subsequent	  studies	   are	   definitely	   warranted	   to	   follow	   up	   and	   characterize	   these	   findings.	   In	  particular,	  our	  results	  point	  to	  a	  possible	  role	  of	  myelination	  in	  mediating	  the	  negative	  effects	   of	   prenatal	   infection,	   and	   this	   aspect	   definitely	   needs	   to	   be	   pursued	   with	  appropriate	  MRI	  and	  imaging	  studies.	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